WO2014141232A1 - Multi-component stent-graft system for aortic dissections - Google Patents
Multi-component stent-graft system for aortic dissections Download PDFInfo
- Publication number
- WO2014141232A1 WO2014141232A1 PCT/IL2014/050174 IL2014050174W WO2014141232A1 WO 2014141232 A1 WO2014141232 A1 WO 2014141232A1 IL 2014050174 W IL2014050174 W IL 2014050174W WO 2014141232 A1 WO2014141232 A1 WO 2014141232A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stent
- graft
- module
- main
- proximal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/856—Single tubular stent with a side portal passage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/89—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/061—Blood vessels provided with means for allowing access to secondary lumens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/075—Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0013—Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0039—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/006—Additional features; Implant or prostheses properties not otherwise provided for modular
Definitions
- the present application relates generally to prostheses and surgical methods, and specifically to tubular prostheses, including endovascular grafts and stent-grafts, and surgical techniques for using the prostheses to maintain patency of body passages such as blood vessels, and treating dissections of arterial walls and/or aneurysms.
- Blood vessels occasionally weaken or even rupture.
- the vascular wall can weaken or tear, resulting in dangerous conditions such as aneurysm and dissection.
- Treatment of such conditions can be performed by implanting a prosthesis within the vascular system using minimally-invasive surgical procedures.
- An endoluminal prosthesis typically includes one or more stents affixed to graft material and is delivered to the treatment site by endovascular insertion. Once the endoluminal prosthesis is radially enlarged, it should remain in place indefinitely by self-attachment to the vessel wall, acting as a substitute vessel for the flow of blood or other fluids.
- Aortic dissection is a tear or partial tear in the inner wall of the aorta, which causes blood to flow between the layers of the wall of the aorta, forcing the layers apart.
- Aortic dissections may be divided into two types in accordance with the Stanford classification: Type A dissections involve the ascending aorta and/or aortic arch, and possibly the descending aorta.
- Type B dissections involves the descending aorta or the arch (distal to right brachiocephalic artery origin), without involvement of the ascending aorta.
- a multi-component stent-graft system for treating a Type B aortic dissection.
- the system is configured to be deployed in the thoracic aorta and the left subclavian artery, and, optionally, the left common carotid artery.
- the stent-grafts of the system are assembled in situ to accommodate the dimensions of the particular patient's anatomy, generally without requiring prior customization of the stent-grafts or in situ modifications to the stent-grafts, which might be expensive and/or complex.
- the multi- component stent-graft system defines a blood-flow path from the ascending aorta, over the aortic arch, and to the descending aorta.
- the multi-component stent-graft system additionally provides or allows blood-flow paths to the three branches of the aortic arch.
- the multi-component stent-graft system comprises a main module and, for some applications, a secondary module.
- the main module comprises a generally tubular main stent-graft
- the secondary module comprises a non-bifurcated secondary stent-graft.
- the stent-grafts are configured to assume radially-compressed states for delivery, and radially-expanded states upon being deployed.
- the main stent-graft typically comprises a main generally tubular support element and a main covering element that is attached to and at least partially covers the main support element.
- the support element typically comprises a plurality of main structural stent elements.
- the main structural stent elements are arranged as a plurality of circumferential stent springs.
- the main covering element and the main support element are shaped so as to together define a lateral fenestration, e.g., exactly one lateral fenestration, through the main stent-graft, when the main stent-graft is unconstrained in its radially-expanded state.
- a first perimeter of a distal main-module end of the main stent- graft (and the main module) is greater than a second perimeter of a proximal main-module end of the main stent-graft (and the main module).
- the first perimeter may equal at least 150% of the second perimeter, such as at least 200%, at least 250%, at least 300%, or at least 400% of the second perimeter.
- the main stent-graft is sized and configured to positioned such that (a) a distal, radially larger, descending-aorta axial portion of the stent-graft, including the distal main-module end thereof, is disposed in the aorta downstream from the bifurcation with the left subclavian artery, at least partially in the upper part of the descending aorta, (b) a proximal, radially smaller, supra-arch axial portion of the main stent-graft, including the proximal main-module end thereof, is disposed in the left subclavian artery, and (c) an arch axial portion, axially between the descending-aorta axial portion and the supra-arch axial portion, is disposed in the aortic arch.
- the main stent-graft when the main stent-graft is unconstrained in its radially- expanded state, the main stent-graft includes a dissection-reinforcement axial portion, which (a) includes a portion of the main structural stent elements, (b) has a proximal dissection-reinforcement end that is disposed along the stent-graft no more than 20 mm proximal to the proximal fenestration end, and/or (c) extends along the stent-graft for a distance equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end.
- the dissection-reinforcement axial portion has a radial strength that is at least 10% greater than an average radial strength of the entire main stent-graft. This greater strength increases the force that the dissection-reinforcement axial portion applies to a tear of the aortic dissection, thereby sealing the tear. (It is noted that providing the entire length of the main stent-graft with a high strength has at least two drawbacks: stent-grafts with higher strengths are more difficult to deploy, and are more likely to cause damage to the vasculature.)
- the dissection- reinforcement axial portion is configured to be generally straight when the main stent- graft is unconstrained in the radially-expanded state.
- the main structural stent elements of the dissection- reinforcement axial portion are arranged as a plurality of circumferential stent springs of the dissection-reinforcement axial portion.
- a height, measured axially along the main stent-graft, of at least one of the stent springs of the dissection- reinforcement axial portion varies by less than 10% around a circumference of the stent spring when the main stent-graft is unconstrained in the radially-expanded state.
- the portion of structural stent elements included by the dissection-reinforcement axial portion is a first portion of the structural stent elements, and when the stent-graft is unconstrained in the radially-expanded state: (a) the main stent-graft includes a distal-end axial portion, which includes a second portion of the structural stent elements, (b) the distal-end axial portion axially extends along the stent- graft from the distal main-module end for a distance equal to between 5% and 32% of a greatest perimeter of the main stent-graft distally to a distal end of the lateral fenestration, and (c) the distal-end axial portion has a radial strength that is at least a 10% greater than the average radial strength of the entire main stent-graft.
- the dissection-reinforcement axial portion includes a first plurality of the stent springs
- the main stent-graft includes a distal axial portion, which includes a second plurality of the stent springs.
- the distal axial portion is disposed along the main stent-graft distal and axially adjacent to the distal dissection-reinforcement end, and extends along the main stent-graft for a distance equal to between 5% and 32% of the greatest perimeter of the main stent-graft distally to the distal fenestration end.
- the distal axial portion extends to and reaches the distal main-module end.
- the stent springs have respective average heights, measured axially along the main stent-graft (the height of each stent spring is averaged circumferentially around the stent-graft).
- An average of the average heights of the first plurality of the stent springs is less than 75% of the average height of a proximal-most one of the second plurality of the stent springs.
- the dissection-reinforcement axial portion is typically configured to be generally straight when the main stent-graft is unconstrained in the radially-expanded state.
- the secondary stent-graft typically comprises a secondary generally tubular support element and a secondary covering element that is attached to and at least partially covers the secondary support element.
- the support element typically comprises a plurality of secondary structural stent elements.
- the secondary module is shaped so as to define a proximal secondary -module end, a sealing interface distal to the proximal secondary-module end, and a central longitudinal axis therebetween.
- the sealing interface is sized and configured to form a blood-impervious seal with the lateral fenestration of the main module;
- the secondary module is shaped so as to define a distal secondary-module end
- the secondary covering element is shaped so as to define at least one lateral opening that begins at and extends from the proximal secondary-module end toward the sealing interface along the central longitudinal axis for a distance equal to at least 50% of a greatest width of the secondary module, measured perpendicular to the central longitudinal axis.
- At least one of the secondary structural stent elements traverses the lateral opening when the secondary module is unconstrained in the radially- expanded state thereof. Such traversal may provide additional structural strength to the secondary module at the lateral opening.
- another configuration of secondary module is provided.
- the secondary module when the secondary module is unconstrained in the radially-expanded state thereof:
- the at least one lateral opening includes at least first and second lateral openings
- the secondary covering element is shaped so as to define the first and second lateral openings, each of which begins at and extends from the proximal secondary-module end toward the sealing interface along the central longitudinal axis for the distance equal to at least 50% of the greatest width of the secondary module;
- first and second lateral openings face in different first and second radial directions extending from the central longitudinal axis
- the first and the second lateral openings at least partially axially overlap along the central longitudinal axis.
- the first and the second lateral openings axially coincide along the central longitudinal axis.
- the first and the second radial directions are opposite each other; in other words the first and second lateral openings face in radially-opposite directions.
- further alternative configurations of secondary module are provided.
- the secondary covering element is shaped so as to define at least one secondary-module lateral fenestration disposed distal to the proximal secondary-module end and proximal to the sealing interface, and (b) a greatest axial length of the secondary-module lateral fenestration equals at least 33% of the first perimeter of the distal main-module end of the main stent-graft of the main module, when the main module is unconstrained in the radially-expanded state thereof.
- a greatest width of the secondary-module lateral fenestration measured circumferentially around the secondary module, equals at least 16% of the first perimeter of the distal main-module end of the main stent-graft of the main module.
- the secondary module further comprises a flexible sheet, which (a) is blood- sealingly joined to a portion of the secondary border, which portion extends around at least 25% of a perimeter of the secondary border and includes a distal end of the secondary border when the secondary module is unconstrained in the radially- expanded state thereof, and (b) extends radially inward from the secondary border (toward or past the central longitudinal axis) when the secondary module is unconstrained in the radially-expanded state thereof.
- a portion of the secondary structural stent elements are attached to the flexible sheet, which facilitates the radially- inward extension of the flexible sheet from secondary border.
- apparatus including a generally tubular stent-graft, which has distal and proximal stent-graft ends and includes:
- a generally tubular support element which includes a plurality of structural stent elements
- a covering element that is attached to and at least partially covers the support element
- the covering element and the support element are shaped so as to together define a lateral fenestration having distal and proximal fenestration ends,
- a first perimeter of the distal stent-graft end equals at least 200% of a second perimeter of the proximal stent-graft end
- the stent-graft includes a dissection-reinforcement axial portion, which (a) includes a portion of the structural stent elements, (b) has (i) a distal dissection- reinforcement end and (ii) a proximal dissection-reinforcement end that is disposed along the stent-graft no more than 20 mm proximal to the proximal fenestration end, (c) extends along the stent-graft for a distance equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end, and (d) has a radial strength that is at least 10% greater than an average radial strength of the entire stent-graft.
- a dissection-reinforcement axial portion which (a) includes a portion of the structural stent elements, (b) has (i) a distal dissection- reinforcement end and (ii) a proximal dissection-re
- the portion of the structural stent elements included by the dissection- reinforcement axial portion is a first portion of the structural stent elements
- the stent-graft includes a distal-end axial portion, which includes a second portion of the structural stent elements, and
- the distal-end axial portion axially extends along the stent-graft from the distal end of stent-graft for a distance equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end, and
- the distal-end axial portion has a radial strength that is at least a 10% greater than the average radial strength of the entire stent-graft.
- an axial length of the dissection-reinforcement axial portion is between 1 and 3 cm when the stent-graft is unconstrained in the radially- expanded state.
- the proximal dissection-reinforcement end is disposed along the stent-graft no more proximal than the distal fenestration end when the stent- graft is unconstrained in the radially-expanded state.
- the proximal dissection-reinforcement end is disposed along the stent-graft between the distal fenestration end and the proximal fenestration end, inclusive, when the stent-graft is unconstrained in the radially-expanded state.
- a distance between the distal dissection-reinforcement end and the distal stent-graft end equals between 32% and 160% of a largest perimeter of the stent-graft when the stent-graft is unconstrained in the radially-expanded state.
- the dissection-reinforcement axial portion extends along the stent-graft for a distance equal to between 10% and 22% of a greatest perimeter of the stent-graft distally to the distal fenestration end when the stent-graft is unconstrained in the radially-expanded state.
- the first perimeter equals at least 250% of the second perimeter.
- the dissection-reinforcement axial portion may be configured to be generally straight when the stent-graft is unconstrained in the radially-expanded state.
- the structural stent elements of the dissection-reinforcement axial portion may be arranged as a plurality of circumferential stent springs, and a height, measured axially along the stent-graft, of at least one of the stent springs may vary by less than 10% around a circumference of the stent spring when the stent-graft is unconstrained in the radially-expanded state.
- the structural stent elements of the dissection-reinforcement axial portion may be arranged as a plurality of circumferential stent springs, and for each one of the stent springs, a height, measured axially along the stent-graft, of the stent spring may vary by less than 10% around a circumference of the stent spring when the stent-graft is unconstrained in the radially-expanded state.
- the first perimeter may be between 5 and 15 cm, and the second perimeter may be between 2.5 and 5.7 cm.
- the stent-graft may be shaped so as to define exactly one lateral fenestration when the stent-graft is unconstrained in the radially- expanded state.
- the lateral fenestration may be an inferior first lateral fenestration, which faces in a first radial direction, and when the main stent-graft is unconstrained in the radially-expanded state, the main covering element and the main support element may be shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction.
- apparatus including a generally tubular stent-graft, which has distal and proximal stent-graft ends and includes:
- a generally tubular support element which includes a plurality of structural stent elements arranged as a plurality circumferential stent springs;
- a covering element that is attached to and at least partially cover the support element
- the covering element and the support element are shaped so as to together define a lateral fenestration having distal and proximal fenestration ends, a first perimeter of the distal stent-graft end equals at least 200% of a second perimeter of the proximal stent-graft end,
- the stent-graft includes a dissection-reinforcement axial portion, which (a) includes a first plurality of the stent springs, (b) has (i) a distal dissection- reinforcement end and (ii) a proximal dissection-reinforcement end that is disposed along the stent-graft no more than 20 mm proximal to the proximal fenestration end, (c) extends along the stent-graft for a distance equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end, and (d) is configured to be generally straight,
- the stent-graft includes a distal axial portion, which (a) includes a second plurality of the stent springs, (b) is disposed along the stent-graft distal and axially adjacent to the distal dissection-reinforcement end, (c) extends along the stent- graft for a distance equal to between 5% and 32% of the greatest perimeter of the stent-graft distally to the distal fenestration end,
- the stent springs have respective average heights, measured axially along the stent-graft, and
- an average of the average heights of the first plurality of the stent springs is less than 75% of the average height of a proximal-most one of the second plurality of the stent springs.
- each of the average heights of the first plurality of the stent springs is less than 75% of the average heights of the proximal-most one of the second plurality of stent springs when the stent-graft is unconstrained in the radially-expanded state.
- the average of the average heights of the first plurality of the stent springs is less than 75% of the average height of a second one of the second plurality of stent springs, other than the proximal-most one of the second plurality of stent springs when the stent-graft is unconstrained in the radially-expanded state.
- the average of the average heights of the first plurality of the stent springs is less than 75% of each of the average heights of the second plurality of stent springs when the stent-graft is unconstrained in the radially-expanded state.
- the distal axial portion is configured to be generally straight when the stent-graft is unconstrained in the radially-expanded state.
- an axial length of the dissection-reinforcement axial portion is between 1 and 3 cm when the stent-graft is unconstrained in the radially- expanded state.
- the proximal dissection-reinforcement end is disposed along the stent-graft no more proximal than the distal fenestration end when the stent- graft is unconstrained in the radially-expanded state.
- the proximal dissection-reinforcement end is disposed along the stent-graft between the distal fenestration end and the proximal fenestration end, inclusive, when the stent-graft is unconstrained in the radially-expanded state.
- an axial spacing between two of the first plurality of the stent springs equals less than 10% of an average of the average heights of the two stent springs.
- the first perimeter equals at least 300% of the second perimeter.
- the dissection-reinforcement axial portion extends along the stent-graft for a distance equal to between 10% and 32% of the greatest perimeter of the stent-graft distally to the distal fenestration end when the stent-graft is unconstrained in the radially-expanded state.
- the distal axial portion extends to and reaches the distal stent-graft end.
- the average height of at least one of the first plurality of stent springs may vary by less than 10% around a circumference of the stent spring when the stent-graft is unconstrained in the radially-expanded state.
- the average height thereof may vary by less than 10% around a circumference of the stent spring when the stent-graft is unconstrained in the radially- expanded state.
- the distal axial portion when the stent-graft is in the radially-expanded state, is placed and constrained in a first curved tube having a circular cross-section and an inner diameter equal to an outer diameter of the distal axial portion, the distal axial portion experiences kinking only when at least an axial portion of the first curved tube has less than a first radius of curvature, and
- the dissection-reinforcement axial portion when the stent-graft is in the radially- expanded state, is placed and constrained in a second curved tube having a circular cross- section and an inner diameter equal to an outer diameter of the dissection-reinforcement axial portion, the dissection-reinforcement axial portion experiences kinking only when at least an axial portion of the second curved tube has less than a second radius of curvature, which second radius of curvature is at least 30% less than the first radius of curvature.
- the lateral fenestration may be an inferior first lateral fenestration, which faces in a first radial direction, and when the main stent-graft is unconstrained in the radially-expanded state, the main covering element and the main support element may be shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction.
- apparatus including a stent-graft system, which includes:
- a main module which has distal and proximal main-module ends, and includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element, wherein the main covering element and the main support element are shaped so as to together define a lateral fenestration when the main module is unconstrained in a radially-expanded state thereof; and
- a secondary module which includes a non-bifurcated secondary stent-graft, which includes (a) a secondary support element, which includes secondary structural stent elements, and (b) a secondary covering element that is attached to and at least partially covers the secondary support element,
- the secondary module is shaped so as to define (a) a proximal secondary- module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) a central longitudinal axis therebetween, wherein the sealing interface is sized and configured to form a blood -impervious seal with the lateral fenestration of the main module, and
- the secondary covering element is shaped so as to define at least one lateral opening that begins at and extends from the proximal secondary-module end toward the sealing interface along the central longitudinal axis for a distance equal to at least 50% of a greatest width of the secondary module, measured perpendicular to the central longitudinal axis.
- a greatest width of the at least one lateral opening, measured circumferentially around the secondary module, equals at least 90 degrees circumferentially around the proximal secondary-module end, the 90 degrees being measured at the sealing interface.
- At least one of the secondary structural stent elements traverses the at least one lateral opening when the secondary module is unconstrained in the radially-expanded state thereof.
- the at least one lateral opening extends from the proximal secondary-module end toward the sealing interface along at least 70% of a greatest width of the secondary module, measured perpendicular to the central longitudinal axis when the secondary module is unconstrained in the radially-expanded state thereof.
- the cross- sectional area of the secondary module measured perpendicular to the central longitudinal axis, gradually tapers from the proximal secondary-module end to the sealing interface when the secondary module is unconstrained in the radially-expanded state thereof.
- the at least one lateral opening may include at least first and second lateral openings
- the secondary covering element may be shaped so as to define the first and the second lateral openings, each of extends from the proximal secondary-module end toward the sealing interface along the central longitudinal axis for the distance equal to at least 50% of the greatest width of the secondary module, the first and the second lateral openings may face in different first and second radial directions extending from the central longitudinal axis, and
- the first and the second lateral openings may at least partially axially overlap along the central longitudinal axis.
- the first and the second lateral openings axially coincide along the central longitudinal axis.
- the first and the second radial directions are opposite each other.
- the secondary covering element is shaped so as to define two portions, which (a) extend to and reach the proximal secondary-module end, and (b) are shaped so as to define respective concave inner surfaces that face each other and the central longitudinal axis, and (c) are not joined to each other at the proximal secondary-module end.
- the at least one lateral opening may include exactly one lateral opening.
- the lateral opening faces in a first radial direction extending from the central longitudinal axis, and a portion of the secondary covering element that faces in a second radial direction opposite the first radial direction extends to and reaches the proximal secondary-module end.
- a first perimeter of the distal main- module end may equal at least 200%, e.g., at least 300%, of a second perimeter of the proximal main-module end when the main module is unconstrained in the radially- expanded state thereof.
- the lateral fenestration may be an inferior first lateral fenestration, which faces in a first radial direction,
- the main covering element and the main support element may be shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction,
- the stent-graft system may further include a generally tubular tertiary stent-graft, and
- the main and the tertiary stent-grafts may be configured such that the tertiary stent- graft forms a blood-impervious seal with the main stent-graft around the superior second lateral fenestration when the tertiary stent-graft is disposed therethrough, and the main stent-graft is in the radially-expanded state thereof and the tertiary stent-graft is in a radially-expanded state thereof.
- apparatus including a stent-graft system, which includes:
- a main module which has distal and proximal main-module ends, and includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element, wherein the main covering element and the main support element are shaped so as to together define a main-module lateral fenestration when the main module is unconstrained in a radially- expanded state thereof; and
- a secondary module which includes a non-bifurcated secondary stent-graft, which includes (a) a secondary support element, which includes secondary structural stent elements, and (b) a secondary covering element that is attached to and at least partially covers the secondary support element,
- the secondary module is shaped so as to define (a) a proximal secondary- module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) a central longitudinal axis therebetween, wherein the sealing interface is sized and configured to form a blood-impervious seal with the main-module lateral fenestration of the main module,
- the secondary covering element is shaped so as to define at least one secondary-module lateral fenestration disposed distal to the proximal secondary- module end and proximal to the sealing interface, and
- a greatest axial length of the secondary-module lateral fenestration, measured parallel to the central longitudinal axis, equals at least 33% of a first perimeter of the distal main-module end when the main module is unconstrained in the radially-expanded state thereof.
- At least one of the secondary structural stent elements traverses the secondary-module lateral fenestration.
- the greatest axial length of the secondary-module lateral fenestration equals at least 50% of the first perimeter of the distal main-module end when the secondary module is unconstrained in the radially-expanded state thereof.
- the cross- sectional area of the secondary module gradually tapers from the proximal secondary-module end to the sealing interface when the secondary module is unconstrained in the radially-expanded state thereof.
- the at least one secondary-module lateral fenestration may include exactly one secondary-module lateral fenestration.
- the secondary-module lateral fenestration faces in a first radial direction extending from the central longitudinal axis, and a portion of the secondary covering element that faces in a second radial direction opposite the first radial direction extends to and reaches the proximal secondary-module end.
- the first perimeter of the distal main- module end may equal at least 200%, e.g., at least 300%, of a second perimeter of the proximal main-module end when the main module is unconstrained in the radially- expanded state thereof.
- the secondary module may further include a flexible sheet, which (a) is blood-sealingly joined to a portion of the secondary border, which portion extends around at least 25% of a perimeter of the secondary border and includes a distal end of the secondary border when the secondary module is unconstrained in the radially-expanded state thereof, and (b) extends radially inward from the secondary border when the secondary module is unconstrained in the radially- expanded state thereof.
- a portion of the secondary structural stent elements are attached to the flexible sheet.
- the main-module lateral fenestration may be an inferior first lateral fenestration, which faces in a first radial direction,
- the main covering element and the main support element may be shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction, the stent-graft system may further include a generally tubular tertiary stent-graft, and
- the main and the tertiary stent-grafts may be configured such that the tertiary stent- graft forms a blood-impervious seal with the main stent-graft around the superior second lateral fenestration when the tertiary stent-graft is disposed therethrough, and the main stent-graft is in the radially-expanded state thereof and the tertiary stent-graft is in a radially-expanded state thereof.
- apparatus including a stent-graft system, which includes:
- a main module which has distal and proximal main-module ends, and includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element, wherein the main covering element and the main support element are shaped so as to together define a main-module lateral fenestration when the main module is unconstrained in a radially- expanded state thereof; and
- a secondary module which includes a non-bifurcated secondary stent-graft, which includes (a) a secondary support element, which includes secondary structural stent elements, (b) a secondary covering element that is attached to and at least partially covers the secondary support element, and (c) a flexible sheet,
- the secondary module is shaped so as to define (a) a proximal secondary- module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) a central longitudinal axis therebetween, wherein the sealing interface is sized and configured to form a blood-impervious seal with the main-module lateral fenestration of the main module,
- the secondary covering element is shaped so as to define at least one secondary-module lateral fenestration disposed distal to the proximal secondary- module end and proximal to the sealing interface, and
- the flexible sheet (a) is blood-sealingly joined to a portion of a secondary border of the secondary-module lateral fenestration, which portion extends around at least 25% of a perimeter of the secondary border and includes a distal end of the secondary border when the secondary module is unconstrained in the radially- expanded state thereof, and (b) extends radially inward from the secondary border when the secondary module is unconstrained in the radially-expanded state thereof.
- a portion of the secondary structural stent elements are attached to the flexible sheet.
- the main-module lateral fenestration is an inferior first lateral fenestration, which faces in a first radial direction
- the main covering element and the main support element are shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction,
- the stent-graft system further includes a generally tubular tertiary stent-graft, and the main and the tertiary stent-grafts are configured such that the tertiary stent- graft forms a blood-impervious seal with the main stent-graft around the superior second lateral fenestration when the tertiary stent-graft is disposed therethrough, and the main stent-graft is in the radially-expanded state thereof and the tertiary stent-graft is in a radially-expanded state thereof.
- apparatus including a stent-graft system, which includes:
- a main module which has distal and proximal main-module ends, and includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element, wherein the main covering element and the main support element are shaped so as to together define a lateral fenestration when the main module is unconstrained in a radially-expanded state thereof; and
- a secondary module which includes a non-bifurcated secondary stent-graft, which includes (a) a secondary support element, which includes secondary structural stent elements, and (b) a secondary covering element that is attached to and partially covers the secondary support element, wherein when the secondary module is unconstrained in a radially-expanded state thereof:
- the secondary module is shaped so as to define (a) a proximal secondary- module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) an anchoring axial portion therebetween having a central longitudinal axis and an anchoring-portion length, measured along the central longitudinal axis from the distal sealing interface to the proximal secondary-module end,
- the sealing interface is sized and configured to form a blood-impervious seal with the lateral fenestration of the main module
- the secondary covering element at least covers the secondary support element along a covered axial portion of the anchoring axial portion, which covered axial portion extends proximally from the distal sealing interface for an axial covering distance equal to between 10% and 50% of the anchoring-portion length, the axial covering distance measured along the central longitudinal axis, wherein the secondary support element is uncovered proximally to the secondary covering element, and
- the anchoring axial portion has a greatest anchoring-portion width that is (a) greater than a greatest proximal-end width at the proximal secondary-module end and (b) at least 20% greater than a greatest sealing-interface width at a narrowest portion of the distal sealing interface, the greatest anchoring-portion, sealing-interface, and proximal-end widths measured perpendicular to the central longitudinal axis.
- the anchoring axial portion has the greatest anchoring- portion width at an axial location at an axial distance from the proximal secondary- module end equal to between 33% and 60% of the anchoring-portion length, the axial distance measured along the central longitudinal axis, when the secondary module is unconstrained in the radially-expanded state thereof.
- the greatest anchoring-portion width is at least 50% greater than the greatest sealing-interface width at the narrowest portion of the distal sealing interface, when the secondary module is unconstrained in the radially-expanded state thereof.
- the axial covering distance from the distal sealing interface is equal to between 20% and 100% of an axial distance between the distal sealing interface and an axial location of the greatest anchoring-portion width, the axial distance measured along the central longitudinal axis, when the secondary module is unconstrained in the radially-expanded state thereof.
- the axial covering distance from the distal sealing interface is equal to between 30% and 60% of the axial distance between the distal sealing interface and the axial location of the greatest anchoring- portion width, when the secondary module is unconstrained in the radially-expanded state thereof.
- the axial covering distance equals between 10% and 35% of the anchoring-portion length, when the secondary module is unconstrained in the radially-expanded state thereof.
- the axial covering distance is at least 15% of the anchoring- portion length, when the secondary module is unconstrained in the radially-expanded state thereof.
- the anchoring axial portion may include a plurality of the secondary structural stent elements, each of which has two longitudinal portions that extend toward the distal sealing interface, and an intermediary longitudinal portion that curves around the proximal secondary-module end, when the secondary module is unconstrained in the radially-expanded state thereof.
- the anchoring axial portion may include a plurality of the secondary structural stent elements, some of which touch one another, and none of which are fixed to one another, when the secondary module is unconstrained in the radially-expanded state thereof.
- an uncovered axial portion of the anchoring portion may extend from the proximal secondary-module end to a proximal end of the covered axial portion, for an axial uncovered distance equal to between 30 and 120 mm, when the secondary module is unconstrained in the radially-expanded state thereof.
- a method for treating a patient including: endovascularly introducing a generally tubular stent-graft, while in a radially- compressed state, and positioning the stent-graft such that (a) a proximal stent-graft end of the stent-graft is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery left subclavian artery, and a left common carotid artery, and (b) a distal stent-graft end of the stent-graft is positioned in a descending aorta, wherein the stent-graft includes (a) a generally tubular support element, which includes a plurality of structural stent elements, and (b) a covering element that is attached to and at least partially covers the support element; and
- the covering element and the support element are shaped so as to together define a lateral fenestration that is disposed in the aortic arch, with the lateral fenestration facing upstream generally toward an ascending aorta, the lateral fenestration having distal and proximal fenestration ends, (b) a first perimeter of a distal stent-graft end of the stent-graft equals at least 200% of a second perimeter of the proximal stent-graft end, and (c) the stent-graft includes a dissection-reinforcement axial portion, which (i) includes a portion of the structural stent elements, (ii) has (x) a distal dissection-reinforcement end and (y) a proximal dissection-reinforcement end that is disposed along the stent-graft no
- the lateral fenestration is an inferior first lateral fenestration, which faces in a first radial direction
- the main covering element and the main support element are shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction, and
- positioning the stent-graft includes positioning the stent-graft such that (a) the proximal stent-graft end is positioned in the left common carotid artery, (b) the inferior first lateral fenestration is disposed in the aortic arch, with the inferior first lateral fenestration facing upstream generally toward the ascending aorta, and (c) the superior second lateral fenestration is axially aligned with and faces the left subclavian artery.
- a method for treating a patient including:
- a proximal stent-graft end of the stent-graft is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery left subclavian artery, and a left common carotid artery, and (b) a distal stent-graft end of the stent-graft is positioned in a descending aorta, wherein the stent-graft includes (a) a generally tubular support element, which includes a plurality of structural stent elements arranged as a plurality circumferential stent springs, and (b) a covering element that is attached to and at least partially covers the support element; and
- the covering element and the support element are shaped so as to together define a lateral fenestration that is disposed in the aortic arch, with the lateral fenestration facing upstream generally toward an ascending aorta, the lateral fenestration having distal and proximal fenestration ends, (b) a first perimeter of a distal stent-graft end of the stent-graft equals at least 200% of a second perimeter of the proximal stent-graft end, (c) the stent- graft includes a dissection-reinforcement axial portion, which (i) includes a first plurality of the stent springs, (ii) has (x) a distal dissection-reinforcement end and (y) a proximal dissection-reinforcement end that is disposed along the stent-graf
- the lateral fenestration is an inferior first lateral fenestration, which faces in a first radial direction
- the main covering element and the main support element are shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction, and
- positioning the stent-graft includes positioning the stent-graft such that (a) the proximal stent-graft end is positioned in the left common carotid artery, (b) the inferior first lateral fenestration is disposed in the aortic arch, with the inferior first lateral fenestration facing upstream generally toward the ascending aorta, and (c) the superior second lateral fenestration is axially aligned with and faces the left subclavian artery.
- a method for treating a patient including:
- a proximal main-module end of the main module is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery left subclavian artery, and a left common carotid artery, and (b) a distal main-module end of the main module is positioned in a descending aorta
- the main module includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element;
- main stent-graft transitioning to a radially-expanded state thereof, in which the main covering element and the main support element are shaped so as to together define a lateral fenestration that is disposed in the aortic arch, with the lateral fenestration facing upstream generally toward an ascending aorta;
- the secondary module includes a non -bifurcated secondary stent- graft, which includes (a) a secondary support element, which includes secondary structural stent elements, and (b) a secondary covering element that is attached to and at least partially covers the secondary support element; and
- the secondary module is shaped so as to define (a) a proximal secondary-module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) a central longitudinal axis therebetween, such that the sealing interface forms a blood -impervious seal with the lateral fenestration of the main module, and the secondary covering element is shaped so as to define at least one lateral opening that begins at and extends from the proximal secondary-module end toward the sealing interface along the central longitudinal axis for a distance equal to at least 50% of a greatest width of the secondary module, measured perpendicular to the central longitudinal axis.
- the lateral fenestration is an inferior first lateral fenestration, which faces in a first radial direction
- the main covering element and the main support element are shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction, and
- positioning the stent-graft includes positioning the stent-graft such that (a) the proximal stent-graft end is positioned in the left common carotid artery, (b) the inferior first lateral fenestration is disposed in the aortic arch, with the inferior first lateral fenestration facing upstream generally toward the ascending aorta, and (c) the superior second lateral fenestration is axially aligned with and faces the left subclavian artery.
- a method for treating a patient including:
- a proximal main-module end of the main module is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery left subclavian artery, and a left common carotid artery, and (b) a distal main-module end of the main module is positioned in a descending aorta
- the main module includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element;
- the main covering element and the main support element are shaped so as to together define a main-module lateral fenestration that is disposed in the aortic arch, with the main-module lateral fenestration facing upstream generally toward an ascending aorta; endovascularly introducing and passing a secondary module, while in a radially- compressed state thereof, through a distal portion of the main stent-graft such that the secondary module is disposed through the main-module lateral fenestration and is disposed partially in the aortic arch, wherein the secondary module includes a non- bifurcated secondary stent-graft, which includes (a) a secondary support element, which includes secondary structural stent elements, and (b) a secondary covering element that is attached to and at least partially covers the secondary support element; and
- the secondary module is shaped so as to define (a) a proximal secondary-module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) a central longitudinal axis therebetween, such that the sealing interface forms a blood -impervious seal with the main-module lateral fenestration of the main module, and the secondary covering element is shaped so as to define at least one secondary-module lateral fenestration disposed distal to the proximal secondary-module end and proximal to the sealing interface, wherein a greatest axial length of the secondary-module lateral fenestration, measured parallel to the central longitudinal axis, equals at least 33% of a first perimeter of the distal main-module end.
- a method for treating a patient including:
- a proximal main-module end of the main module is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery left subclavian artery, and a left common carotid artery, and (b) a distal main-module end of the main module is positioned in a descending aorta
- the main module includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element;
- the main covering element and the main support element are shaped so as to together define a main-module lateral fenestration that is disposed in the aortic arch, with the main-module lateral fenestration facing upstream generally toward an ascending aorta; endovascularly introducing and passing a secondary module, while in a radially- compressed state thereof, through a distal portion of the main stent-graft such that the secondary module is disposed through the main-module lateral fenestration and is disposed partially in the aortic arch, wherein the secondary module includes a non- bifurcated secondary stent-graft, which includes (a) a secondary support element, which includes secondary structural stent elements, (b) a secondary covering element that is attached to and at least partially covers the secondary support element, and (c) a flexible sheet; and
- the secondary module is shaped so as to define (a) a proximal secondary- module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) a central longitudinal axis therebetween, such that the sealing interface forms a blood- impervious seal with the main-module lateral fenestration of the main module, (b) the secondary covering element is shaped so as to define at least one secondary -module lateral fenestration disposed distal to the proximal secondary-module end and proximal to the sealing interface, and (c) the flexible sheet (i) is blood- sealingly joined to a portion of a secondary border of the secondary-module lateral fenestration, which portion extends around at least 25% of a perimeter of the secondary border and includes a distal end of the secondary border, and (ii) extends radially inward from the secondary border when
- a method for treating a patient including:
- a proximal main-module end of the main module is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery left subclavian artery, and a left common carotid artery, and (b) a distal main-module end of the main module is positioned in a descending aorta
- the main module includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element; thereafter, transitioning the main stent-graft to a radially-expanded state thereof, in which the main covering element and the main support element are shaped so as to together define a lateral fenestration that is disposed in the
- the secondary module includes a non -bifurcated secondary stent- graft, which includes (a) a secondary support element, which includes secondary structural stent elements, and (b) a secondary covering element that is attached to and partially covers the secondary support element; and thereafter, transitioning the secondary module to a radially-expanded state thereof, in which the secondary module is shaped so as to define (a) a proximal secondary-module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) an anchoring axial portion therebetween having a central longitudinal axis and an anchoring - portion length, measured along the central longitudinal axis from the distal sealing interface to the proximal
- FIG. 1 is a schematic illustration of multi-component stent-graft system, in accordance with an application of the present invention
- Figs. 2A-B are schematic illustrations of a main module of the multi-component stent-graft system of Fig. 1, in accordance with respective applications of the present invention
- Fig. 3 is a schematic illustration of a secondary module of the multi-component stent-graft system of Fig. 1, in accordance with an application of the present invention
- Fig. 4 is a schematic illustration of another configuration of the secondary module of the multi-component stent-graft system of Fig. 1, in accordance with an application of the present invention
- Figs. 5 and 6 are schematic illustrations of alternative configurations of the secondary module of the multi-component stent-graft system of Fig. 1, in accordance with respective applications of the present invention
- Fig. 7 is a schematic illustration of yet another configuration of the secondary module of the secondary module of the multi-component stent-graft system of Fig. 1, in accordance with an application of the present invention
- Fig. 8 is a schematic illustration of yet another configuration of the secondary module of the secondary module of the multi-component stent-graft system of Fig. 1, in accordance with an application of the present invention
- Fig. 9 is a schematic illustration of still another configuration of the secondary module of the secondary module of the multi-component stent-graft system of Fig. 1, in accordance with an application of the present invention
- Fig. 10 is a schematic illustration of the secondary module of Fig. 9 deployed in an aortic arch, sealingly coupled to a lateral fenestration of a main module of the multi- component stent-graft system, in accordance with an application of the present invention
- Fig. 11 is a schematic illustration of another multi-component stent-graft system, in accordance with an application of the present invention.
- Fig. 12 is a schematic illustration of a main module of the multi-component stent- graft system of Fig. 11, in accordance with an application of the present invention
- Figs. 13A and 13B are schematic illustrations of respective configurations of a tertiary module of the multi-component stent-graft system of Fig. 11, in accordance with respective applications of the present invention
- Figs. 14A-B are schematic illustrations of kinking properties of different axial portions of a main stent-graft of the multi-component stent-graft system of Fig. 1, in accordance with an application of the present invention.
- Fig. 15 is a schematic illustration of kinking in a stent-graft.
- Fig. 1 is a schematic illustration of multi -component stent-graft system 10, in accordance with an application of the present invention.
- multi-component stent-graft system 10 is provided for treating a Type B aortic dissection 12.
- the system is configured to be deployed in a thoracic aorta 14 and a left subclavian artery 16, and, optionally, a left common carotid artery 18.
- the multi- component stent-graft system is configured to be deployed in a straightforward procedure.
- the stent-grafts of the system are assembled in situ to accommodate the dimensions of the particular patient's anatomy, generally without requiring prior customization of the stent- grafts or in situ modifications to the stent-grafts, which might be expensive and/or complex.
- the multi-component stent-graft system defines a blood-flow path from an ascending aorta 17, over an aortic arch 19, and to the descending aorta.
- the multi-component stent-graft system additionally provides or allows blood-flow paths to the three branches of the aortic arch.
- Multi-component stent-graft system 10 comprises a main module 20 and, for some applications, a secondary module 22.
- Main module 20 comprises a generally tubular main stent-graft 24, and secondary module 22 comprises a non-bifurcated secondary stent-graft 26.
- the stent-grafts are configured to assume radially-compressed states, such as when initially positioned in one or more outer tubes of one or more delivery tools, and to assume radially-expanded states upon being deployed from the outer tube(s).
- Fig. 1 shows the stent-grafts in their radially-expanded states in situ.
- the stent-grafts are relaxed in their radially-expanded states.
- the stent- grafts are configured to be self-expanding. For example, they may be heat-set to assume their radially-expanded states.
- FIG. 1 is still made to Fig. 1, and is additionally made to Figs. 2A-B, which are schematic illustrations of main module 20 that comprises main stent-graft 24, in accordance with respective applications of the present invention.
- Figs. 2A-B show main stent-graft 24 unconstrained in its radially-expanded state, i.e., no forces are applied to the stent-graft by a delivery tool, walls of a blood vessel, or otherwise.
- Main stent-graft 24 typically comprises a main generally tubular support element 30 and a main covering element 32 that is attached to and at least partially covers (e.g., only partially covers) the main support element.
- Support element 30 typically comprises a plurality of main structural stent elements 31.
- main structural stent elements 31 are arranged as a plurality of circumferential stent springs 33.
- support element 30, as well as support elements 130, 230 and 330, which are described hereinbelow, comprise a super-elastic alloy, such as Nitinol.
- Main covering element 32 serves as a blood flow guide through at least a portion of the main stent-graft.
- Main covering element 32 typically comprises at least one biologically-compatible substantially blood-impervious flexible sheet, which is attached (such as by stitching) to at least a portion of the respective support element, on either side of the surfaces defined by the support element.
- the flexible sheet may comprise, for example, a polymeric material (e.g., a polyester, or polytetrafluoroethylene), a textile material (e.g., polyethylene terephthalate (PET)), natural tissue (e.g., saphenous vein or collagen), or a combination thereof.
- a polymeric material e.g., a polyester, or polytetrafluoroethylene
- a textile material e.g., polyethylene terephthalate (PET)
- natural tissue e.g., saphenous vein or collagen
- Main covering element 32 and main support element 30 are shaped so as to together define a lateral fenestration 34, e.g., exactly one lateral fenestration 34, through main stent-graft 24, which lateral fenestration has distal and proximal fenestration ends 35 and 37, when main stent-graft 24 is unconstrained in its radially-expanded state.
- a "fenestration" is an opening entirely surrounded by a covering element. For example, lateral opening 174, described hereinbelow with reference to Fig.
- lateral fenestration 34 serves as an inferior lateral fenestration.
- at least a portion of the border of lateral fenestration 34 is defined by an undulating portion of one or more of structural stent elements 31.
- a first perimeter PI of a distal main-module end 36 of main stent-graft 24 (and main module 20) is greater than a second perimeter P2 of a proximal main-module end 38 of the main stent-graft (and the main module), and/or a first cross- sectional area of the distal main-module end 36 is greater than a second cross- sectional area of proximal main-module end 38.
- first and second perimeters PI and P2 are first and second diameters.
- first perimeter PI may equal at least 150% of second perimeter P2, such as at least 200%, at least 250%, at least 300%, or at least 400%
- first cross -sectional area may equal at least 225% of the second cross-sectional area, such as at least 400%, at least 625%, at least 900%, or at least 1600%.
- first perimeter PI may be at least 5 cm, no more than 15 cm, and/or between 5 and 15 cm, such as at least 7.5 cm, e.g., at least 9 cm, no more than 13 cm, and/or between 7.5 (e.g., 9) and 13 cm
- second perimeter P2 may be at least 2.5 cm, no more than 5.7 cm, and/or between 2.5 and 5.7 cm, such as at least 3 cm, no more than 4.5 cm, and/or between 3 and 4.5 cm.
- a perimeter of lateral fenestration 34 is at least 5 cm, no more than 15 cm, and/or between 5 and 15 cm, such as at least 7.5 cm, e.g., at least 9 cm, no more than 13 cm, and/or between 7.5 cm (e.g., 9 cm) and 13 cm.
- a perimeter of lateral fenestration 34 is at least 80%, no more than 120%, and/or between 80% and 120% of first perimeter PI, and/or at least 150%, no more than 250%, and/or between 150% and 250% of second perimeter P2.
- second module 22 is not necessary for providing blood flow into the lateral fenestration, and is thus optionally not provided.
- second module 22 may not be necessary when lateral fenestration 34 is sufficiently large (e.g., has a perimeter of at least 9 cm and/or at least 80% of first perimeter PI).
- main stent-graft 24 when unconstrained in its radially- expanded state, has an axial length of at least 5 cm, no more than 40 cm, and/or between 5 and 30 cm, such as at least 10 cm, no more than 30 cm, and/or between 10 and 30 cm.
- main stent-graft 24 when unconstrained in its radially-expanded state, has a greatest perimeter (at any axial location along the stent-graft) of at least 7.5 cm, no more than 19 cm, and/or between 7.5 and 19 cm, such as at least 12.5 cm, no more than 16 cm, and/or between 12.5 and 16 cm. These values are typical for adult subjects, in which the vast majority of dissections occur. For pediatric subjects, in which dissections are rare, these dimensions may be reduced by a factor of up to 1:3.
- main stent-graft 24 allows main stent-graft 24 to be positioned such that (a) a distal, radially larger, descending-aorta axial portion 42 of the stent-graft, including distal main-module end 36 thereof, is disposed in the aorta downstream from the bifurcation with the left subclavian artery, at least partially in the upper part of the descending aorta, (b) a proximal, radially smaller, supra-arch axial portion 44 of the main stent-graft, including proximal main-module end 38 thereof, is disposed in left subclavian artery 16, as shown in Fig.
- arch axial portion 46 axially between descending-aorta axial portion 42 and supra-arch axial portion 44, is disposed in aortic arch 19.
- arch axial portion 46 at least partially axially overlaps fenestration 34, since the fenestration should be disposed in the apex of the arch.
- descending-aorta axial portion 42 has an average perimeter that is greater than (e.g., between 5% and 15% greater than) an average perimeter of the portion of the aorta in which it is disposed.
- supra-arch axial portion 44 has an average perimeter that is greater than (e.g., between 5% and 15% greater than) the average perimeter of the portion of the left subclavian artery in which it is disposed.
- main stent-graft 24 when main stent-graft 24 is unconstrained in its radially- expanded state, the main stent-graft includes a dissection-reinforcement axial portion 48, which:
- proximal dissection-reinforcement end 52 has a proximal dissection-reinforcement end 52 that is disposed along the stent-graft no more than 20 mm proximal to proximal fenestration end 37; proximal dissection-reinforcement end 52 may be either proximal or distal to proximal fenestration end 37.
- proximal dissection- reinforcement end 52 is disposed along the main stent-graft no more proximal than distal fenestration end 35 when the stent-graft is unconstrained in the radially-expanded state, such as shown in Figs. 1 and 2A.
- proximal dissection-reinforcement end 52 is disposed along the main stent-graft between distal fenestration end 35 and proximal fenestration end 37, inclusive, when the stent-graft is unconstrained in the radially- expanded state, such as shown in Fig. 2B; and/or
- dissection-reinforcement axial portion 48 has a radial strength that is at least 10% greater than an average radial strength of the entire main stent-graft, such as at least 15% greater, or at least 30% greater. This greater strength increases the force that dissection-reinforcement axial portion 48 applies to a tear 56 of aortic dissection 12, thereby sealing the tear. Tear 56 is generally located in an upper portion of thoracic aorta 14, and sometimes additionally in a lower portion of left subclavian artery 16 and/or at the take-off of left subclavian artery 16 from thoracic aorta 14.
- stent-grafts with higher strengths are more difficult to deploy, and are more likely to cause damage to the vasculature.
- an arch axial portion 46 and dissection-reinforcement axial portion 48 do not include any bare main structural stent elements 31, such that main covering element 32 intervenes between the stent elements and the blood vessel wall in the vicinity of tear 56.
- an axial length of dissection-reinforcement axial portion 48 is at least 1 cm, no more than 3 cm, and/or between 1 and 3 cm when the main stent-graft is unconstrained in the radially-expanded state.
- a distance Dl between distal dissection-reinforcement end 50 and distal main-module end 36 is at least 32%, no more than 160%, and/or between
- distance Dl is at least 3 cm, no more than 5 cm, and/or between 3 and 5 cm, when the main stent-graft is unconstrained in the radially-expanded state.
- distance Dl equals between at least 20%, no more than 66%, and/or between 20% and 66% of a total length LI of main stent-graft 24, and/or (b) a distance D2 between proximal dissection-reinforcement end 52 and proximal main-module end 38 equals at least 33%, no more than 80%, and/or between 33% and 80% of total length LI.
- dissection-reinforcement axial portion 48 is configured to be generally straight when the main stent-graft is unconstrained in the radially-expanded state.
- main structural stent elements 31 of dissection- reinforcement axial portion 48 are arranged as a plurality of circumferential stent springs 33 of dissection-reinforcement axial portion 48.
- a strut height H, measured axially along the main stent-graft, of at least one of stent springs 33 of dissection-reinforcement axial portion 48 varies by less than 10% around a circumference of the stent spring when the main stent-graft is unconstrained in the radially-expanded state.
- height H of the stent spring varies by less than 10% around a circumference of the stent spring when the main stent-graft is unconstrained in the radially-expanded state.
- the portion of structural stent elements 31 included by dissection-reinforcement axial portion 48 is a first portion of structural stent elements 31, and when the stent-graft is unconstrained in the radially-expanded state: (a) main stent- graft 24 includes a distal-end axial portion 54, which includes a second portion of structural stent elements 31, (b) distal-end axial portion 54 axially extends along the stent- graft from distal main-module end 36 for a distance equal to at least 5%, no more than 32%, and/or between 5% and 32% of a greatest perimeter of the main stent-graft distally to distal fenestration end 35, such as at least 11%, no more than 22%, and/or between 11% and 22%, and (c) distal-end axial portion 54 has a radial strength that is at least a 10% greater than the average radial strength of the entire main stent-graft
- dissection-reinforcement axial portion 48 includes a first plurality 60 of stent springs 33
- main stent-graft 24 includes a distal axial portion 58, which includes a second plurality 62 of stent springs 33.
- Distal axial portion 58 is disposed along the main stent-graft distal and axially adjacent to distal dissection- reinforcement end 50, and extends along the main stent-graft for a distance equal to at least 5%, no more than 32%, and/or between 5% and 32% of the greatest perimeter of the main stent-graft distally to the distal fenestration end 35.
- distal axial portion 58 extends to and reaches the distal main-module end 36.
- Stent springs 33 have respective average strut heights, measured axially along the main stent-graft (the height of each stent spring is averaged circumferentially around the stent-graft).
- An average of the average heights of first plurality 60 of stent springs 33 is less than 75% (e.g., less than 70%) of the average height of a proximal-most one 64 of second plurality 62 of stent springs 33.
- These smaller average heights generally allow dissection-reinforcement axial portion 48 to bend without the stent springs thereof coming into contact with one another.
- dissection-reinforcement axial portion 48 is typically configured to be generally straight when the main stent-graft is unconstrained in the radially-expanded state.
- each of the average heights of first plurality 60 of stent springs 33 is less than 75% (e.g., less than 70%) of the average height of proximal-most one 64 of second plurality 62 of stent springs 33 when the main stent-graft is unconstrained in the radially-expanded state.
- the average of the average heights of first plurality 60 of stent springs 33 is less than 75% (e.g., less than 70%) of the average height of a second one 66 of second plurality 62 of stent springs 33, other than proximal-most one 64 of second plurality 62 of stent springs 33 when the main stent-graft is unconstrained in the radially-expanded state.
- the average of the average heights of first plurality 60 of stent springs 33 is less than 75% (e.g., less than 70%) of each of the average heights of second plurality 62 of stent springs 33 when the main stent-graft is unconstrained in the radially-expanded state.
- an axial spacing S between two of first plurality 60 of stent springs 33 of dissection-reinforcement axial portion 48 equals less than 10% of an average of the average heights H of the two stent springs 33.
- Such low axial spacing between the stent springs of reduces the risk of kinking of dissection-reinforcement axial portion 48.
- the use of a greater axial spacing S would make dissection-reinforcement axial portion 48 more prone to kinking, such as described hereinbelow with reference to Fig. 14.
- distal axial portion 58 is configured to be generally straight when the main stent-graft is unconstrained in the radially-expanded state.
- FIG. 3 is a schematic illustration of secondary module 22 that comprises secondary stent-graft 26, in accordance with an application of the present invention.
- Fig. 3 shows secondary stent- graft 26 unconstrained in its radially-expanded state, i.e., no forces are applied to the stent-graft by a delivery tool, walls of a blood vessel, or otherwise.
- Secondary stent-graft 26 typically comprises a secondary generally tubular support element 130 and a secondary covering element 132 that is attached to and at least partially covers (e.g., only partially covers) the secondary support element.
- Support element 130 typically comprises a plurality of secondary structural stent elements 131.
- secondary structural stent elements 131 are arranged as a plurality of circumferential stent springs 133.
- Secondary covering element 132 serves as a blood flow guide through at least a portion of the secondary stent-graft.
- Secondary covering element 132 typically comprises at least one biologically-compatible substantially blood-impervious flexible sheet, which is attached (such as by stitching) to at least a portion of the respective support element, on either side of the surfaces defined by the support element.
- the flexible sheet may comprise, for example, a polymeric material (e.g., a polyester, or polytetrafluoroethylene), a textile material (e.g., polyethylene terephthalate (PET)), natural tissue (e.g., saphenous vein or collagen), or a combination thereof.
- a polymeric material e.g., a polyester, or polytetrafluoroethylene
- a textile material e.g., polyethylene terephthalate (PET)
- natural tissue e.g., saphenous vein or collagen
- ⁇ secondary module 22 is shaped so as to define a proximal secondary-module end 138, a sealing interface 172 distal to proximal secondary-module end 138, and a central longitudinal axis 140 therebetween.
- Sealing interface 172 is sized and configured to form a blood-impervious seal with lateral fenestration 34 of main module 20;
- ⁇ secondary module 22 is shaped so as to define a distal secondary-module end
- secondary covering element 132 is shaped so as to define at least one lateral opening 174 that begins at and extends from proximal secondary-module end 138 toward sealing interface 172 along central longitudinal axis 140 for a distance D3 equal to at least 50% (e.g., at least 70%) of a greatest width Wl of secondary module 22, measured perpendicular to central longitudinal axis 140.
- lateral opening 174 reaches proximal secondary-module end 138, is thus not entirely surrounded by secondary covering element 132, and therefore is not a fenestration, as defined hereinabove with reference to Figs. 1 and 2A-B.
- a greatest width W2 of at least one lateral opening 174 equals at least 90 degrees circumferentially around proximal secondary-module end 138, the 90 degrees being measured at sealing interface 172 (even though the lateral opening typically does not extend to the sealing interface, and may have its greatest width W2 at proximal secondary-module end 138).
- At least one of secondary structural stent elements 131 traverses lateral opening 174 when the secondary module is unconstrained in the radially- expanded state thereof.
- two secondary structural stent elements 13 IB are shown traversing lateral opening 174.
- Such traversal may provide additional structural strength to secondary module 22 at the lateral opening.
- support element 130 is shaped so as to define a complete tube, which is only partially covered by secondary covering element 132.
- support element 130 is shaped so as to define a partial tube circumferentially.
- the at least one lateral opening 174 comprises exactly one lateral opening 174.
- lateral opening 174 faces in a first radial direction extending from central longitudinal axis 140, and a portion 176 of secondary covering element 132 that faces in a second radial direction opposite the first radial direction extends to and reaches proximal secondary- module end 138.
- secondary module 22 is covered by secondary covering element 132 on the side circumferentially opposite lateral opening 174, such that lateral opening 174 and portion 176 face in radially-opposite directions.
- the stent-grafts together provide continuous coverage covering element material along the blood flow path, which may help prevent further trauma to aorta, and sub-tears in the aorta.
- Fig. 1 schematically shows a portion of a typical aorta, including thoracic aorta 14, which includes an upper part of ascending aorta 17, and aortic arch 19, and an upper part of a supra-renal descending aorta. Also shown are the three branches of aortic arch 19: a brachiocephalic artery 70, left common carotid artery 18, and left subclavian artery 16.
- a brachiocephalic artery 70 left common carotid artery 18
- left subclavian artery 16 left subclavian artery 16.
- the stent-grafts of system 10 are endovascularly (typically percutaneously) introduced into the thoracic aorta, such as via one of the iliac arteries, while the stent-grafts are positioned in one or more outer tubes of a delivery tool in their radially-compressed states.
- the exemplary procedure begins with the advancing of a guidewire up the descending aorta and into left subclavian artery 16.
- Main stent-graft 24 of main module 20 is initially positioned in its radially-compressed state within an outer tube of a delivery tool, typically near a leading end of the outer tube.
- the outer tube is advanced over the guidewire, until main stent-graft 24 is partially disposed in left subclavian artery 16 and partially disposed in the upper part of the descending aorta.
- the guidewire is withdrawn, leaving the outer tube in place.
- the main stent-graft is held in place as the outer tube is withdrawn, thereby delivering the main stent-graft from the outer tube.
- Main stent-graft 24 typically self-expands, until it assumes its radially-expanded state, upon reaching typically about 80-90% of its maximum unconstrained size, and/or being constrained from further expansion by the wall of the blood vessels, as shown in Fig. 1.
- the main stent-graft (and/or the other stent-grafts, as described hereinbelow) is delivered using an over-the-wire (OTW) approach, in which the guidewire is left in place until the stent-graft is expanded, and thereafter the guidewire is withdrawn.
- OW over-the-wire
- Arch axial portion 46 of main stent-graft 24, including lateral fenestration 34, is disposed in aortic arch 19, with the lateral fenestration facing upstream, generally toward ascending aorta 17, in a vicinity of the bifurcation of aortic arch 19 and left subclavian artery 16.
- main stent-graft 24 may comprise one or more radiopaque markers in a vicinity of (e.g., on a periphery of) the lateral fenestration.
- a guidewire (either the same guidewire used to deploy the main stent-graft, or a second guidewire) is advanced up the descending aorta, through a distal portion of main stent-graft 24, out of lateral fenestration 34, and into aortic arch 19, extending toward, or partially into, ascending aorta 17.
- Secondary stent-graft 26 of secondary module 22 is positioned in its radially-compressed state within an outer tube of a delivery tool (either the same outer tube used to deploy the main stent-graft, or a second outer tube), typically near a leading end of the outer tube.
- the outer tube is advanced over the guidewire, until secondary stent-graft 26 is partially disposed in aortic arch 19, extending toward, or partially into, ascending aorta 17, and partially disposed within radially-expanded main stent-graft 24 in the upper part of the descending aorta.
- the guidewire is withdrawn, leaving the outer tube in place.
- the secondary stent-graft is rotationally aligned such that the at least one lateral opening 174 faces left common carotid artery 18, so as to allow blood flow to the left common carotid artery (and, for applications in which the secondary stent-graft is long enough, so as to allow blood flow into brachiocephalic artery 70).
- the secondary stent- graft may comprise one or more radiopaque markers to facilitate such proper rotational alignment.
- the radiopaque markers may be positioned on one or more edges of the at least one lateral opening.
- Secondary module 22 is positioned so as to not block brachiocephalic artery 70 or left common carotid artery 18.
- Secondary stent-graft 26 is held in place as the outer tube is withdrawn, thereby delivering the secondary stent-graft from the outer tube.
- Secondary stent-graft 26 typically self-expands, until it assumes its radially-expanded state, upon reaching its maximum unconstrained size, and/or being constrained from further expansion by the wall of the blood vessels.
- Secondary stent-graft 26 is thus adapted for transluminal delivery in its radially-compressed state through a portion of main stent-graft 24 and lateral fenestration 34, while the main stent-graft is in its radially-expanded state.
- Secondary module 22 reduces blood turbulence in the aortic arch, and serves as a funnel that creates a gradual taper of the blood flow into lateral fenestration 34 of main stent-graft 24.
- main and secondary stent-grafts 24 and 26 when in their respective radially-expanded states, constrained by the respective blood vessels in which they are positioned, have some or all of the dimensional and/or strength characteristics described herein as applicable when the stent-grafts are unconstrained in their radially- expanded states.
- first perimeter PI of distal main-module end 36 of main stent-graft 24 may equal at least 200% (e.g., at least 250%, at least 300%, or at least 400%) of second perimeter P2 of proximal main-module end 38 of the main stent-graft
- proximal dissection-reinforcement end 52 may be disposed along the main stent-graft no more than 20 mm proximal to proximal fenestration end 37
- dissection-reinforcement axial portion 48 may extends along the main stent-graft for a distance equal to between 5% and 32% of the greatest perimeter of the main stent-graft distally to distal fenestration end 35, and/or dissection-reinforcement axial portion 48 may have a radial strength that is at least 10% greater than an average radial strength of the entire main stent-graft.
- FIG. 4 is a schematic illustration of another configuration of secondary module 22, in accordance with an application of the present invention.
- secondary module 22 when secondary module 22 is unconstrained in the radially-expanded state thereof:
- the at least one lateral opening 174 includes at least first and second lateral openings 174 A and 174B;
- secondary covering element 132 is shaped so as to define first and second lateral openings 174 A and 174B, each of which begins at and extends from proximal secondary-module end 138 toward sealing interface 172 along central longitudinal axis 140 for distance D3 equal to at least 50% of greatest width Wl of secondary module 22;
- first and second lateral openings 174A and 174B face in different first and second radial directions extending from central longitudinal axis 140;
- first and second lateral openings 174A and 174B at least partially axially overlap along central longitudinal axis 140.
- first and second lateral openings 174A and 174B axially coincide along central longitudinal axis 140.
- the first and the second radial directions are opposite each other; in other words first and second lateral openings 174A and 174B face in radially-opposite directions.
- secondary covering element 132 is shaped so as to define two portions 176A and 176B, which (a) extend to and reach proximal secondary-module end 138, and (b) are shaped so as to define respective concave inner surfaces 178 A and 178B that face each other and central longitudinal axis 140, and (c) are not joined to each other at proximal secondary-module end 138.
- the secondary module is rotationally aligned such that one of first and second lateral openings 174A and 174B faces left common carotid artery 18, so as to allow blood flow into the left common carotid artery (and, for applications in which the secondary stent-graft is long enough, so as to allow blood flow into brachiocephalic artery 70).
- the other of the lateral openings faces downward toward the wall of aortic arch 19 opposite the left common carotid artery, and may serve to prevent blood from becoming trapped below the bottom side of the secondary module, which might cause blood coagulation.
- FIGs. 5 and 6 are schematic illustrations of alternative configurations of secondary module 22, in accordance with respective applications of the present invention.
- secondary module 22 when secondary module 22 is unconstrained in the radially-expanded state thereof:
- secondary module 22 is shaped so as to define proximal secondary-module end 138, sealing interface 172, and central longitudinal axis 140 therebetween. Sealing interface 172 is sized and configured to form a blood-impervious seal with lateral fenestration 34 of main module 20; ⁇ secondary module 22 is shaped so as to define distal secondary-module end
- secondary covering element 132 is shaped so as to define at least one secondary-module lateral fenestration 134 disposed distal to proximal secondary-module end 138 and proximal to sealing interface 172, and ⁇ a greatest axial length L2 of secondary-module lateral fenestration 134, measured parallel to central longitudinal axis 140, equals at least 33% (e.g., at least 50%) of first perimeter PI of distal main-module end 36 of main stent- graft 24 of main module 20, when the main module is unconstrained in the radially-expanded state thereof.
- a greatest width W3 of secondary-module lateral fenestration 134 measured circumferentially around secondary module 22, equals at least 16% of first perimeter PI, such as at least 25% of first perimeter PI. These dimensions of greatest axial length L2 and greatest width W3 may allow secondary-module lateral fenestration 134 to allow sufficient blood flow to both left common carotid artery 18 and brachiocephalic artery 70.
- secondary covering element 132 is shaped so as to define an additional fixation zone 184 between secondary-module lateral fenestration 134 and proximal secondary-module end 138.
- At least one of secondary structural stent elements 131 traverses secondary-module lateral fenestration 134 when secondary module 22 is unconstrained in the radially-expanded state thereof.
- one secondary structural stent element 13 IB is shown traversing secondary-module lateral fenestration 134
- two secondary structural stent elements 13 IB are shown traversing secondary-module lateral fenestration 134.
- three or more secondary structural stent elements 13 IB traverse secondary-module lateral fenestration 134. Such traversal may provide additional structural strength to secondary module 22 at the secondary-module lateral fenestration.
- At least a portion of the border of secondary-module lateral fenestration 134 is defined by an undulating portion of one or more of secondary structural stent elements 131.
- a cross-sectional area of secondary module 22 gradually tapers from proximal secondary-module end 138 to sealing interface 172 when the secondary module is unconstrained in the radially-expanded state thereof.
- the at least one secondary-module lateral fenestration 134 comprises exactly one secondary-module lateral fenestration 134.
- secondary-module lateral fenestration 134 faces in a first radial direction extending from central longitudinal axis 140, and a portion 182 of secondary covering element 132 that faces in a second radial direction opposite the first radial direction extends to and reaches proximal secondary-module end 138.
- secondary module 22 is covered by secondary covering element 132 on the side circumferentially opposite secondary-module lateral fenestration 134, such that secondary-module lateral fenestration 134 and portion 182 face in radially-opposite directions.
- the secondary module is rotationally aligned such that secondary-module lateral fenestration 134 faces left common carotid artery 18, so as to allow blood flow into the left common carotid artery.
- secondary module 22 further comprises a flexible sheet 190, which (a) is blood-sealingly joined to a portion of a secondary border 180 of secondary-module lateral fenestration 134, which portion extends around at least 25% of a perimeter of the secondary border and includes a distal end 192 of secondary border 180 when secondary module 22 is unconstrained in the radially-expanded state thereof, and (b) extends radially inward from secondary border 180 (toward or past central longitudinal axis 140) when secondary module 22 is unconstrained in the radially-expanded state thereof.
- a portion 194 of secondary structural stent elements 131 are attached to flexible sheet 190, which facilitates the radially-inward extension of flexible sheet 190 from secondary border 180.
- secondary module 20 is rotationally aligned such that secondary-module lateral fenestration 134 faces left common carotid artery 18.
- Flexible sheet 190 serves to direct a portion of the blood flow into the left common carotid artery.
- FIG. 7 is a schematic illustration of yet another configuration of secondary module 22, in accordance with an application of the present invention.
- secondary module 22 is shaped so as to define proximal secondary-module end 138, sealing interface 172, and an anchoring axial portion 160 therebetween having central longitudinal axis 140 and an anchoring -portion length L3, measured along the central longitudinal axis from distal sealing interface 172 to proximal secondary-module end 138.
- Anchoring axial portion 160 is typically configured to (a) accommodate the anatomy of aortic arch 19 without blocking blood flow in the arch or to left common carotid artery 18 or brachiocephalic artery 70, (b) provide support for anchoring the secondary module in the aortic arch, and/or (c) provide support for secondary covering element 132, as described below.
- Anchoring axial portion 160 includes a plurality (e.g., at least 8) of secondary structural stent elements 131, which, for example may comprise respective wires.
- each of plurality of secondary structural stent elements 131 has two longitudinal portions 168 that extend toward (e.g., reach) distal sealing interface 172, and an intermediary longitudinal portion 170 that curves around proximal secondary-module end 136, when secondary module 22 is unconstrained in the radially-expanded state thereof (by way of example, one of such secondary structural stent elements 131 is labeled with reference numeral 167 in Fig. 7).
- Curved portions 170 of the plurality of secondary structural stent elements 131 may or may not converge at a single point at proximal secondary-module end 136.
- the plurality of secondary structural stent elements 131 of anchoring axial portion 160 includes some structural stent elements that touch one another (e.g. at or near proximal secondary-module end 138), and no structural stent elements that are fixed to one another, when the secondary module is unconstrained in the radially-expanded state thereof.
- secondary structural stent elements 131 may include a loop element, e.g. a polygonal or elliptical (e.g., circular) loop, at proximal secondary-module end 136, to which loop element respective ends of the plurality of secondary structural stent elements 131 are coupled (configuration not shown).
- secondary covering element 132 when secondary module 22 is unconstrained in the radially- expanded state thereof, secondary covering element 132 at least covers secondary support element 130 along a covered axial portion 162 of anchoring axial portion 160.
- Secondary structural stent elements 131 of anchoring axial portion 160 provide support for secondary covering element 132, holding the secondary covering element open so as to facilitate blood flow to sealing interface 172 and through lateral fenestration 34 of main stent-graft 24.
- Covered axial portion 162 extends proximally from distal sealing interface 172 for an axial covering distance D4 equal to at least 10% (e.g., at least 15%, such as at least 20%), no more than 50% (e.g., no more than 35%), and/or between 10% and 50% (e.g., between 10% and 35%, or between 20% and 35%) of anchoring -portion length L3, axial covering distance D4 measured along central longitudinal axis 140, when secondary module 22 is unconstrained in the radially-expanded state thereof.
- Secondary support element 130 is uncovered proximally to secondary covering element 132.
- an uncovered axial portion 163 of anchoring axial portion 160 extends from proximal secondary-module end 138 to a proximal end 165 of covered axial portion 162, for an axial uncovered distance D7 equal to at least 50% (e.g., at least 65%), no more than 90% (e.g., no more than 80%), and/or between 50% and 90% (e.g., between 65% and 80%) of anchoring-portion length L3, measured along central longitudinal axis 140.
- anchoring axial portion 160 has a greatest anchoring-portion width W4 that is (a) greater than a greatest proximal-end width W5 at the proximal secondary-module end (W5 is optionally zero, as shown, for configurations in which the plurality of secondary structural stent elements 131 converge at a single point) and (b) at least 20%, e.g., at least 50%, at least 75%, or at least 100%, greater than a greatest sealing-interface width W6 at a narrowest portion 164 of distal sealing interface 172, greatest anchoring- portion, sealing-interface, and proximal-end widths W4, W5, and W6 measured perpendicular to central longitudinal axis 140.
- anchoring axial portion 160 has greatest anchoring-portion width W4 at an axial location 166 at an axial distance D5 from proximal secondary-module end 138 equal to at least 33%, no more than 60%, and/or between 33% and 60% of anchoring-portion length L3, axial distance D5 measured along central longitudinal axis 140, when secondary module 22 is unconstrained in the radially-expanded state thereof.
- axial covering distance D4 from distal sealing interface 172 is equal to at least 20% (e.g., at least 30%), no more than 100% (e.g., no more than 60%), and/or between 20% and 100% (e.g., between 30% and 60%) of an axial distance D6 between distal sealing interface 172 and axial location 166 of greatest anchoring-portion width W4, axial distance D6 measured along central longitudinal axis 140, when secondary module 22 is unconstrained in the radially-expanded state thereof.
- secondary module 22 when secondary module 22 is unconstrained in the radially- expanded state thereof:
- anchoring-portion length L3 equals at least 50 mm, no more than 150 mm, and/or between 50 and 150 mm;
- greatest proximal-end width W5 equals at least 0 mm, no more than 35 mm, and/or between 0 and 35 mm, and/or at least 0 mm, no more than 40% of W4, and/or between 0 mm and 40% of W4;
- axial covering distance D4 equals at least 10 mm, no more than 30 mm, and/or between 10 and 30 mm;
- axial distance D5 equals at least 20 mm, no more than 80 mm, and/or between 20 and 80 mm;
- axial distance D6 equals at least 30 mm, no more than 80 mm, and/or between 30 and 80 mm;
- Fig. 8 is a schematic illustration of yet another configuration of secondary module 22, in accordance with an application of the present invention.
- Fig. 8 shows secondary module 22 deployed in aortic arch 19, sealingly coupled to lateral fenestration 34 of main module 20.
- secondary covering element 132 is shaped so as to define at least one lateral opening 174 that begins at and extends from proximal secondary-module end 138 toward sealing interface 172, such as described hereinabove with reference to Figs. 3 and 4.
- the configuration of Fig. 8 may be implemented in combination with the configurations described hereinabove with reference to Figs. 5, 6, and/or 7.
- secondary module 22 comprises an extension structure 200, which is disposed radially outward of a fluid-flow path defined by secondary module 22, in a same radially direction as one of the at least one lateral opening of secondary covering element 132 (in the case of the configuration shown in Figs. 3 and 4, at least one lateral opening 174, and in the case of Fig. 5 and 6, at least one secondary-module lateral fenestration 134).
- Extension structure 200 typically comprises one or more of secondary structural stent elements 131. Extension structure 200 is shaped so as to help hold secondary module 22 properly positioned in aortic arch 19.
- Figs. 9 and 10 are schematic illustrations of a secondary module 222, in accordance with an application of the present invention.
- Fig. 9 shows secondary module 222
- Fig. 10 shows secondary module 222 deployed in aortic arch 19, sealingly coupled to lateral fenestration 34 of main module 20.
- Fig. 9 shows secondary module 222 unconstrained in its radially-expanded state, i.e., no forces are applied to the module by a delivery tool, walls of a blood vessel, or otherwise.
- Secondary module 222 comprises a non-bifurcated secondary stent-graft 226, which typically comprises a secondary generally tubular support element 230 and a secondary covering element 232 that is attached to and at least partially covers a covered axial portion 242 of support element 230 and at least partially does not cover an uncovered axial portion 244 of support element 230.
- secondary covering element 232 partially covers an overlap axial portion 246 along which first and second axial portions 244 and 246 axially overlap; for example, a distal end 250 of secondary covering element 232 may be generally diagonally- shaped, such as shown in Fig. 9.
- Support element 230 typically comprises a plurality of secondary structural stent elements 231.
- secondary structural stent elements 231 are arranged as a plurality of circumferential stent springs 233.
- Secondary covering element 232 serves as a blood flow guide through at least a portion of the secondary stent-graft.
- Secondary covering element 232 typically comprises at least one biologically-compatible substantially blood-impervious flexible sheet, which is attached (such as by stitching) to at least a portion of the respective support element, on either side of the surfaces defined by the support element.
- the flexible sheet may comprise, for example, a polymeric material (e.g., a polyester, or polytetrafluoroethylene), a textile material (e.g., polyethylene terephthalate (PET)), natural tissue (e.g., saphenous vein or collagen), or a combination thereof.
- a polymeric material e.g., a polyester, or polytetrafluoroethylene
- a textile material e.g., polyethylene terephthalate (PET)
- natural tissue e.g., saphenous vein or collagen
- secondary module 222 is configured to be partially inserted into main module 20, such that uncovered axial portion 244 is positioned within main module 20, and covered axial portion 242 is partially positioned outside of and partially positioned within main module 20, through lateral fenestration 34.
- a portion of secondary covering element 232 passes through lateral fenestration 34, so as to form a blood-tight seal with main module 20.
- Fig. 11 is a schematic illustration of a multi-component stent-graft system 310, in accordance with an application of the present invention.
- Multi-component stent-graft system 310 comprises a main module 320, a secondary module 322, and typically a tertiary module 328, which comprise respective stent-grafts, as described below.
- the stent- grafts are configured to assume radially-compressed states, such as when initially positioned in one or more outer tubes of one or more delivery tools, and to assume radially-expanded states upon being deployed from the outer tube(s).
- Fig. 11 shows the stent-grafts in their radially-expanded states in situ.
- Fig. 12 is a schematic illustration of main module 320, in accordance with an application of the present invention.
- Fig. 12 shows main stent-graft 24 unconstrained in its radially-expanded state, i.e., no forces are applied to the stent-graft by a delivery tool, walls of a blood vessel, or otherwise.
- main module 320 may implement any or all of the features of main module 20, described hereinabove with reference to Figs. 1 and 2A-B, including, but not limited to, dissection-reinforcement axial portion 48, descending-aorta axial portion 42, supra-arch axial portion 44, arch axial portion 46, and/or distal axial portion 58.
- Main module 320 comprises a generally tubular main stent-graft 324, such as described hereinabove with reference to Figs. 2A-B regarding main stent-graft 24.
- main covering element 32 and main support element 30 of main stent-graft 324 are shaped so as to together define two lateral fenestrations through main stent-graft 324: a first lateral fenestration 34, as defined by stent-graft 24, and a second lateral fenestration 368, when main stent-graft 324 is unconstrained in its radially- expanded state.
- first lateral fenestration 34 faces in a first radial direction
- second lateral fenestration 368 faces in a second radially direction generally circumferentially opposite the first radial direction.
- first lateral fenestration may be disposed at between 11 o'clock and 1 o'clock (e.g., at 12 o'clock)
- the second lateral fenestration may be disposed at between 5 o'clock and 7 o'clock (e.g., at 6 o'clock).
- first lateral fenestration 34 serves as an inferior lateral fenestration
- second lateral fenestration 368 serves as a superior lateral fenestration
- a first perimeter of first (inferior) lateral fenestration 34 equals at least 200%, no more than 400%, and/or between 200% and 400% of a second perimeter of second (superior) lateral fenestration 368.
- supra-arch axial portion 44 of main stent-graft 324 is internally lined with ePTFE film, or main covering element 32 of main stent-graft 324 comprises entirely ePTFE (and thus does not comprise any polyester).
- main covering element 32 along other portions of the main stent-graft comprises polyester.
- secondary module 320 may implement any of the configurations of secondary module 20 described hereinabove with reference to Figs. 1, 3, 4, 5, 6, 7, 8, 9, and/or 10 mutatis mutandis.
- secondary module is shown in Fig. 11 in the configuration of secondary module 20 shown in Figs. 1 and 3. (For applications in which secondary module is configured as described hereinabove with reference to Fig. 5 and/or Fig.
- greatest axial length L2 of secondary-module lateral fenestration 134 may be less than described hereinabove, e.g., may equal at least 20% of first perimeter PI of distal main-module end 36 of main stent-graft 24 of main module 20, when the main module is unconstrained in the radially-expanded state thereof.
- secondary-module lateral fenestration 134 need only be sufficiently large to allow sufficient blood flow to brachiocephalic artery 70.
- Figs. 13A and 13B are schematic illustrations of respective configurations of tertiary module 328, in accordance with respective applications of the present invention.
- Tertiary module 328 comprises a generally tubular tertiary stent-graft 380, which typically comprises a tertiary generally tubular support element 382 and a tertiary covering element 384 that is attached to and at least partially covers (e.g., only partially covers) the tertiary support element.
- Tertiary module 328 and stent-graft 380 have distal and proximal ends 381 and 383.
- Support element 382 typically comprises a plurality of tertiary structural stent elements 386.
- tertiary structural stent elements 386 are arranged as a plurality of circumferential stent springs 388.
- Tertiary covering element 384 serves as a blood flow guide through at least a portion of the tertiary stent-graft.
- Tertiary covering element 384 typically comprises at least one biologically-compatible substantially blood-impervious flexible sheet, which is attached (such as by stitching) to at least a portion of the respective support element, on either side of the surfaces defined by the support element.
- the flexible sheet may comprise, for example, a polymeric material (e.g., a polyester, or polytetrafluoroethylene), a textile material (e.g., polyethylene terephthalate (PET)), natural tissue (e.g., saphenous vein or collagen), or a combination thereof.
- a polymeric material e.g., a polyester, or polytetrafluoroethylene
- a textile material e.g., polyethylene terephthalate (PET)
- natural tissue e.g., saphenous vein or collagen
- tertiary module 328 is shaped so as to define a sealing interface 372, which is similar to sealing interface 172 described hereinabove with reference to Figs. 3, 4, 5, 6, and 7, and/or hereinbelow with reference to Figs. 1, 3, 4, 5, 6, 7, 8, and 11.
- Sealing interface 372 is sized and configured to form a blood-impervious seal with second (superior) lateral fenestration 368 of main module 320, as shown in Fig. 11.
- sealing interface 372 and/or second (superior) lateral fenestration 368 implement sealing techniques described in US Patent Application Publication 2012/0179236 to Benary et al. and/or PCT Publication WO 2013/005207 to Shalev.
- tertiary module 328 includes covered and uncovered axial portions, similar to the covered and uncovered axial portions 242 and 244 described hereinabove with reference to Fig. 9.
- Tertiary module 328 may implement any of the features described hereinabove with reference to Fig. 9, mutatis mutandis.
- Tertiary module 328 is sized and configured to form a blood-impervious seat with second (superior) lateral fenestration 368 of main module 320, using the techniques described hereinabove with reference to Fig. 10, mutatis mutandis.
- the stent-grafts of system 310 are endovascularly (typically percutaneously) introduced into the thoracic aorta, such as via one of the iliac arteries, while the stent-grafts are positioned in one or more outer tubes of a delivery tool in their radially-compressed states.
- the exemplary procedure begins with the advancing of a guidewire up the descending aorta and into left common carotid artery 18.
- Main stent-graft 324 of main module 320 is initially positioned in its radially-compressed state within an outer tube of a delivery tool, typically near a leading end of the outer tube.
- the outer tube is advanced over the guidewire, until main stent-graft 324 is partially disposed in left common carotid artery 18 and partially disposed in the upper part of the descending aorta.
- the guidewire is withdrawn, leaving the outer tube in place.
- the main stent-graft is held in place as the outer tube is withdrawn, thereby delivering the main stent-graft from the outer tube.
- Main stent-graft 324 typically self-expands, until it assumes its radially-expanded state, upon reaching typically about 80-90% of its maximum unconstrained size, and/or being constrained from further expansion by the wall of the blood vessels, as shown in Fig. 11.
- the main stent-graft (and/or the other stent-grafts, as described hereinbelow) is delivered using an over-the-wire (OTW) approach, in which the guidewire is left in place until the stent-graft is expanded, and thereafter the guidewire is withdrawn.
- OW over-the-wire
- First (inferior) lateral fenestration 34 is disposed in aortic arch 19 facing upstream, generally toward ascending aorta 17, in a vicinity of the bifurcation of aortic arch 19 and left common carotid artery 18.
- Second (superior) lateral fenestration 368 is axially aligned with and faces left subclavian artery 16.
- main stent-graft 324 may comprise one or more radiopaque markers in a vicinity of (e.g., on a periphery of) the one or both of the lateral fenestrations.
- a guidewire (either the same guidewire used to deploy the main stent-graft, or a second guidewire) is advanced up the descending aorta, through a proximal portion of main stent-graft 324, through second (superior) lateral fenestration 368, and into left subclavian artery 16.
- Tertiary stent-graft 380 of tertiary module 328 is positioned in its radially-compressed state within an outer tube of a delivery tool (either the same outer tube used to deploy the main stent-graft, or a second outer tube), typically near a leading end of the outer tube.
- the outer tube is advanced over the guidewire, until tertiary stent- graft 380 is partially disposed in left subclavian artery 16, and partially disposed within radially-expanded main stent-graft 324.
- the guidewire is withdrawn, leaving the outer tube in place.
- Tertiary stent-graft 380 is held in place as the outer tube is withdrawn, thereby delivering the tertiary stent-graft from the outer tube.
- Tertiary stent-graft 380 typically self-expands, until it assumes its radially-expanded state, upon reaching its maximum unconstrained size, and/or being constrained from further expansion by the wall of the left subclavian artery.
- Tertiary stent-graft 380 is thus adapted for transluminal delivery in its radially-compressed state through a portion of main stent-graft 324 and second (superior) lateral fenestration 368, while the main stent-graft is in its radially-expanded state.
- a guidewire (either the same guidewire used to deploy the main stent-graft and/or tertiary stent-graft, or another guidewire) is advanced up the descending aorta, through a distal portion of main stent-graft 324, out of first (inferior) lateral fenestration 34, and into aortic arch 19, extending toward, or partially into, ascending aorta 17.
- Secondary stent- graft 26 of secondary module 322 is positioned in its radially-compressed state within an outer tube of a delivery tool (either the same outer tube used to deploy the main stent-graft and/or the tertiary stent-graft, or another outer tube), typically near a leading end of the outer tube.
- the outer tube is advanced over the guidewire, until secondary stent-graft 26 is partially disposed in aortic arch 19, extending toward, or partially into, ascending aorta 17, and partially disposed within radially-expanded main stent-graft 324 in the upper part of the descending aorta.
- the guidewire is withdrawn, leaving the outer tube in place.
- the secondary stent-graft is rotationally aligned such that the at least one lateral opening 174 faces left common carotid artery 18, so as to allow blood flow to the left common carotid artery (and, for applications in which the secondary stent-graft is long enough, so as to allow blood flow into brachiocephalic artery 70).
- the secondary stent-graft may comprise one or more radiopaque markers to facilitate such proper rotational alignment.
- the radiopaque markers may be positioned on one or more edges of the at least one lateral opening.
- Secondary stent-graft 26 is held in place as the outer tube is withdrawn, thereby delivering the secondary stent-graft from the outer tube.
- Secondary stent-graft 26 typically self-expands, until it assumes its radially-expanded state, upon reaching its maximum unconstrained size, and/or being constrained from further expansion by the wall of the blood vessels.
- Secondary stent-graft 26 is thus adapted for transluminal delivery in its radially-compressed state through a portion of main stent-graft 324 and first (inferior) lateral fenestration 34, while the main stent-graft is in its radially-expanded state.
- Secondary module 322 reduces blood turbulence in the aortic arch, and serves as a funnel that creates a gradual taper of the blood flow into first (inferior) lateral fenestration 34 of main stent-graft 324.
- sealing interface 172 is shaped so as to define a neck portion longitudinally flanked by proximal and distal portions. The neck portion is generally radially narrower than the proximal and distal portions.
- sealing interface 172 and/or lateral fenestration 34 implement sealing techniques described in US Patent Application Publication 2012/0179236 to Benary et al. and/or PCT Publication WO 2013/005207 to Shalev, which are incorporated herein by reference.
- 1, 3, 4, 5, 6, 7, 8, and 11 may implement the sealing techniques described hereinabove regarding secondary module 222 with reference to Figs. 9 and 10 (i.e., rather than defining a narrower neck portion, secondary covering element 132 of secondary stent-graft 26 may instead only partially axially cover secondary support element 130 and define sealing interface 172B).
- Figs. 1 and 2A-B are schematic illustrations of kinking properties of different axial portions of main stent-graft 24, in accordance with an application of the present invention.
- ⁇ if distal axial portion 58 of main stent-graft 24, when the main stent-graft is in the radially-expanded state, is placed and constrained in a first curved tube 390 having a circular cross-section and an inner diameter equal to an outer diameter of distal axial portion 58, distal axial portion 58 experiences kinking only when at least an axial portion 392 of the first curved tube has less than a first radius of curvature rl, as shown in Fig. 14A, and
- kinking means that the graft material of main covering element 32 is pinched, or folded in a blood-flow- disturbing manner. It is noted that the outer diameters of the axial portions may vary axially therealong, in which case the inner diameters of the curved tubes would also correspondingly vary. It is also noted that the first and second curved tubes are not elements of multi-component stent-graft system 10, but are rather geometric constructs used to describe certain features of the main stent-graft.
- Fig. 15 is a schematic illustration of kinking in a stent-graft 400.
- dissection-reinforcement axial portion 48 is configured to avoid kinking. Without such configuration, for example if substantial axial spacing is provided between adjacent stent springs 402 of stent-graft 400, the stent-graft would be more prone to kinking 404, as shown in Fig. 14.
- multi-component stent-graft systems 10 and 310 are generally described herein as being used for treating Type B aortic dissection, the scope of the present invention also includes using these systems for treating other conditions, such as aortic aneurysms.
Abstract
A generally tubular stent-graft has distal and proximal stent-graft ends and includes a generally tubular support element and a covering element. When the stent-graft is unconstrained in a radially-expanded state: the covering and support elements are shaped so as to together define a lateral fenestration having distal and proximal fenestration ends, a perimeter of the distal stent-graft end equals at least 200% of a perimeter of the proximal stent-graft end, and the stent-graft includes a dissection-reinforcement axial portion, which (a) has a proximal dissection-reinforcement end that is disposed no more than 20 mm proximal to the proximal fenestration end, extends along the stent-graft for a distance equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end, and (c) has a radial strength that is at least 10% greater than an average radial strength of the entire stent-graft.
Description
MULTI-COMPONENT STENT-GRAFT SYSTEM FOR AORTIC DISSECTIONS
CROSS-REFERENCE TO RELATED APPLICATION
The present application claims priority from US Provisional Application 61/775,964, filed March 11, 2013, which is assigned to the assignee of the present application and is incorporated herein by reference.
FIELD OF THE APPLICATION
The present application relates generally to prostheses and surgical methods, and specifically to tubular prostheses, including endovascular grafts and stent-grafts, and surgical techniques for using the prostheses to maintain patency of body passages such as blood vessels, and treating dissections of arterial walls and/or aneurysms.
BACKGROUND OF THE APPLICATION
Blood vessels occasionally weaken or even rupture. For example, in the aortic artery, the vascular wall can weaken or tear, resulting in dangerous conditions such as aneurysm and dissection. Treatment of such conditions can be performed by implanting a prosthesis within the vascular system using minimally-invasive surgical procedures. An endoluminal prosthesis typically includes one or more stents affixed to graft material and is delivered to the treatment site by endovascular insertion. Once the endoluminal prosthesis is radially enlarged, it should remain in place indefinitely by self-attachment to the vessel wall, acting as a substitute vessel for the flow of blood or other fluids. Aortic dissection is a tear or partial tear in the inner wall of the aorta, which causes blood to flow between the layers of the wall of the aorta, forcing the layers apart. Aortic dissections may be divided into two types in accordance with the Stanford classification: Type A dissections involve the ascending aorta and/or aortic arch, and possibly the descending aorta. Type B dissections involves the descending aorta or the arch (distal to right brachiocephalic artery origin), without involvement of the ascending aorta.
SUMMARY OF THE APPLICATION
In some applications of the present invention, a multi-component stent-graft system is provided for treating a Type B aortic dissection. The system is configured to be deployed in the thoracic aorta and the left subclavian artery, and, optionally, the left
common carotid artery. The stent-grafts of the system are assembled in situ to accommodate the dimensions of the particular patient's anatomy, generally without requiring prior customization of the stent-grafts or in situ modifications to the stent-grafts, which might be expensive and/or complex. Typically, upon deployment, the multi- component stent-graft system defines a blood-flow path from the ascending aorta, over the aortic arch, and to the descending aorta. The multi-component stent-graft system additionally provides or allows blood-flow paths to the three branches of the aortic arch.
The multi-component stent-graft system comprises a main module and, for some applications, a secondary module. The main module comprises a generally tubular main stent-graft, and the secondary module comprises a non-bifurcated secondary stent-graft. The stent-grafts are configured to assume radially-compressed states for delivery, and radially-expanded states upon being deployed.
The main stent-graft typically comprises a main generally tubular support element and a main covering element that is attached to and at least partially covers the main support element. The support element typically comprises a plurality of main structural stent elements. For some applications, the main structural stent elements are arranged as a plurality of circumferential stent springs.
The main covering element and the main support element are shaped so as to together define a lateral fenestration, e.g., exactly one lateral fenestration, through the main stent-graft, when the main stent-graft is unconstrained in its radially-expanded state.
For some applications, when the main stent-graft is unconstrained in its radially- expanded state, i.e., no forces are applied to the stent-graft by a delivery tool, walls of a blood vessel, or otherwise, a first perimeter of a distal main-module end of the main stent- graft (and the main module) is greater than a second perimeter of a proximal main-module end of the main stent-graft (and the main module). For example, the first perimeter may equal at least 150% of the second perimeter, such as at least 200%, at least 250%, at least 300%, or at least 400% of the second perimeter.
For some applications, the main stent-graft is sized and configured to positioned such that (a) a distal, radially larger, descending-aorta axial portion of the stent-graft, including the distal main-module end thereof, is disposed in the aorta downstream from the bifurcation with the left subclavian artery, at least partially in the upper part of the descending aorta, (b) a proximal, radially smaller, supra-arch axial portion of the main
stent-graft, including the proximal main-module end thereof, is disposed in the left subclavian artery, and (c) an arch axial portion, axially between the descending-aorta axial portion and the supra-arch axial portion, is disposed in the aortic arch.
For some applications, when the main stent-graft is unconstrained in its radially- expanded state, the main stent-graft includes a dissection-reinforcement axial portion, which (a) includes a portion of the main structural stent elements, (b) has a proximal dissection-reinforcement end that is disposed along the stent-graft no more than 20 mm proximal to the proximal fenestration end, and/or (c) extends along the stent-graft for a distance equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end.
For some applications, the dissection-reinforcement axial portion has a radial strength that is at least 10% greater than an average radial strength of the entire main stent-graft. This greater strength increases the force that the dissection-reinforcement axial portion applies to a tear of the aortic dissection, thereby sealing the tear. (It is noted that providing the entire length of the main stent-graft with a high strength has at least two drawbacks: stent-grafts with higher strengths are more difficult to deploy, and are more likely to cause damage to the vasculature.) For some applications, the dissection- reinforcement axial portion is configured to be generally straight when the main stent- graft is unconstrained in the radially-expanded state. For some applications, the main structural stent elements of the dissection- reinforcement axial portion are arranged as a plurality of circumferential stent springs of the dissection-reinforcement axial portion. For some applications, a height, measured axially along the main stent-graft, of at least one of the stent springs of the dissection- reinforcement axial portion varies by less than 10% around a circumference of the stent spring when the main stent-graft is unconstrained in the radially-expanded state.
For some applications, the portion of structural stent elements included by the dissection-reinforcement axial portion is a first portion of the structural stent elements, and when the stent-graft is unconstrained in the radially-expanded state: (a) the main stent-graft includes a distal-end axial portion, which includes a second portion of the structural stent elements, (b) the distal-end axial portion axially extends along the stent- graft from the distal main-module end for a distance equal to between 5% and 32% of a greatest perimeter of the main stent-graft distally to a distal end of the lateral fenestration,
and (c) the distal-end axial portion has a radial strength that is at least a 10% greater than the average radial strength of the entire main stent-graft.
For some applications, the dissection-reinforcement axial portion includes a first plurality of the stent springs, and the main stent-graft includes a distal axial portion, which includes a second plurality of the stent springs. The distal axial portion is disposed along the main stent-graft distal and axially adjacent to the distal dissection-reinforcement end, and extends along the main stent-graft for a distance equal to between 5% and 32% of the greatest perimeter of the main stent-graft distally to the distal fenestration end. Typically, the distal axial portion extends to and reaches the distal main-module end. The stent springs have respective average heights, measured axially along the main stent-graft (the height of each stent spring is averaged circumferentially around the stent-graft). An average of the average heights of the first plurality of the stent springs is less than 75% of the average height of a proximal-most one of the second plurality of the stent springs. For these applications, the dissection-reinforcement axial portion is typically configured to be generally straight when the main stent-graft is unconstrained in the radially-expanded state.
The secondary stent-graft typically comprises a secondary generally tubular support element and a secondary covering element that is attached to and at least partially covers the secondary support element. The support element typically comprises a plurality of secondary structural stent elements. When the secondary module (and the secondary stent-graft) is unconstrained in the radially-expanded state thereof:
• the secondary module is shaped so as to define a proximal secondary -module end, a sealing interface distal to the proximal secondary-module end, and a central longitudinal axis therebetween. The sealing interface is sized and configured to form a blood-impervious seal with the lateral fenestration of the main module;
• the secondary module is shaped so as to define a distal secondary-module end; and
• the secondary covering element is shaped so as to define at least one lateral opening that begins at and extends from the proximal secondary-module end toward the sealing interface along the central longitudinal axis for a distance equal to at least 50% of a greatest width of the secondary module, measured
perpendicular to the central longitudinal axis.
For some applications, at least one of the secondary structural stent elements traverses the lateral opening when the secondary module is unconstrained in the radially- expanded state thereof. Such traversal may provide additional structural strength to the secondary module at the lateral opening.
In some applications of the present invention, another configuration of secondary module is provided. In this configuration, when the secondary module is unconstrained in the radially-expanded state thereof:
• the at least one lateral opening includes at least first and second lateral openings;
• the secondary covering element is shaped so as to define the first and second lateral openings, each of which begins at and extends from the proximal secondary-module end toward the sealing interface along the central longitudinal axis for the distance equal to at least 50% of the greatest width of the secondary module;
• the first and second lateral openings face in different first and second radial directions extending from the central longitudinal axis; and
• the first and the second lateral openings at least partially axially overlap along the central longitudinal axis. For some applications, the first and the second lateral openings axially coincide along the central longitudinal axis. For some applications, the first and the second radial directions are opposite each other; in other words the first and second lateral openings face in radially-opposite directions.
In some applications of the present invention, further alternative configurations of secondary module are provided. In these configurations, when the secondary module is unconstrained in the radially-expanded state thereof, (a) the secondary covering element is shaped so as to define at least one secondary-module lateral fenestration disposed distal to the proximal secondary-module end and proximal to the sealing interface, and (b) a greatest axial length of the secondary-module lateral fenestration equals at least 33% of the first perimeter of the distal main-module end of the main stent-graft of the main module, when the main module is unconstrained in the radially-expanded state thereof.
For some applications, a greatest width of the secondary-module lateral fenestration, measured circumferentially around the secondary module, equals at least 16% of the first perimeter of the distal main-module end of the main stent-graft of the main module.
For some applications, the secondary module further comprises a flexible sheet, which (a) is blood- sealingly joined to a portion of the secondary border, which portion extends around at least 25% of a perimeter of the secondary border and includes a distal end of the secondary border when the secondary module is unconstrained in the radially- expanded state thereof, and (b) extends radially inward from the secondary border (toward or past the central longitudinal axis) when the secondary module is unconstrained in the radially-expanded state thereof. For some applications, a portion of the secondary structural stent elements are attached to the flexible sheet, which facilitates the radially- inward extension of the flexible sheet from secondary border.
There is therefore provided, in accordance with an application of the present invention, apparatus including a generally tubular stent-graft, which has distal and proximal stent-graft ends and includes:
a generally tubular support element, which includes a plurality of structural stent elements; and
a covering element that is attached to and at least partially covers the support element,
wherein when the stent-graft is unconstrained in a radially-expanded state:
the covering element and the support element are shaped so as to together define a lateral fenestration having distal and proximal fenestration ends,
a first perimeter of the distal stent-graft end equals at least 200% of a second perimeter of the proximal stent-graft end, and
the stent-graft includes a dissection-reinforcement axial portion, which (a) includes a portion of the structural stent elements, (b) has (i) a distal dissection- reinforcement end and (ii) a proximal dissection-reinforcement end that is disposed along the stent-graft no more than 20 mm proximal to the proximal fenestration end, (c) extends along the stent-graft for a distance equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end, and (d) has a radial strength that is at least 10% greater than an average radial strength of the entire stent-graft.
For some applications:
the portion of the structural stent elements included by the dissection- reinforcement axial portion is a first portion of the structural stent elements, and
when the stent-graft is unconstrained in the radially-expanded state:
the stent-graft includes a distal-end axial portion, which includes a second portion of the structural stent elements, and
the distal-end axial portion axially extends along the stent-graft from the distal end of stent-graft for a distance equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end, and
the distal-end axial portion has a radial strength that is at least a 10% greater than the average radial strength of the entire stent-graft.
For some applications, an axial length of the dissection-reinforcement axial portion is between 1 and 3 cm when the stent-graft is unconstrained in the radially- expanded state. For some applications, the proximal dissection-reinforcement end is disposed along the stent-graft no more proximal than the distal fenestration end when the stent- graft is unconstrained in the radially-expanded state. Alternatively, for some applications, the proximal dissection-reinforcement end is disposed along the stent-graft between the distal fenestration end and the proximal fenestration end, inclusive, when the stent-graft is unconstrained in the radially-expanded state.
For some applications, a distance between the distal dissection-reinforcement end and the distal stent-graft end equals between 32% and 160% of a largest perimeter of the stent-graft when the stent-graft is unconstrained in the radially-expanded state.
For some applications, the dissection-reinforcement axial portion extends along the stent-graft for a distance equal to between 10% and 22% of a greatest perimeter of the stent-graft distally to the distal fenestration end when the stent-graft is unconstrained in the radially-expanded state.
For some applications, the first perimeter equals at least 250% of the second perimeter. For any of the applications described above, the dissection-reinforcement axial portion may be configured to be generally straight when the stent-graft is unconstrained in
the radially-expanded state.
For any of the applications described above, the structural stent elements of the dissection-reinforcement axial portion may be arranged as a plurality of circumferential stent springs, and a height, measured axially along the stent-graft, of at least one of the stent springs may vary by less than 10% around a circumference of the stent spring when the stent-graft is unconstrained in the radially-expanded state.
For any of the applications described above, the structural stent elements of the dissection-reinforcement axial portion may be arranged as a plurality of circumferential stent springs, and for each one of the stent springs, a height, measured axially along the stent-graft, of the stent spring may vary by less than 10% around a circumference of the stent spring when the stent-graft is unconstrained in the radially-expanded state.
For any of the applications described above, the first perimeter may be between 5 and 15 cm, and the second perimeter may be between 2.5 and 5.7 cm.
For any of the applications described above, the stent-graft may be shaped so as to define exactly one lateral fenestration when the stent-graft is unconstrained in the radially- expanded state.
For any of the applications described above, the lateral fenestration may be an inferior first lateral fenestration, which faces in a first radial direction, and when the main stent-graft is unconstrained in the radially-expanded state, the main covering element and the main support element may be shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction.
There is further provided, in accordance with an application of the present invention, apparatus including a generally tubular stent-graft, which has distal and proximal stent-graft ends and includes:
a generally tubular support element, which includes a plurality of structural stent elements arranged as a plurality circumferential stent springs; and
a covering element that is attached to and at least partially cover the support element,
wherein when the stent-graft is unconstrained in a radially-expanded state:
the covering element and the support element are shaped so as to together
define a lateral fenestration having distal and proximal fenestration ends, a first perimeter of the distal stent-graft end equals at least 200% of a second perimeter of the proximal stent-graft end,
the stent-graft includes a dissection-reinforcement axial portion, which (a) includes a first plurality of the stent springs, (b) has (i) a distal dissection- reinforcement end and (ii) a proximal dissection-reinforcement end that is disposed along the stent-graft no more than 20 mm proximal to the proximal fenestration end, (c) extends along the stent-graft for a distance equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end, and (d) is configured to be generally straight,
the stent-graft includes a distal axial portion, which (a) includes a second plurality of the stent springs, (b) is disposed along the stent-graft distal and axially adjacent to the distal dissection-reinforcement end, (c) extends along the stent- graft for a distance equal to between 5% and 32% of the greatest perimeter of the stent-graft distally to the distal fenestration end,
the stent springs have respective average heights, measured axially along the stent-graft, and
an average of the average heights of the first plurality of the stent springs is less than 75% of the average height of a proximal-most one of the second plurality of the stent springs.
For some applications, each of the average heights of the first plurality of the stent springs is less than 75% of the average heights of the proximal-most one of the second plurality of stent springs when the stent-graft is unconstrained in the radially-expanded state.
For some applications, the average of the average heights of the first plurality of the stent springs is less than 75% of the average height of a second one of the second plurality of stent springs, other than the proximal-most one of the second plurality of stent springs when the stent-graft is unconstrained in the radially-expanded state.
For some applications, the average of the average heights of the first plurality of the stent springs is less than 75% of each of the average heights of the second plurality of stent springs when the stent-graft is unconstrained in the radially-expanded state.
For some applications, the distal axial portion is configured to be generally
straight when the stent-graft is unconstrained in the radially-expanded state.
For some applications, an axial length of the dissection-reinforcement axial portion is between 1 and 3 cm when the stent-graft is unconstrained in the radially- expanded state. For some applications, the proximal dissection-reinforcement end is disposed along the stent-graft no more proximal than the distal fenestration end when the stent- graft is unconstrained in the radially-expanded state.
For some applications, the proximal dissection-reinforcement end is disposed along the stent-graft between the distal fenestration end and the proximal fenestration end, inclusive, when the stent-graft is unconstrained in the radially-expanded state.
For some applications, an axial spacing between two of the first plurality of the stent springs equals less than 10% of an average of the average heights of the two stent springs.
For some applications, the first perimeter equals at least 300% of the second perimeter.
For some applications, the dissection-reinforcement axial portion extends along the stent-graft for a distance equal to between 10% and 32% of the greatest perimeter of the stent-graft distally to the distal fenestration end when the stent-graft is unconstrained in the radially-expanded state. For some applications, the distal axial portion extends to and reaches the distal stent-graft end.
For any of the applications described above, the average height of at least one of the first plurality of stent springs may vary by less than 10% around a circumference of the stent spring when the stent-graft is unconstrained in the radially-expanded state. For any of the applications described above, for each one of the first plurality of stent springs, the average height thereof may vary by less than 10% around a circumference of the stent spring when the stent-graft is unconstrained in the radially- expanded state.
For any of the applications described above, optionally:
if the distal axial portion, when the stent-graft is in the radially-expanded state, is
placed and constrained in a first curved tube having a circular cross-section and an inner diameter equal to an outer diameter of the distal axial portion, the distal axial portion experiences kinking only when at least an axial portion of the first curved tube has less than a first radius of curvature, and
if the dissection-reinforcement axial portion, when the stent-graft is in the radially- expanded state, is placed and constrained in a second curved tube having a circular cross- section and an inner diameter equal to an outer diameter of the dissection-reinforcement axial portion, the dissection-reinforcement axial portion experiences kinking only when at least an axial portion of the second curved tube has less than a second radius of curvature, which second radius of curvature is at least 30% less than the first radius of curvature.
For any of the applications described above, the lateral fenestration may be an inferior first lateral fenestration, which faces in a first radial direction, and when the main stent-graft is unconstrained in the radially-expanded state, the main covering element and the main support element may be shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction.
There is still further provided, in accordance with an application of the present invention, apparatus including a stent-graft system, which includes:
a main module, which has distal and proximal main-module ends, and includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element, wherein the main covering element and the main support element are shaped so as to together define a lateral fenestration when the main module is unconstrained in a radially-expanded state thereof; and
a secondary module, which includes a non-bifurcated secondary stent-graft, which includes (a) a secondary support element, which includes secondary structural stent elements, and (b) a secondary covering element that is attached to and at least partially covers the secondary support element,
wherein when the secondary module is unconstrained in a radially-expanded state thereof:
the secondary module is shaped so as to define (a) a proximal secondary-
module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) a central longitudinal axis therebetween, wherein the sealing interface is sized and configured to form a blood -impervious seal with the lateral fenestration of the main module, and
the secondary covering element is shaped so as to define at least one lateral opening that begins at and extends from the proximal secondary-module end toward the sealing interface along the central longitudinal axis for a distance equal to at least 50% of a greatest width of the secondary module, measured perpendicular to the central longitudinal axis.
For some applications, a greatest width of the at least one lateral opening, measured circumferentially around the secondary module, equals at least 90 degrees circumferentially around the proximal secondary-module end, the 90 degrees being measured at the sealing interface.
For some applications, at least one of the secondary structural stent elements traverses the at least one lateral opening when the secondary module is unconstrained in the radially-expanded state thereof.
For some applications, the at least one lateral opening extends from the proximal secondary-module end toward the sealing interface along at least 70% of a greatest width of the secondary module, measured perpendicular to the central longitudinal axis when the secondary module is unconstrained in the radially-expanded state thereof.
For some applications, the cross- sectional area of the secondary module, measured perpendicular to the central longitudinal axis, gradually tapers from the proximal secondary-module end to the sealing interface when the secondary module is unconstrained in the radially-expanded state thereof.
For any of the applications described above, when the secondary module is unconstrained in the radially-expanded state thereof:
the at least one lateral opening may include at least first and second lateral openings,
the secondary covering element may be shaped so as to define the first and the second lateral openings, each of extends from the proximal secondary-module end toward the sealing interface along the central longitudinal axis for the distance equal to at least 50% of the greatest width of the secondary module,
the first and the second lateral openings may face in different first and second radial directions extending from the central longitudinal axis, and
the first and the second lateral openings may at least partially axially overlap along the central longitudinal axis. For some applications, the first and the second lateral openings axially coincide along the central longitudinal axis. For some applications, the first and the second radial directions are opposite each other. For some applications, the secondary covering element is shaped so as to define two portions, which (a) extend to and reach the proximal secondary-module end, and (b) are shaped so as to define respective concave inner surfaces that face each other and the central longitudinal axis, and (c) are not joined to each other at the proximal secondary-module end.
For any of the applications described above, the at least one lateral opening may include exactly one lateral opening. For some applications, when the secondary module is unconstrained in the radially-expanded state thereof, the lateral opening faces in a first radial direction extending from the central longitudinal axis, and a portion of the secondary covering element that faces in a second radial direction opposite the first radial direction extends to and reaches the proximal secondary-module end.
For any of the applications described above, a first perimeter of the distal main- module end may equal at least 200%, e.g., at least 300%, of a second perimeter of the proximal main-module end when the main module is unconstrained in the radially- expanded state thereof.
For any of the applications described above:
the lateral fenestration may be an inferior first lateral fenestration, which faces in a first radial direction,
when the main stent-graft is unconstrained in the radially-expanded state, the main covering element and the main support element may be shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction,
the stent-graft system may further include a generally tubular tertiary stent-graft, and
the main and the tertiary stent-grafts may be configured such that the tertiary stent- graft forms a blood-impervious seal with the main stent-graft around the superior second
lateral fenestration when the tertiary stent-graft is disposed therethrough, and the main stent-graft is in the radially-expanded state thereof and the tertiary stent-graft is in a radially-expanded state thereof.
There is additionally provided, in accordance with an application of the present invention, apparatus including a stent-graft system, which includes:
a main module, which has distal and proximal main-module ends, and includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element, wherein the main covering element and the main support element are shaped so as to together define a main-module lateral fenestration when the main module is unconstrained in a radially- expanded state thereof; and
a secondary module, which includes a non-bifurcated secondary stent-graft, which includes (a) a secondary support element, which includes secondary structural stent elements, and (b) a secondary covering element that is attached to and at least partially covers the secondary support element,
wherein when the secondary module is unconstrained in a radially-expanded state thereof:
the secondary module is shaped so as to define (a) a proximal secondary- module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) a central longitudinal axis therebetween, wherein the sealing interface is sized and configured to form a blood-impervious seal with the main-module lateral fenestration of the main module,
the secondary covering element is shaped so as to define at least one secondary-module lateral fenestration disposed distal to the proximal secondary- module end and proximal to the sealing interface, and
a greatest axial length of the secondary-module lateral fenestration, measured parallel to the central longitudinal axis, equals at least 33% of a first perimeter of the distal main-module end when the main module is unconstrained in the radially-expanded state thereof.
For some applications, at least one of the secondary structural stent elements traverses the secondary-module lateral fenestration.
For some applications, the greatest axial length of the secondary-module lateral fenestration equals at least 50% of the first perimeter of the distal main-module end when the secondary module is unconstrained in the radially-expanded state thereof.
For some applications, the cross- sectional area of the secondary module gradually tapers from the proximal secondary-module end to the sealing interface when the secondary module is unconstrained in the radially-expanded state thereof.
For any of the applications described above, the at least one secondary-module lateral fenestration may include exactly one secondary-module lateral fenestration. For some applications, when the secondary module is unconstrained in the radially-expanded state thereof, the secondary-module lateral fenestration faces in a first radial direction extending from the central longitudinal axis, and a portion of the secondary covering element that faces in a second radial direction opposite the first radial direction extends to and reaches the proximal secondary-module end.
For any of the applications described above, the first perimeter of the distal main- module end may equal at least 200%, e.g., at least 300%, of a second perimeter of the proximal main-module end when the main module is unconstrained in the radially- expanded state thereof.
For any of the applications described above, the secondary module may further include a flexible sheet, which (a) is blood-sealingly joined to a portion of the secondary border, which portion extends around at least 25% of a perimeter of the secondary border and includes a distal end of the secondary border when the secondary module is unconstrained in the radially-expanded state thereof, and (b) extends radially inward from the secondary border when the secondary module is unconstrained in the radially- expanded state thereof. For some applications, a portion of the secondary structural stent elements are attached to the flexible sheet.
For any of the applications described above:
the main-module lateral fenestration may be an inferior first lateral fenestration, which faces in a first radial direction,
when the main stent-graft is unconstrained in the radially-expanded state, the main covering element and the main support element may be shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction,
the stent-graft system may further include a generally tubular tertiary stent-graft, and
the main and the tertiary stent-grafts may be configured such that the tertiary stent- graft forms a blood-impervious seal with the main stent-graft around the superior second lateral fenestration when the tertiary stent-graft is disposed therethrough, and the main stent-graft is in the radially-expanded state thereof and the tertiary stent-graft is in a radially-expanded state thereof.
There is yet additionally provided, in accordance with an application of the present invention; apparatus including a stent-graft system, which includes:
a main module, which has distal and proximal main-module ends, and includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element, wherein the main covering element and the main support element are shaped so as to together define a main-module lateral fenestration when the main module is unconstrained in a radially- expanded state thereof; and
a secondary module, which includes a non-bifurcated secondary stent-graft, which includes (a) a secondary support element, which includes secondary structural stent elements, (b) a secondary covering element that is attached to and at least partially covers the secondary support element, and (c) a flexible sheet,
wherein when the secondary module is unconstrained in a radially-expanded state thereof:
the secondary module is shaped so as to define (a) a proximal secondary- module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) a central longitudinal axis therebetween, wherein the sealing interface is sized and configured to form a blood-impervious seal with the main-module lateral fenestration of the main module,
the secondary covering element is shaped so as to define at least one secondary-module lateral fenestration disposed distal to the proximal secondary- module end and proximal to the sealing interface, and
the flexible sheet (a) is blood-sealingly joined to a portion of a secondary border of the secondary-module lateral fenestration, which portion extends around at least 25% of a perimeter of the secondary border and includes a distal end of the
secondary border when the secondary module is unconstrained in the radially- expanded state thereof, and (b) extends radially inward from the secondary border when the secondary module is unconstrained in the radially-expanded state thereof. For some applications, a portion of the secondary structural stent elements are attached to the flexible sheet.
For some applications:
the main-module lateral fenestration is an inferior first lateral fenestration, which faces in a first radial direction,
when the main stent-graft is unconstrained in the radially-expanded state, the main covering element and the main support element are shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction,
the stent-graft system further includes a generally tubular tertiary stent-graft, and the main and the tertiary stent-grafts are configured such that the tertiary stent- graft forms a blood-impervious seal with the main stent-graft around the superior second lateral fenestration when the tertiary stent-graft is disposed therethrough, and the main stent-graft is in the radially-expanded state thereof and the tertiary stent-graft is in a radially-expanded state thereof. There is also provided, in accordance with an application of the present invention, apparatus including a stent-graft system, which includes:
a main module, which has distal and proximal main-module ends, and includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element, wherein the main covering element and the main support element are shaped so as to together define a lateral fenestration when the main module is unconstrained in a radially-expanded state thereof; and
a secondary module, which includes a non-bifurcated secondary stent-graft, which includes (a) a secondary support element, which includes secondary structural stent elements, and (b) a secondary covering element that is attached to and partially covers the secondary support element,
wherein when the secondary module is unconstrained in a radially-expanded state thereof:
the secondary module is shaped so as to define (a) a proximal secondary- module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) an anchoring axial portion therebetween having a central longitudinal axis and an anchoring-portion length, measured along the central longitudinal axis from the distal sealing interface to the proximal secondary-module end,
the sealing interface is sized and configured to form a blood-impervious seal with the lateral fenestration of the main module,
the secondary covering element at least covers the secondary support element along a covered axial portion of the anchoring axial portion, which covered axial portion extends proximally from the distal sealing interface for an axial covering distance equal to between 10% and 50% of the anchoring-portion length, the axial covering distance measured along the central longitudinal axis, wherein the secondary support element is uncovered proximally to the secondary covering element, and
the anchoring axial portion has a greatest anchoring-portion width that is (a) greater than a greatest proximal-end width at the proximal secondary-module end and (b) at least 20% greater than a greatest sealing-interface width at a narrowest portion of the distal sealing interface, the greatest anchoring-portion, sealing-interface, and proximal-end widths measured perpendicular to the central longitudinal axis.
For some applications, the anchoring axial portion has the greatest anchoring- portion width at an axial location at an axial distance from the proximal secondary- module end equal to between 33% and 60% of the anchoring-portion length, the axial distance measured along the central longitudinal axis, when the secondary module is unconstrained in the radially-expanded state thereof.
For some applications, the greatest anchoring-portion width is at least 50% greater than the greatest sealing-interface width at the narrowest portion of the distal sealing interface, when the secondary module is unconstrained in the radially-expanded state thereof.
For some applications, the axial covering distance from the distal sealing interface
is equal to between 20% and 100% of an axial distance between the distal sealing interface and an axial location of the greatest anchoring-portion width, the axial distance measured along the central longitudinal axis, when the secondary module is unconstrained in the radially-expanded state thereof. For some applications, the axial covering distance from the distal sealing interface is equal to between 30% and 60% of the axial distance between the distal sealing interface and the axial location of the greatest anchoring- portion width, when the secondary module is unconstrained in the radially-expanded state thereof.
For some applications, the axial covering distance equals between 10% and 35% of the anchoring-portion length, when the secondary module is unconstrained in the radially-expanded state thereof.
For some applications, the axial covering distance is at least 15% of the anchoring- portion length, when the secondary module is unconstrained in the radially-expanded state thereof. For any of the applications described above, the anchoring axial portion may include a plurality of the secondary structural stent elements, each of which has two longitudinal portions that extend toward the distal sealing interface, and an intermediary longitudinal portion that curves around the proximal secondary-module end, when the secondary module is unconstrained in the radially-expanded state thereof. For any of the applications described above, the anchoring axial portion may include a plurality of the secondary structural stent elements, some of which touch one another, and none of which are fixed to one another, when the secondary module is unconstrained in the radially-expanded state thereof.
For any of the applications described above, an uncovered axial portion of the anchoring portion may extend from the proximal secondary-module end to a proximal end of the covered axial portion, for an axial uncovered distance equal to between 30 and 120 mm, when the secondary module is unconstrained in the radially-expanded state thereof.
For any of the applications described above, the greatest proximal-end width may equal zero. There is further provided, in accordance with an application of the present invention, a method for treating a patient including:
endovascularly introducing a generally tubular stent-graft, while in a radially- compressed state, and positioning the stent-graft such that (a) a proximal stent-graft end of the stent-graft is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery left subclavian artery, and a left common carotid artery, and (b) a distal stent-graft end of the stent-graft is positioned in a descending aorta, wherein the stent-graft includes (a) a generally tubular support element, which includes a plurality of structural stent elements, and (b) a covering element that is attached to and at least partially covers the support element; and
thereafter, transitioning the stent-graft to a radially-expanded state, in which (a) the covering element and the support element are shaped so as to together define a lateral fenestration that is disposed in the aortic arch, with the lateral fenestration facing upstream generally toward an ascending aorta, the lateral fenestration having distal and proximal fenestration ends, (b) a first perimeter of a distal stent-graft end of the stent-graft equals at least 200% of a second perimeter of the proximal stent-graft end, and (c) the stent-graft includes a dissection-reinforcement axial portion, which (i) includes a portion of the structural stent elements, (ii) has (x) a distal dissection-reinforcement end and (y) a proximal dissection-reinforcement end that is disposed along the stent-graft no more than 20 mm proximal to the proximal fenestration end, (iii) extends along the stent-graft for an axial distance equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end, and (iv) has a radial strength that is at least 10% greater than an average radial strength of the entire stent-graft.
For some applications:
the lateral fenestration is an inferior first lateral fenestration, which faces in a first radial direction,
when the main stent-graft is in the radially-expanded state, the main covering element and the main support element are shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction, and
positioning the stent-graft includes positioning the stent-graft such that (a) the proximal stent-graft end is positioned in the left common carotid artery, (b) the inferior first lateral fenestration is disposed in the aortic arch, with the inferior first lateral fenestration facing upstream generally toward the ascending aorta, and (c) the superior second lateral fenestration is axially aligned with and faces the left subclavian artery.
There is still further provided, in accordance with an application of the present invention, a method for treating a patient including:
endovascularly introducing a generally tubular stent-graft, while in a radially- compressed state, and positioning the stent-graft such that (a) a proximal stent-graft end of the stent-graft is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery left subclavian artery, and a left common carotid artery, and (b) a distal stent-graft end of the stent-graft is positioned in a descending aorta, wherein the stent-graft includes (a) a generally tubular support element, which includes a plurality of structural stent elements arranged as a plurality circumferential stent springs, and (b) a covering element that is attached to and at least partially covers the support element; and
thereafter, transitioning the stent-graft to a radially-expanded state, in which (a) the covering element and the support element are shaped so as to together define a lateral fenestration that is disposed in the aortic arch, with the lateral fenestration facing upstream generally toward an ascending aorta, the lateral fenestration having distal and proximal fenestration ends, (b) a first perimeter of a distal stent-graft end of the stent-graft equals at least 200% of a second perimeter of the proximal stent-graft end, (c) the stent- graft includes a dissection-reinforcement axial portion, which (i) includes a first plurality of the stent springs, (ii) has (x) a distal dissection-reinforcement end and (y) a proximal dissection-reinforcement end that is disposed along the stent-graft no more than 20 mm proximal to the proximal fenestration end, (iii) extends along the stent-graft for a distance equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end, and (iv) is configured to be generally straight when the stent-graft is unconstrained in the radially-constrained state, (d) the stent-graft includes a distal axial portion, which (i) includes a second plurality of the stent springs, (ii) is disposed along the stent-graft distal and axially adjacent to the distal dissection-reinforcement end, (iii) extends along the stent-graft for a distance equal to between 5% and 32% of the greatest perimeter of the stent-graft distally to the distal fenestration end, (e) the stent springs have respective average heights, measured axially along the stent-graft, and (f) an average of the average heights of the first plurality of the stent springs is less than 75% of the average height of a proximal-most one of the second plurality of the stent springs.
For some applications:
the lateral fenestration is an inferior first lateral fenestration, which faces in a first
radial direction,
when the main stent-graft is in the radially-expanded state, the main covering element and the main support element are shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction, and
positioning the stent-graft includes positioning the stent-graft such that (a) the proximal stent-graft end is positioned in the left common carotid artery, (b) the inferior first lateral fenestration is disposed in the aortic arch, with the inferior first lateral fenestration facing upstream generally toward the ascending aorta, and (c) the superior second lateral fenestration is axially aligned with and faces the left subclavian artery.
There is additionally provided, in accordance with an application of the present invention, a method for treating a patient including:
endovascularly introducing a main module, while in a radially-compressed state thereof, and positioning the main module such that (a) a proximal main-module end of the main module is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery left subclavian artery, and a left common carotid artery, and (b) a distal main-module end of the main module is positioned in a descending aorta, wherein the main module includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element;
thereafter, transitioning the main stent-graft to a radially-expanded state thereof, in which the main covering element and the main support element are shaped so as to together define a lateral fenestration that is disposed in the aortic arch, with the lateral fenestration facing upstream generally toward an ascending aorta;
endovascularly introducing and passing a secondary module, while in a radially- compressed state thereof, through a distal portion of the main stent-graft such that the secondary module is disposed through the lateral fenestration and is disposed partially in the aortic arch, wherein the secondary module includes a non -bifurcated secondary stent- graft, which includes (a) a secondary support element, which includes secondary structural stent elements, and (b) a secondary covering element that is attached to and at least partially covers the secondary support element; and
thereafter, transitioning the secondary module to a radially-expanded state thereof,
in which the secondary module is shaped so as to define (a) a proximal secondary-module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) a central longitudinal axis therebetween, such that the sealing interface forms a blood -impervious seal with the lateral fenestration of the main module, and the secondary covering element is shaped so as to define at least one lateral opening that begins at and extends from the proximal secondary-module end toward the sealing interface along the central longitudinal axis for a distance equal to at least 50% of a greatest width of the secondary module, measured perpendicular to the central longitudinal axis.
For some applications:
the lateral fenestration is an inferior first lateral fenestration, which faces in a first radial direction,
when the main stent-graft is in the radially-expanded state, the main covering element and the main support element are shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction, and
positioning the stent-graft includes positioning the stent-graft such that (a) the proximal stent-graft end is positioned in the left common carotid artery, (b) the inferior first lateral fenestration is disposed in the aortic arch, with the inferior first lateral fenestration facing upstream generally toward the ascending aorta, and (c) the superior second lateral fenestration is axially aligned with and faces the left subclavian artery.
There is yet additionally provided, in accordance with an application of the present invention, a method for treating a patient including:
endovascularly introducing a main module, while in a radially-compressed state thereof, and positioning the main module such that (a) a proximal main-module end of the main module is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery left subclavian artery, and a left common carotid artery, and (b) a distal main-module end of the main module is positioned in a descending aorta, wherein the main module includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element;
thereafter, transitioning the main stent-graft to a radially-expanded state thereof, in
which the main covering element and the main support element are shaped so as to together define a main-module lateral fenestration that is disposed in the aortic arch, with the main-module lateral fenestration facing upstream generally toward an ascending aorta; endovascularly introducing and passing a secondary module, while in a radially- compressed state thereof, through a distal portion of the main stent-graft such that the secondary module is disposed through the main-module lateral fenestration and is disposed partially in the aortic arch, wherein the secondary module includes a non- bifurcated secondary stent-graft, which includes (a) a secondary support element, which includes secondary structural stent elements, and (b) a secondary covering element that is attached to and at least partially covers the secondary support element; and
thereafter, transitioning the secondary module to a radially-expanded state thereof, in which the secondary module is shaped so as to define (a) a proximal secondary-module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) a central longitudinal axis therebetween, such that the sealing interface forms a blood -impervious seal with the main-module lateral fenestration of the main module, and the secondary covering element is shaped so as to define at least one secondary-module lateral fenestration disposed distal to the proximal secondary-module end and proximal to the sealing interface, wherein a greatest axial length of the secondary-module lateral fenestration, measured parallel to the central longitudinal axis, equals at least 33% of a first perimeter of the distal main-module end.
There is also provided, in accordance with an application of the present invention, a method for treating a patient including:
endovascularly introducing a main module, while in a radially-compressed state thereof, and positioning the main module such that (a) a proximal main-module end of the main module is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery left subclavian artery, and a left common carotid artery, and (b) a distal main-module end of the main module is positioned in a descending aorta, wherein the main module includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element;
thereafter, transitioning the main stent-graft to a radially-expanded state thereof, in which the main covering element and the main support element are shaped so as to
together define a main-module lateral fenestration that is disposed in the aortic arch, with the main-module lateral fenestration facing upstream generally toward an ascending aorta; endovascularly introducing and passing a secondary module, while in a radially- compressed state thereof, through a distal portion of the main stent-graft such that the secondary module is disposed through the main-module lateral fenestration and is disposed partially in the aortic arch, wherein the secondary module includes a non- bifurcated secondary stent-graft, which includes (a) a secondary support element, which includes secondary structural stent elements, (b) a secondary covering element that is attached to and at least partially covers the secondary support element, and (c) a flexible sheet; and
thereafter, transitioning the secondary module to a radially-expanded state thereof, in which (a) the secondary module is shaped so as to define (a) a proximal secondary- module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) a central longitudinal axis therebetween, such that the sealing interface forms a blood- impervious seal with the main-module lateral fenestration of the main module, (b) the secondary covering element is shaped so as to define at least one secondary -module lateral fenestration disposed distal to the proximal secondary-module end and proximal to the sealing interface, and (c) the flexible sheet (i) is blood- sealingly joined to a portion of a secondary border of the secondary-module lateral fenestration, which portion extends around at least 25% of a perimeter of the secondary border and includes a distal end of the secondary border, and (ii) extends radially inward from the secondary border when the secondary module is unconstrained in the radially-expanded state thereof.
There is further provided, in accordance with an application of the present invention, a method for treating a patient including:
endovascularly introducing a main module, while in a radially-compressed state thereof, and positioning the main module such that (a) a proximal main-module end of the main module is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery left subclavian artery, and a left common carotid artery, and (b) a distal main-module end of the main module is positioned in a descending aorta, wherein the main module includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element;
thereafter, transitioning the main stent-graft to a radially-expanded state thereof, in which the main covering element and the main support element are shaped so as to together define a lateral fenestration that is disposed in the aortic arch, with the lateral fenestration facing upstream generally toward an ascending aorta;
endovascularly introducing and passing a secondary module, while in a radially- compressed state thereof, through a distal portion of the main stent-graft such that the secondary module is disposed through the lateral fenestration and is disposed partially in the aortic arch, wherein the secondary module includes a non -bifurcated secondary stent- graft, which includes (a) a secondary support element, which includes secondary structural stent elements, and (b) a secondary covering element that is attached to and partially covers the secondary support element; and thereafter, transitioning the secondary module to a radially-expanded state thereof, in which the secondary module is shaped so as to define (a) a proximal secondary-module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) an anchoring axial portion therebetween having a central longitudinal axis and an anchoring - portion length, measured along the central longitudinal axis from the distal sealing interface to the proximal secondary-module end, such that the sealing interface forms a blood-impervious seal with the lateral fenestration of the main module, the secondary covering element at least covers the secondary support element along a covered axial portion of the anchoring axial portion, which covered axial portion extends proximally from the distal sealing interface for an axial covering distance equal to between 10% and 50% of the anchoring-portion length, the axial covering distance measured along the central longitudinal axis, wherein the secondary support element is uncovered proximally to the secondary covering element, and the anchoring axial portion has a greatest anchoring-portion width that is (a) greater than a greatest proximal-end width at the proximal secondary-module end and (b) at least 20% greater than a greatest sealing- interface width at a narrowest portion of the distal sealing interface, the greatest anchoring-portion, sealing-interface, and proximal-end widths measured perpendicular to the central longitudinal axis. The present invention will be more fully understood from the following detailed description of embodiments thereof, taken together with the drawings, in which:
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is a schematic illustration of multi-component stent-graft system, in accordance with an application of the present invention;
Figs. 2A-B are schematic illustrations of a main module of the multi-component stent-graft system of Fig. 1, in accordance with respective applications of the present invention;
Fig. 3 is a schematic illustration of a secondary module of the multi-component stent-graft system of Fig. 1, in accordance with an application of the present invention;
Fig. 4 is a schematic illustration of another configuration of the secondary module of the multi-component stent-graft system of Fig. 1, in accordance with an application of the present invention;
Figs. 5 and 6 are schematic illustrations of alternative configurations of the secondary module of the multi-component stent-graft system of Fig. 1, in accordance with respective applications of the present invention;
Fig. 7 is a schematic illustration of yet another configuration of the secondary module of the secondary module of the multi-component stent-graft system of Fig. 1, in accordance with an application of the present invention;
Fig. 8 is a schematic illustration of yet another configuration of the secondary module of the secondary module of the multi-component stent-graft system of Fig. 1, in accordance with an application of the present invention; Fig. 9 is a schematic illustration of still another configuration of the secondary module of the secondary module of the multi-component stent-graft system of Fig. 1, in accordance with an application of the present invention;
Fig. 10 is a schematic illustration of the secondary module of Fig. 9 deployed in an aortic arch, sealingly coupled to a lateral fenestration of a main module of the multi- component stent-graft system, in accordance with an application of the present invention;
Fig. 11 is a schematic illustration of another multi-component stent-graft system, in accordance with an application of the present invention;
Fig. 12 is a schematic illustration of a main module of the multi-component stent- graft system of Fig. 11, in accordance with an application of the present invention; Figs. 13A and 13B are schematic illustrations of respective configurations of a
tertiary module of the multi-component stent-graft system of Fig. 11, in accordance with respective applications of the present invention;
Figs. 14A-B are schematic illustrations of kinking properties of different axial portions of a main stent-graft of the multi-component stent-graft system of Fig. 1, in accordance with an application of the present invention; and
Fig. 15 is a schematic illustration of kinking in a stent-graft.
DETAILED DESCRIPTION OF APPLICATIONS
Fig. 1 is a schematic illustration of multi -component stent-graft system 10, in accordance with an application of the present invention. In some applications of the present invention, multi-component stent-graft system 10 is provided for treating a Type B aortic dissection 12. The system is configured to be deployed in a thoracic aorta 14 and a left subclavian artery 16, and, optionally, a left common carotid artery 18. The multi- component stent-graft system is configured to be deployed in a straightforward procedure. The stent-grafts of the system are assembled in situ to accommodate the dimensions of the particular patient's anatomy, generally without requiring prior customization of the stent- grafts or in situ modifications to the stent-grafts, which might be expensive and/or complex.
Typically, upon deployment, the multi-component stent-graft system defines a blood-flow path from an ascending aorta 17, over an aortic arch 19, and to the descending aorta. The multi-component stent-graft system additionally provides or allows blood-flow paths to the three branches of the aortic arch.
Multi-component stent-graft system 10 comprises a main module 20 and, for some applications, a secondary module 22. Main module 20 comprises a generally tubular main stent-graft 24, and secondary module 22 comprises a non-bifurcated secondary stent-graft 26. The stent-grafts are configured to assume radially-compressed states, such as when initially positioned in one or more outer tubes of one or more delivery tools, and to assume radially-expanded states upon being deployed from the outer tube(s). Fig. 1 shows the stent-grafts in their radially-expanded states in situ. For some applications, the stent-grafts are relaxed in their radially-expanded states. For some applications, the stent- grafts are configured to be self-expanding. For example, they may be heat-set to assume their radially-expanded states.
Exemplary configuration of the main module
Reference is still made to Fig. 1, and is additionally made to Figs. 2A-B, which are schematic illustrations of main module 20 that comprises main stent-graft 24, in accordance with respective applications of the present invention. Figs. 2A-B show main stent-graft 24 unconstrained in its radially-expanded state, i.e., no forces are applied to the stent-graft by a delivery tool, walls of a blood vessel, or otherwise. Main stent-graft 24 typically comprises a main generally tubular support element 30 and a main covering element 32 that is attached to and at least partially covers (e.g., only partially covers) the main support element. Support element 30 typically comprises a plurality of main structural stent elements 31. For some applications, main structural stent elements 31 are arranged as a plurality of circumferential stent springs 33. For some applications, support element 30, as well as support elements 130, 230 and 330, which are described hereinbelow, comprise a super-elastic alloy, such as Nitinol. Main covering element 32 serves as a blood flow guide through at least a portion of the main stent-graft. Main covering element 32 typically comprises at least one biologically-compatible substantially blood-impervious flexible sheet, which is attached (such as by stitching) to at least a portion of the respective support element, on either side of the surfaces defined by the support element. The flexible sheet may comprise, for example, a polymeric material (e.g., a polyester, or polytetrafluoroethylene), a textile material (e.g., polyethylene terephthalate (PET)), natural tissue (e.g., saphenous vein or collagen), or a combination thereof.
Main covering element 32 and main support element 30 are shaped so as to together define a lateral fenestration 34, e.g., exactly one lateral fenestration 34, through main stent-graft 24, which lateral fenestration has distal and proximal fenestration ends 35 and 37, when main stent-graft 24 is unconstrained in its radially-expanded state. As used in the present application, including in the claims, a "fenestration" is an opening entirely surrounded by a covering element. For example, lateral opening 174, described hereinbelow with reference to Fig. 3, is not a fenestration, because the lateral opening extends from the end of module and thus is not surrounded by the covering element along a proximal edge of the lateral opening. When multi-component stent-graft system 10 is implanted as shown in Fig. 1, lateral fenestration 34 serves as an inferior lateral fenestration. Typically, at least a portion of the border of lateral fenestration 34 is defined by an undulating portion of one or more of structural stent elements 31.
For some applications, when main stent- graft 24 is unconstrained in its radially- expanded state, i.e., no forces are applied to the stent-graft by a delivery tool, walls of a blood vessel, or otherwise, a first perimeter PI of a distal main-module end 36 of main stent-graft 24 (and main module 20) is greater than a second perimeter P2 of a proximal main-module end 38 of the main stent-graft (and the main module), and/or a first cross- sectional area of the distal main-module end 36 is greater than a second cross- sectional area of proximal main-module end 38. For applications in which main stent-graft 24 is generally cylindrical when unconstrained in its radially-expanded state, first and second perimeters PI and P2 are first and second diameters. For example, first perimeter PI may equal at least 150% of second perimeter P2, such as at least 200%, at least 250%, at least 300%, or at least 400%, and/or the first cross -sectional area may equal at least 225% of the second cross-sectional area, such as at least 400%, at least 625%, at least 900%, or at least 1600%.
For example, first perimeter PI may be at least 5 cm, no more than 15 cm, and/or between 5 and 15 cm, such as at least 7.5 cm, e.g., at least 9 cm, no more than 13 cm, and/or between 7.5 (e.g., 9) and 13 cm, and second perimeter P2 may be at least 2.5 cm, no more than 5.7 cm, and/or between 2.5 and 5.7 cm, such as at least 3 cm, no more than 4.5 cm, and/or between 3 and 4.5 cm.
For some applications, when main stent-graft 24 is unconstrained in its radially- expanded state, a perimeter of lateral fenestration 34 is at least 5 cm, no more than 15 cm, and/or between 5 and 15 cm, such as at least 7.5 cm, e.g., at least 9 cm, no more than 13 cm, and/or between 7.5 cm (e.g., 9 cm) and 13 cm. For some applications, when main stent-graft 24 is unconstrained in its radially-expanded state, a perimeter of lateral fenestration 34 is at least 80%, no more than 120%, and/or between 80% and 120% of first perimeter PI, and/or at least 150%, no more than 250%, and/or between 150% and 250% of second perimeter P2.
For some applications, second module 22 is not necessary for providing blood flow into the lateral fenestration, and is thus optionally not provided. For example, second module 22 may not be necessary when lateral fenestration 34 is sufficiently large (e.g., has a perimeter of at least 9 cm and/or at least 80% of first perimeter PI).
For some applications, main stent-graft 24, when unconstrained in its radially- expanded state, has an axial length of at least 5 cm, no more than 40 cm, and/or between 5
and 30 cm, such as at least 10 cm, no more than 30 cm, and/or between 10 and 30 cm. (The axial length is measured along a central longitudinal axis 40 of the stent-graft.) For some applications, main stent-graft 24, when unconstrained in its radially-expanded state, has a greatest perimeter (at any axial location along the stent-graft) of at least 7.5 cm, no more than 19 cm, and/or between 7.5 and 19 cm, such as at least 12.5 cm, no more than 16 cm, and/or between 12.5 and 16 cm. These values are typical for adult subjects, in which the vast majority of dissections occur. For pediatric subjects, in which dissections are rare, these dimensions may be reduced by a factor of up to 1:3.
For some applications, such dimensions allow main stent-graft 24 to be positioned such that (a) a distal, radially larger, descending-aorta axial portion 42 of the stent-graft, including distal main-module end 36 thereof, is disposed in the aorta downstream from the bifurcation with the left subclavian artery, at least partially in the upper part of the descending aorta, (b) a proximal, radially smaller, supra-arch axial portion 44 of the main stent-graft, including proximal main-module end 38 thereof, is disposed in left subclavian artery 16, as shown in Fig. 1, and (c) an arch axial portion 46, axially between descending-aorta axial portion 42 and supra-arch axial portion 44, is disposed in aortic arch 19. Typically, arch axial portion 46 at least partially axially overlaps fenestration 34, since the fenestration should be disposed in the apex of the arch. For some applications, descending-aorta axial portion 42 has an average perimeter that is greater than (e.g., between 5% and 15% greater than) an average perimeter of the portion of the aorta in which it is disposed. For some applications, supra-arch axial portion 44 has an average perimeter that is greater than (e.g., between 5% and 15% greater than) the average perimeter of the portion of the left subclavian artery in which it is disposed.
For some applications, when main stent-graft 24 is unconstrained in its radially- expanded state, the main stent-graft includes a dissection-reinforcement axial portion 48, which:
• includes a portion of main structural stent elements 31 ;
• has a distal dissection-reinforcement end 50;
• has a proximal dissection-reinforcement end 52 that is disposed along the stent-graft no more than 20 mm proximal to proximal fenestration end 37; proximal dissection-reinforcement end 52 may be either proximal or distal to proximal fenestration end 37. For some applications, proximal dissection-
reinforcement end 52 is disposed along the main stent-graft no more proximal than distal fenestration end 35 when the stent-graft is unconstrained in the radially-expanded state, such as shown in Figs. 1 and 2A. For other applications, proximal dissection-reinforcement end 52 is disposed along the main stent-graft between distal fenestration end 35 and proximal fenestration end 37, inclusive, when the stent-graft is unconstrained in the radially- expanded state, such as shown in Fig. 2B; and/or
• extends along the stent-graft for a distance equal to at least 5%, no more than 32%, and/or between 5% and 32% of a greatest perimeter of the stent-graft distally to distal fenestration end 35, such as at least 10%, no more than 20%, and/or between 10% and 20%.
For some applications, dissection-reinforcement axial portion 48 has a radial strength that is at least 10% greater than an average radial strength of the entire main stent-graft, such as at least 15% greater, or at least 30% greater. This greater strength increases the force that dissection-reinforcement axial portion 48 applies to a tear 56 of aortic dissection 12, thereby sealing the tear. Tear 56 is generally located in an upper portion of thoracic aorta 14, and sometimes additionally in a lower portion of left subclavian artery 16 and/or at the take-off of left subclavian artery 16 from thoracic aorta 14. (It is noted that providing the entire length of the main stent-graft with a high strength has at least two drawbacks: stent-grafts with higher strengths are more difficult to deploy, and are more likely to cause damage to the vasculature.)
Typically, an arch axial portion 46 and dissection-reinforcement axial portion 48 do not include any bare main structural stent elements 31, such that main covering element 32 intervenes between the stent elements and the blood vessel wall in the vicinity of tear 56.
For some applications, an axial length of dissection-reinforcement axial portion 48 is at least 1 cm, no more than 3 cm, and/or between 1 and 3 cm when the main stent-graft is unconstrained in the radially-expanded state.
For some applications, a distance Dl between distal dissection-reinforcement end 50 and distal main-module end 36 is at least 32%, no more than 160%, and/or between
32% and 160% of a largest perimeter of the main stent-graft, when the main stent-graft is unconstrained in the radially-expanded state. Alternatively or additionally, for some
applications, distance Dl is at least 3 cm, no more than 5 cm, and/or between 3 and 5 cm, when the main stent-graft is unconstrained in the radially-expanded state. Still further alternatively or additionally, for some applications, when the main stent-graft is unconstrained in the radially-expanded state: (a) distance Dl equals between at least 20%, no more than 66%, and/or between 20% and 66% of a total length LI of main stent-graft 24, and/or (b) a distance D2 between proximal dissection-reinforcement end 52 and proximal main-module end 38 equals at least 33%, no more than 80%, and/or between 33% and 80% of total length LI.
For some applications, such as shown in Figs. 2A-B, dissection-reinforcement axial portion 48 is configured to be generally straight when the main stent-graft is unconstrained in the radially-expanded state.
For some applications, main structural stent elements 31 of dissection- reinforcement axial portion 48 are arranged as a plurality of circumferential stent springs 33 of dissection-reinforcement axial portion 48. For some applications, a strut height H, measured axially along the main stent-graft, of at least one of stent springs 33 of dissection-reinforcement axial portion 48 varies by less than 10% around a circumference of the stent spring when the main stent-graft is unconstrained in the radially-expanded state. For some applications, for each one of stent springs 33 of dissection-reinforcement axial portion 48, height H of the stent spring varies by less than 10% around a circumference of the stent spring when the main stent-graft is unconstrained in the radially-expanded state.
For some applications, the portion of structural stent elements 31 included by dissection-reinforcement axial portion 48 is a first portion of structural stent elements 31, and when the stent-graft is unconstrained in the radially-expanded state: (a) main stent- graft 24 includes a distal-end axial portion 54, which includes a second portion of structural stent elements 31, (b) distal-end axial portion 54 axially extends along the stent- graft from distal main-module end 36 for a distance equal to at least 5%, no more than 32%, and/or between 5% and 32% of a greatest perimeter of the main stent-graft distally to distal fenestration end 35, such as at least 11%, no more than 22%, and/or between 11% and 22%, and (c) distal-end axial portion 54 has a radial strength that is at least a 10% greater than the average radial strength of the entire main stent-graft.
For some applications, dissection-reinforcement axial portion 48 includes a first
plurality 60 of stent springs 33, and main stent-graft 24 includes a distal axial portion 58, which includes a second plurality 62 of stent springs 33. Distal axial portion 58 is disposed along the main stent-graft distal and axially adjacent to distal dissection- reinforcement end 50, and extends along the main stent-graft for a distance equal to at least 5%, no more than 32%, and/or between 5% and 32% of the greatest perimeter of the main stent-graft distally to the distal fenestration end 35. Typically, distal axial portion 58 extends to and reaches the distal main-module end 36. Stent springs 33 have respective average strut heights, measured axially along the main stent-graft (the height of each stent spring is averaged circumferentially around the stent-graft). An average of the average heights of first plurality 60 of stent springs 33 is less than 75% (e.g., less than 70%) of the average height of a proximal-most one 64 of second plurality 62 of stent springs 33. These smaller average heights generally allow dissection-reinforcement axial portion 48 to bend without the stent springs thereof coming into contact with one another. For these applications, dissection-reinforcement axial portion 48 is typically configured to be generally straight when the main stent-graft is unconstrained in the radially-expanded state.
For some applications, each of the average heights of first plurality 60 of stent springs 33 is less than 75% (e.g., less than 70%) of the average height of proximal-most one 64 of second plurality 62 of stent springs 33 when the main stent-graft is unconstrained in the radially-expanded state. For some applications, the average of the average heights of first plurality 60 of stent springs 33 is less than 75% (e.g., less than 70%) of the average height of a second one 66 of second plurality 62 of stent springs 33, other than proximal-most one 64 of second plurality 62 of stent springs 33 when the main stent-graft is unconstrained in the radially-expanded state. For some applications, the average of the average heights of first plurality 60 of stent springs 33 is less than 75% (e.g., less than 70%) of each of the average heights of second plurality 62 of stent springs 33 when the main stent-graft is unconstrained in the radially-expanded state.
For some applications, an axial spacing S between two of first plurality 60 of stent springs 33 of dissection-reinforcement axial portion 48 equals less than 10% of an average of the average heights H of the two stent springs 33. Such low axial spacing between the stent springs of reduces the risk of kinking of dissection-reinforcement axial portion 48. The use of a greater axial spacing S would make dissection-reinforcement axial portion 48 more prone to kinking, such as described hereinbelow with reference to
Fig. 14.
For some applications, distal axial portion 58 is configured to be generally straight when the main stent-graft is unconstrained in the radially-expanded state.
Exemplary configuration of the secondary module Reference is still made to Fig. 1, and is additionally made to Fig. 3, which is a schematic illustration of secondary module 22 that comprises secondary stent-graft 26, in accordance with an application of the present invention. Fig. 3 shows secondary stent- graft 26 unconstrained in its radially-expanded state, i.e., no forces are applied to the stent-graft by a delivery tool, walls of a blood vessel, or otherwise. Secondary stent-graft 26 typically comprises a secondary generally tubular support element 130 and a secondary covering element 132 that is attached to and at least partially covers (e.g., only partially covers) the secondary support element. Support element 130 typically comprises a plurality of secondary structural stent elements 131. For some applications, secondary structural stent elements 131 are arranged as a plurality of circumferential stent springs 133. Secondary covering element 132 serves as a blood flow guide through at least a portion of the secondary stent-graft. Secondary covering element 132 typically comprises at least one biologically-compatible substantially blood-impervious flexible sheet, which is attached (such as by stitching) to at least a portion of the respective support element, on either side of the surfaces defined by the support element. The flexible sheet may comprise, for example, a polymeric material (e.g., a polyester, or polytetrafluoroethylene), a textile material (e.g., polyethylene terephthalate (PET)), natural tissue (e.g., saphenous vein or collagen), or a combination thereof.
When secondary module 22 (and secondary stent-graft 26) is unconstrained in the radially-expanded state thereof: · secondary module 22 is shaped so as to define a proximal secondary-module end 138, a sealing interface 172 distal to proximal secondary-module end 138, and a central longitudinal axis 140 therebetween. Sealing interface 172 is sized and configured to form a blood-impervious seal with lateral fenestration 34 of main module 20; · secondary module 22 is shaped so as to define a distal secondary-module end
136; and
• secondary covering element 132 is shaped so as to define at least one lateral opening 174 that begins at and extends from proximal secondary-module end 138 toward sealing interface 172 along central longitudinal axis 140 for a distance D3 equal to at least 50% (e.g., at least 70%) of a greatest width Wl of secondary module 22, measured perpendicular to central longitudinal axis 140. In other words, lateral opening 174 reaches proximal secondary-module end 138, is thus not entirely surrounded by secondary covering element 132, and therefore is not a fenestration, as defined hereinabove with reference to Figs. 1 and 2A-B.
For some applications, a greatest width W2 of at least one lateral opening 174, measured circumferentially around secondary module 22, equals at least 90 degrees circumferentially around proximal secondary-module end 138, the 90 degrees being measured at sealing interface 172 (even though the lateral opening typically does not extend to the sealing interface, and may have its greatest width W2 at proximal secondary-module end 138).
For some applications, at least one of secondary structural stent elements 131 traverses lateral opening 174 when the secondary module is unconstrained in the radially- expanded state thereof. By way of example, in Fig. 3 two secondary structural stent elements 13 IB are shown traversing lateral opening 174. Alternatively, a single secondary structural stent element 13 IB, or three or more secondary structural stent elements 13 IB, traverse lateral opening 174. Such traversal may provide additional structural strength to secondary module 22 at the lateral opening. For some applications of this configuration, support element 130 is shaped so as to define a complete tube, which is only partially covered by secondary covering element 132. For some other applications in which none of secondary structural stent elements 131 traverses lateral opening 174, support element 130 is shaped so as to define a partial tube circumferentially.
For some applications, a cross-sectional area of secondary module 22, measured perpendicular to central longitudinal axis 40, gradually tapers from proximal secondary- module end 138 to sealing interface 172 when the secondary module is unconstrained in the radially-expanded state thereof.
For some applications, such as shown in Fig. 3, the at least one lateral opening 174
comprises exactly one lateral opening 174. For some of these applications, when secondary module 22 is unconstrained in the radially-expanded state thereof, lateral opening 174 faces in a first radial direction extending from central longitudinal axis 140, and a portion 176 of secondary covering element 132 that faces in a second radial direction opposite the first radial direction extends to and reaches proximal secondary- module end 138. In other words, secondary module 22 is covered by secondary covering element 132 on the side circumferentially opposite lateral opening 174, such that lateral opening 174 and portion 176 face in radially-opposite directions.
Typically, upon deployment of main and secondary stent-grafts 20 and 22, the stent-grafts together provide continuous coverage covering element material along the blood flow path, which may help prevent further trauma to aorta, and sub-tears in the aorta.
Exemplary deployment of the
multi-component stent-graft system Reference is again made to Fig. 1, which schematically shows a portion of a typical aorta, including thoracic aorta 14, which includes an upper part of ascending aorta 17, and aortic arch 19, and an upper part of a supra-renal descending aorta. Also shown are the three branches of aortic arch 19: a brachiocephalic artery 70, left common carotid artery 18, and left subclavian artery 16. In an exemplary transluminal delivery procedure for implanting multi-component stent-graft system 10, as configured in Figs. 1 and 2A-B, the stent-grafts of system 10 are endovascularly (typically percutaneously) introduced into the thoracic aorta, such as via one of the iliac arteries, while the stent-grafts are positioned in one or more outer tubes of a delivery tool in their radially-compressed states. Typically, the exemplary procedure begins with the advancing of a guidewire up the descending aorta and into left subclavian artery 16. Main stent-graft 24 of main module 20 is initially positioned in its radially-compressed state within an outer tube of a delivery tool, typically near a leading end of the outer tube. The outer tube is advanced over the guidewire, until main stent-graft 24 is partially disposed in left subclavian artery 16 and partially disposed in the upper part of the descending aorta. The guidewire is withdrawn, leaving the outer tube in place. The main stent-graft is held in place as the
outer tube is withdrawn, thereby delivering the main stent-graft from the outer tube. Main stent-graft 24 typically self-expands, until it assumes its radially-expanded state, upon reaching typically about 80-90% of its maximum unconstrained size, and/or being constrained from further expansion by the wall of the blood vessels, as shown in Fig. 1. Alternatively, the main stent-graft (and/or the other stent-grafts, as described hereinbelow) is delivered using an over-the-wire (OTW) approach, in which the guidewire is left in place until the stent-graft is expanded, and thereafter the guidewire is withdrawn.
Descending-aorta axial portion 42 of main stent-graft 24, including distal main- module end 36, is positioned in the upper part of the descending aorta, and supra-arch axial portion 44 of main stent-graft 24, including proximal main-module end 38, is positioned in left subclavian artery 16. Arch axial portion 46 of main stent-graft 24, including lateral fenestration 34, is disposed in aortic arch 19, with the lateral fenestration facing upstream, generally toward ascending aorta 17, in a vicinity of the bifurcation of aortic arch 19 and left subclavian artery 16. For some applications, proper rotational alignment and/or axial orientation of the lateral fenestration is achieved using fluoroscopy. For example, main stent-graft 24 may comprise one or more radiopaque markers in a vicinity of (e.g., on a periphery of) the lateral fenestration.
A guidewire (either the same guidewire used to deploy the main stent-graft, or a second guidewire) is advanced up the descending aorta, through a distal portion of main stent-graft 24, out of lateral fenestration 34, and into aortic arch 19, extending toward, or partially into, ascending aorta 17. Secondary stent-graft 26 of secondary module 22 is positioned in its radially-compressed state within an outer tube of a delivery tool (either the same outer tube used to deploy the main stent-graft, or a second outer tube), typically near a leading end of the outer tube. The outer tube is advanced over the guidewire, until secondary stent-graft 26 is partially disposed in aortic arch 19, extending toward, or partially into, ascending aorta 17, and partially disposed within radially-expanded main stent-graft 24 in the upper part of the descending aorta. The guidewire is withdrawn, leaving the outer tube in place.
The secondary stent-graft is rotationally aligned such that the at least one lateral opening 174 faces left common carotid artery 18, so as to allow blood flow to the left common carotid artery (and, for applications in which the secondary stent-graft is long enough, so as to allow blood flow into brachiocephalic artery 70). The secondary stent-
graft may comprise one or more radiopaque markers to facilitate such proper rotational alignment. For example, the radiopaque markers may be positioned on one or more edges of the at least one lateral opening. Secondary module 22 is positioned so as to not block brachiocephalic artery 70 or left common carotid artery 18. The secondary stent-graft is held in place as the outer tube is withdrawn, thereby delivering the secondary stent-graft from the outer tube. Secondary stent-graft 26 typically self-expands, until it assumes its radially-expanded state, upon reaching its maximum unconstrained size, and/or being constrained from further expansion by the wall of the blood vessels. Secondary stent-graft 26 is thus adapted for transluminal delivery in its radially-compressed state through a portion of main stent-graft 24 and lateral fenestration 34, while the main stent-graft is in its radially-expanded state.
A distal portion of secondary stent-graft 26, including distal secondary-module end 136, is positioned within main stent-graft 24, and sealing interface 172 of secondary stent-graft 26 is sealingly coupled to lateral fenestration 34 of main stent-graft 24. A proximal portion of secondary stent-graft 26, including proximal end 138, is positioned in aortic arch 19. As mentioned, the at least one lateral opening 174 faces left common carotid artery 18. Secondary module 22 reduces blood turbulence in the aortic arch, and serves as a funnel that creates a gradual taper of the blood flow into lateral fenestration 34 of main stent-graft 24. For some applications, main and secondary stent-grafts 24 and 26, when in their respective radially-expanded states, constrained by the respective blood vessels in which they are positioned, have some or all of the dimensional and/or strength characteristics described herein as applicable when the stent-grafts are unconstrained in their radially- expanded states. By way of example and not limitation, (a) first perimeter PI of distal main-module end 36 of main stent-graft 24 may equal at least 200% (e.g., at least 250%, at least 300%, or at least 400%) of second perimeter P2 of proximal main-module end 38 of the main stent-graft, (b) proximal dissection-reinforcement end 52 may be disposed along the main stent-graft no more than 20 mm proximal to proximal fenestration end 37, (c) dissection-reinforcement axial portion 48 may extends along the main stent-graft for a distance equal to between 5% and 32% of the greatest perimeter of the main stent-graft distally to distal fenestration end 35, and/or dissection-reinforcement axial portion 48 may have a radial strength that is at least 10% greater than an average radial strength of the
entire main stent-graft.
Alternative configurations of the secondary module
Reference is now made to Fig. 4, which is a schematic illustration of another configuration of secondary module 22, in accordance with an application of the present invention. In this configuration, when secondary module 22 is unconstrained in the radially-expanded state thereof:
• the at least one lateral opening 174 includes at least first and second lateral openings 174 A and 174B;
• secondary covering element 132 is shaped so as to define first and second lateral openings 174 A and 174B, each of which begins at and extends from proximal secondary-module end 138 toward sealing interface 172 along central longitudinal axis 140 for distance D3 equal to at least 50% of greatest width Wl of secondary module 22;
• first and second lateral openings 174A and 174B face in different first and second radial directions extending from central longitudinal axis 140; and
• first and second lateral openings 174A and 174B at least partially axially overlap along central longitudinal axis 140.
For some applications, such as shown in Fig. 4, first and second lateral openings 174A and 174B axially coincide along central longitudinal axis 140. For some applications, such as shown in Fig. 4, the first and the second radial directions are opposite each other; in other words first and second lateral openings 174A and 174B face in radially-opposite directions.
For some applications, such as shown in Fig. 4, secondary covering element 132 is shaped so as to define two portions 176A and 176B, which (a) extend to and reach proximal secondary-module end 138, and (b) are shaped so as to define respective concave inner surfaces 178 A and 178B that face each other and central longitudinal axis 140, and (c) are not joined to each other at proximal secondary-module end 138.
During deployment of secondary module 20 in aortic arch 19, such as described hereinabove with reference to Fig. 1, the secondary module is rotationally aligned such that one of first and second lateral openings 174A and 174B faces left common carotid
artery 18, so as to allow blood flow into the left common carotid artery (and, for applications in which the secondary stent-graft is long enough, so as to allow blood flow into brachiocephalic artery 70). The other of the lateral openings faces downward toward the wall of aortic arch 19 opposite the left common carotid artery, and may serve to prevent blood from becoming trapped below the bottom side of the secondary module, which might cause blood coagulation.
Reference is now made to Figs. 5 and 6, which are schematic illustrations of alternative configurations of secondary module 22, in accordance with respective applications of the present invention. In these configurations, when secondary module 22 is unconstrained in the radially-expanded state thereof:
• secondary module 22 is shaped so as to define proximal secondary-module end 138, sealing interface 172, and central longitudinal axis 140 therebetween. Sealing interface 172 is sized and configured to form a blood-impervious seal with lateral fenestration 34 of main module 20; · secondary module 22 is shaped so as to define distal secondary-module end
136;
• secondary covering element 132 is shaped so as to define at least one secondary-module lateral fenestration 134 disposed distal to proximal secondary-module end 138 and proximal to sealing interface 172, and · a greatest axial length L2 of secondary-module lateral fenestration 134, measured parallel to central longitudinal axis 140, equals at least 33% (e.g., at least 50%) of first perimeter PI of distal main-module end 36 of main stent- graft 24 of main module 20, when the main module is unconstrained in the radially-expanded state thereof. For some applications, a greatest width W3 of secondary-module lateral fenestration 134, measured circumferentially around secondary module 22, equals at least 16% of first perimeter PI, such as at least 25% of first perimeter PI. These dimensions of greatest axial length L2 and greatest width W3 may allow secondary-module lateral fenestration 134 to allow sufficient blood flow to both left common carotid artery 18 and brachiocephalic artery 70.
Because secondary-module lateral fenestration 134 does not reach proximal
secondary-module end 138, secondary covering element 132 is shaped so as to define an additional fixation zone 184 between secondary-module lateral fenestration 134 and proximal secondary-module end 138.
For some applications, at least one of secondary structural stent elements 131 traverses secondary-module lateral fenestration 134 when secondary module 22 is unconstrained in the radially-expanded state thereof. By way of example, in Fig. 5 one secondary structural stent element 13 IB is shown traversing secondary-module lateral fenestration 134, and in Fig. 6 two secondary structural stent elements 13 IB are shown traversing secondary-module lateral fenestration 134. Alternatively, three or more secondary structural stent elements 13 IB traverse secondary-module lateral fenestration 134. Such traversal may provide additional structural strength to secondary module 22 at the secondary-module lateral fenestration.
Typically, at least a portion of the border of secondary-module lateral fenestration 134 is defined by an undulating portion of one or more of secondary structural stent elements 131.
For some applications, a cross-sectional area of secondary module 22 gradually tapers from proximal secondary-module end 138 to sealing interface 172 when the secondary module is unconstrained in the radially-expanded state thereof.
For some applications, such as shown in Fig. 5, the at least one secondary-module lateral fenestration 134 comprises exactly one secondary-module lateral fenestration 134. For some of these applications, when secondary module 22 is unconstrained in the radially-expanded state thereof, secondary-module lateral fenestration 134 faces in a first radial direction extending from central longitudinal axis 140, and a portion 182 of secondary covering element 132 that faces in a second radial direction opposite the first radial direction extends to and reaches proximal secondary-module end 138. In other words, secondary module 22 is covered by secondary covering element 132 on the side circumferentially opposite secondary-module lateral fenestration 134, such that secondary-module lateral fenestration 134 and portion 182 face in radially-opposite directions. During deployment of secondary module 20 in aortic arch 19, such as described hereinabove with reference to Fig. 1, the secondary module is rotationally aligned such that secondary-module lateral fenestration 134 faces left common carotid artery 18, so as
to allow blood flow into the left common carotid artery.
Reference is made to Fig. 6. For some applications, secondary module 22 further comprises a flexible sheet 190, which (a) is blood-sealingly joined to a portion of a secondary border 180 of secondary-module lateral fenestration 134, which portion extends around at least 25% of a perimeter of the secondary border and includes a distal end 192 of secondary border 180 when secondary module 22 is unconstrained in the radially-expanded state thereof, and (b) extends radially inward from secondary border 180 (toward or past central longitudinal axis 140) when secondary module 22 is unconstrained in the radially-expanded state thereof. For some applications, a portion 194 of secondary structural stent elements 131 are attached to flexible sheet 190, which facilitates the radially-inward extension of flexible sheet 190 from secondary border 180.
As mentioned above, during deployment of secondary module 20 in aortic arch 19, such as described hereinabove with reference to Fig. 1, the secondary module is rotationally aligned such that secondary-module lateral fenestration 134 faces left common carotid artery 18. Flexible sheet 190 serves to direct a portion of the blood flow into the left common carotid artery.
Reference is now made to Fig. 7, which is a schematic illustration of yet another configuration of secondary module 22, in accordance with an application of the present invention. In this configuration, secondary module 22 is shaped so as to define proximal secondary-module end 138, sealing interface 172, and an anchoring axial portion 160 therebetween having central longitudinal axis 140 and an anchoring -portion length L3, measured along the central longitudinal axis from distal sealing interface 172 to proximal secondary-module end 138. Anchoring axial portion 160 is typically configured to (a) accommodate the anatomy of aortic arch 19 without blocking blood flow in the arch or to left common carotid artery 18 or brachiocephalic artery 70, (b) provide support for anchoring the secondary module in the aortic arch, and/or (c) provide support for secondary covering element 132, as described below.
Anchoring axial portion 160 includes a plurality (e.g., at least 8) of secondary structural stent elements 131, which, for example may comprise respective wires. For some applications, each of plurality of secondary structural stent elements 131 has two longitudinal portions 168 that extend toward (e.g., reach) distal sealing interface 172, and an intermediary longitudinal portion 170 that curves around proximal secondary-module
end 136, when secondary module 22 is unconstrained in the radially-expanded state thereof (by way of example, one of such secondary structural stent elements 131 is labeled with reference numeral 167 in Fig. 7). Curved portions 170 of the plurality of secondary structural stent elements 131 may or may not converge at a single point at proximal secondary-module end 136. For some applications, the plurality of secondary structural stent elements 131 of anchoring axial portion 160 includes some structural stent elements that touch one another (e.g. at or near proximal secondary-module end 138), and no structural stent elements that are fixed to one another, when the secondary module is unconstrained in the radially-expanded state thereof. For some applications, secondary structural stent elements 131 may include a loop element, e.g. a polygonal or elliptical (e.g., circular) loop, at proximal secondary-module end 136, to which loop element respective ends of the plurality of secondary structural stent elements 131 are coupled (configuration not shown).
In this configuration, when secondary module 22 is unconstrained in the radially- expanded state thereof, secondary covering element 132 at least covers secondary support element 130 along a covered axial portion 162 of anchoring axial portion 160. Secondary structural stent elements 131 of anchoring axial portion 160 provide support for secondary covering element 132, holding the secondary covering element open so as to facilitate blood flow to sealing interface 172 and through lateral fenestration 34 of main stent-graft 24.
Covered axial portion 162 extends proximally from distal sealing interface 172 for an axial covering distance D4 equal to at least 10% (e.g., at least 15%, such as at least 20%), no more than 50% (e.g., no more than 35%), and/or between 10% and 50% (e.g., between 10% and 35%, or between 20% and 35%) of anchoring -portion length L3, axial covering distance D4 measured along central longitudinal axis 140, when secondary module 22 is unconstrained in the radially-expanded state thereof. Secondary support element 130 is uncovered proximally to secondary covering element 132. When secondary module 22 is unconstrained in the radially-expanded state thereof, an uncovered axial portion 163 of anchoring axial portion 160 extends from proximal secondary-module end 138 to a proximal end 165 of covered axial portion 162, for an axial uncovered distance D7 equal to at least 50% (e.g., at least 65%), no more than 90% (e.g., no more than 80%), and/or between 50% and 90% (e.g., between 65% and 80%) of
anchoring-portion length L3, measured along central longitudinal axis 140.
Typically, when secondary module 22 is unconstrained in the radially-expanded state thereof, anchoring axial portion 160 has a greatest anchoring-portion width W4 that is (a) greater than a greatest proximal-end width W5 at the proximal secondary-module end (W5 is optionally zero, as shown, for configurations in which the plurality of secondary structural stent elements 131 converge at a single point) and (b) at least 20%, e.g., at least 50%, at least 75%, or at least 100%, greater than a greatest sealing-interface width W6 at a narrowest portion 164 of distal sealing interface 172, greatest anchoring- portion, sealing-interface, and proximal-end widths W4, W5, and W6 measured perpendicular to central longitudinal axis 140. For some applications, anchoring axial portion 160 has greatest anchoring-portion width W4 at an axial location 166 at an axial distance D5 from proximal secondary-module end 138 equal to at least 33%, no more than 60%, and/or between 33% and 60% of anchoring-portion length L3, axial distance D5 measured along central longitudinal axis 140, when secondary module 22 is unconstrained in the radially-expanded state thereof.
For some applications, axial covering distance D4 from distal sealing interface 172 is equal to at least 20% (e.g., at least 30%), no more than 100% (e.g., no more than 60%), and/or between 20% and 100% (e.g., between 30% and 60%) of an axial distance D6 between distal sealing interface 172 and axial location 166 of greatest anchoring-portion width W4, axial distance D6 measured along central longitudinal axis 140, when secondary module 22 is unconstrained in the radially-expanded state thereof.
For some applications, when secondary module 22 is unconstrained in the radially- expanded state thereof:
• anchoring-portion length L3 equals at least 50 mm, no more than 150 mm, and/or between 50 and 150 mm;
• greatest width W4 equals at least 30 mm, no more than 60 mm, and/or between 30 and 60 mm;
• greatest proximal-end width W5 equals at least 0 mm, no more than 35 mm, and/or between 0 and 35 mm, and/or at least 0 mm, no more than 40% of W4, and/or between 0 mm and 40% of W4;
• greatest sealing-interface width W6 equals at least 25 mm, no more than 40
mm, and/or between 25 and 40 mm;
• axial covering distance D4 equals at least 10 mm, no more than 30 mm, and/or between 10 and 30 mm;
• axial distance D5 equals at least 20 mm, no more than 80 mm, and/or between 20 and 80 mm;
• axial distance D6 equals at least 30 mm, no more than 80 mm, and/or between 30 and 80 mm; and/or
• axial uncovered distance D7 equals at least 30 mm, no more than 120 mm, and/or between 30 and 120 mm. Reference is now made to Fig. 8, which is a schematic illustration of yet another configuration of secondary module 22, in accordance with an application of the present invention. Fig. 8 shows secondary module 22 deployed in aortic arch 19, sealingly coupled to lateral fenestration 34 of main module 20. In this configuration, secondary covering element 132 is shaped so as to define at least one lateral opening 174 that begins at and extends from proximal secondary-module end 138 toward sealing interface 172, such as described hereinabove with reference to Figs. 3 and 4. Alternatively, the configuration of Fig. 8 may be implemented in combination with the configurations described hereinabove with reference to Figs. 5, 6, and/or 7.
In this configuration, secondary module 22 comprises an extension structure 200, which is disposed radially outward of a fluid-flow path defined by secondary module 22, in a same radially direction as one of the at least one lateral opening of secondary covering element 132 (in the case of the configuration shown in Figs. 3 and 4, at least one lateral opening 174, and in the case of Fig. 5 and 6, at least one secondary-module lateral fenestration 134). Extension structure 200 typically comprises one or more of secondary structural stent elements 131. Extension structure 200 is shaped so as to help hold secondary module 22 properly positioned in aortic arch 19.
For some applications, at least one of secondary structural stent elements 131 traverses the lateral opening when the secondary module is unconstrained in the radially- expanded state thereof, and extension structure 200 is coupled to the lateral opening. Reference is now made to Figs. 9 and 10, which are schematic illustrations of a secondary module 222, in accordance with an application of the present invention. Fig. 9
shows secondary module 222, and Fig. 10 shows secondary module 222 deployed in aortic arch 19, sealingly coupled to lateral fenestration 34 of main module 20. Fig. 9 shows secondary module 222 unconstrained in its radially-expanded state, i.e., no forces are applied to the module by a delivery tool, walls of a blood vessel, or otherwise. Secondary module 222 comprises a non-bifurcated secondary stent-graft 226, which typically comprises a secondary generally tubular support element 230 and a secondary covering element 232 that is attached to and at least partially covers a covered axial portion 242 of support element 230 and at least partially does not cover an uncovered axial portion 244 of support element 230. For some applications, secondary covering element 232 partially covers an overlap axial portion 246 along which first and second axial portions 244 and 246 axially overlap; for example, a distal end 250 of secondary covering element 232 may be generally diagonally- shaped, such as shown in Fig. 9.
Support element 230 typically comprises a plurality of secondary structural stent elements 231. For some applications, secondary structural stent elements 231 are arranged as a plurality of circumferential stent springs 233. Secondary covering element 232 serves as a blood flow guide through at least a portion of the secondary stent-graft. Secondary covering element 232 typically comprises at least one biologically-compatible substantially blood-impervious flexible sheet, which is attached (such as by stitching) to at least a portion of the respective support element, on either side of the surfaces defined by the support element. The flexible sheet may comprise, for example, a polymeric material (e.g., a polyester, or polytetrafluoroethylene), a textile material (e.g., polyethylene terephthalate (PET)), natural tissue (e.g., saphenous vein or collagen), or a combination thereof. As shown in Fig. 10, secondary module 222 is configured to be partially inserted into main module 20, such that uncovered axial portion 244 is positioned within main module 20, and covered axial portion 242 is partially positioned outside of and partially positioned within main module 20, through lateral fenestration 34. A portion of secondary covering element 232 passes through lateral fenestration 34, so as to form a blood-tight seal with main module 20. The portion of covered axial portion 242 positioned outside of main module 20 is short enough so as to not block blood flow left common carotid artery 18 or brachiocephalic artery 70.
Reference is now made to Figs. 11, 12, and 13A-B. Fig. 11 is a schematic illustration of a multi-component stent-graft system 310, in accordance with an application of the present invention. Multi-component stent-graft system 310 comprises a main module 320, a secondary module 322, and typically a tertiary module 328, which comprise respective stent-grafts, as described below. The stent- grafts are configured to assume radially-compressed states, such as when initially positioned in one or more outer tubes of one or more delivery tools, and to assume radially-expanded states upon being deployed from the outer tube(s). Fig. 11 shows the stent-grafts in their radially-expanded states in situ. Fig. 12 is a schematic illustration of main module 320, in accordance with an application of the present invention. Fig. 12 shows main stent-graft 24 unconstrained in its radially-expanded state, i.e., no forces are applied to the stent-graft by a delivery tool, walls of a blood vessel, or otherwise. Other than as described hereinbelow, main module 320 may implement any or all of the features of main module 20, described hereinabove with reference to Figs. 1 and 2A-B, including, but not limited to, dissection-reinforcement axial portion 48, descending-aorta axial portion 42, supra-arch axial portion 44, arch axial portion 46, and/or distal axial portion 58. Main module 320 comprises a generally tubular main stent-graft 324, such as described hereinabove with reference to Figs. 2A-B regarding main stent-graft 24. Unlike stent-graft 24, main covering element 32 and main support element 30 of main stent-graft 324 are shaped so as to together define two lateral fenestrations through main stent-graft 324: a first lateral fenestration 34, as defined by stent-graft 24, and a second lateral fenestration 368, when main stent-graft 324 is unconstrained in its radially- expanded state. Typically, when main stent-graft 324 is unconstrained in its radially- expanded state, first lateral fenestration 34 faces in a first radial direction, and second lateral fenestration 368 faces in a second radially direction generally circumferentially opposite the first radial direction. For example, if the stent-graft is viewed from one end, the first lateral fenestration may be disposed at between 11 o'clock and 1 o'clock (e.g., at 12 o'clock), and the second lateral fenestration may disposed at between 5 o'clock and 7 o'clock (e.g., at 6 o'clock).
When multi-component stent-graft system 310 is implanted as shown in Fig. 11, first lateral fenestration 34 serves as an inferior lateral fenestration, and second lateral
fenestration 368 serves as a superior lateral fenestration.
Typically, a first perimeter of first (inferior) lateral fenestration 34 equals at least 200%, no more than 400%, and/or between 200% and 400% of a second perimeter of second (superior) lateral fenestration 368. For some applications, supra-arch axial portion 44 of main stent-graft 324 is internally lined with ePTFE film, or main covering element 32 of main stent-graft 324 comprises entirely ePTFE (and thus does not comprise any polyester). Optionally, main covering element 32 along other portions of the main stent-graft comprises polyester. (This configuration may also be implemented in main stent-graft 24, described hereinabove with reference to Figs. 1 and 2A-B.)
Other than as described hereinbelow, secondary module 320 may implement any of the configurations of secondary module 20 described hereinabove with reference to Figs. 1, 3, 4, 5, 6, 7, 8, 9, and/or 10 mutatis mutandis. By way of example and not limitation, secondary module is shown in Fig. 11 in the configuration of secondary module 20 shown in Figs. 1 and 3. (For applications in which secondary module is configured as described hereinabove with reference to Fig. 5 and/or Fig. 6, greatest axial length L2 of secondary-module lateral fenestration 134 may be less than described hereinabove, e.g., may equal at least 20% of first perimeter PI of distal main-module end 36 of main stent-graft 24 of main module 20, when the main module is unconstrained in the radially-expanded state thereof. In the configuration described with reference to Figs. 11 and 12, secondary-module lateral fenestration 134 need only be sufficiently large to allow sufficient blood flow to brachiocephalic artery 70.)
Figs. 13A and 13B are schematic illustrations of respective configurations of tertiary module 328, in accordance with respective applications of the present invention. Tertiary module 328 comprises a generally tubular tertiary stent-graft 380, which typically comprises a tertiary generally tubular support element 382 and a tertiary covering element 384 that is attached to and at least partially covers (e.g., only partially covers) the tertiary support element. Tertiary module 328 and stent-graft 380 have distal and proximal ends 381 and 383. Support element 382 typically comprises a plurality of tertiary structural stent elements 386. For some applications, tertiary structural stent elements 386 are arranged as a plurality of circumferential stent springs 388. Tertiary covering element 384 serves as a blood flow guide through at least a portion of the tertiary stent-graft.
Tertiary covering element 384 typically comprises at least one biologically-compatible substantially blood-impervious flexible sheet, which is attached (such as by stitching) to at least a portion of the respective support element, on either side of the surfaces defined by the support element. The flexible sheet may comprise, for example, a polymeric material (e.g., a polyester, or polytetrafluoroethylene), a textile material (e.g., polyethylene terephthalate (PET)), natural tissue (e.g., saphenous vein or collagen), or a combination thereof.
In the configuration shown in Fig. 13A, tertiary module 328 is shaped so as to define a sealing interface 372, which is similar to sealing interface 172 described hereinabove with reference to Figs. 3, 4, 5, 6, and 7, and/or hereinbelow with reference to Figs. 1, 3, 4, 5, 6, 7, 8, and 11. Sealing interface 372 is sized and configured to form a blood-impervious seal with second (superior) lateral fenestration 368 of main module 320, as shown in Fig. 11. For some applications, sealing interface 372 and/or second (superior) lateral fenestration 368 implement sealing techniques described in US Patent Application Publication 2012/0179236 to Benary et al. and/or PCT Publication WO 2013/005207 to Shalev.
In the configuration shown in Fig. 13A, tertiary module 328 includes covered and uncovered axial portions, similar to the covered and uncovered axial portions 242 and 244 described hereinabove with reference to Fig. 9. Tertiary module 328 may implement any of the features described hereinabove with reference to Fig. 9, mutatis mutandis. Tertiary module 328 is sized and configured to form a blood-impervious seat with second (superior) lateral fenestration 368 of main module 320, using the techniques described hereinabove with reference to Fig. 10, mutatis mutandis.
Reference is again made to Fig. 11. In an exemplary transluminal delivery procedure for implanting multi-component stent-graft system 310, the stent-grafts of system 310 are endovascularly (typically percutaneously) introduced into the thoracic aorta, such as via one of the iliac arteries, while the stent-grafts are positioned in one or more outer tubes of a delivery tool in their radially-compressed states.
Typically, the exemplary procedure begins with the advancing of a guidewire up the descending aorta and into left common carotid artery 18. Main stent-graft 324 of main module 320 is initially positioned in its radially-compressed state within an outer tube of a delivery tool, typically near a leading end of the outer tube. The outer tube is advanced
over the guidewire, until main stent-graft 324 is partially disposed in left common carotid artery 18 and partially disposed in the upper part of the descending aorta. The guidewire is withdrawn, leaving the outer tube in place. The main stent-graft is held in place as the outer tube is withdrawn, thereby delivering the main stent-graft from the outer tube. Main stent-graft 324 typically self-expands, until it assumes its radially-expanded state, upon reaching typically about 80-90% of its maximum unconstrained size, and/or being constrained from further expansion by the wall of the blood vessels, as shown in Fig. 11. Alternatively, the main stent-graft (and/or the other stent-grafts, as described hereinbelow) is delivered using an over-the-wire (OTW) approach, in which the guidewire is left in place until the stent-graft is expanded, and thereafter the guidewire is withdrawn.
Descending-aorta axial portion 42 of main stent-graft 324, including distal main- module end 336, is positioned in the upper part of the descending aorta, and supra-arch axial portion 44 of main stent-graft 324, including proximal main-module end 338, is positioned in left common carotid artery 18. First (inferior) lateral fenestration 34 is disposed in aortic arch 19 facing upstream, generally toward ascending aorta 17, in a vicinity of the bifurcation of aortic arch 19 and left common carotid artery 18. Second (superior) lateral fenestration 368 is axially aligned with and faces left subclavian artery 16. For some applications, proper rotational alignment and/or axial orientation of the first and/or second lateral fenestrations is achieved using fluoroscopy. For example, main stent-graft 324 may comprise one or more radiopaque markers in a vicinity of (e.g., on a periphery of) the one or both of the lateral fenestrations.
A guidewire (either the same guidewire used to deploy the main stent-graft, or a second guidewire) is advanced up the descending aorta, through a proximal portion of main stent-graft 324, through second (superior) lateral fenestration 368, and into left subclavian artery 16. Tertiary stent-graft 380 of tertiary module 328 is positioned in its radially-compressed state within an outer tube of a delivery tool (either the same outer tube used to deploy the main stent-graft, or a second outer tube), typically near a leading end of the outer tube. The outer tube is advanced over the guidewire, until tertiary stent- graft 380 is partially disposed in left subclavian artery 16, and partially disposed within radially-expanded main stent-graft 324. The guidewire is withdrawn, leaving the outer tube in place.
The tertiary stent-graft is held in place as the outer tube is withdrawn, thereby
delivering the tertiary stent-graft from the outer tube. Tertiary stent-graft 380 typically self-expands, until it assumes its radially-expanded state, upon reaching its maximum unconstrained size, and/or being constrained from further expansion by the wall of the left subclavian artery. Tertiary stent-graft 380 is thus adapted for transluminal delivery in its radially-compressed state through a portion of main stent-graft 324 and second (superior) lateral fenestration 368, while the main stent-graft is in its radially-expanded state.
A proximal portion of tertiary stent-graft 380, including distal end 383, is positioned within main stent-graft 324, and tertiary covering element 384 (e.g., at sealing interface 372 in the configuration shown in Figs. 11 and 13 A) of tertiary stent-graft 380 is sealingly coupled to second (superior) lateral fenestration 368 of main stent-graft 324.
A guidewire (either the same guidewire used to deploy the main stent-graft and/or tertiary stent-graft, or another guidewire) is advanced up the descending aorta, through a distal portion of main stent-graft 324, out of first (inferior) lateral fenestration 34, and into aortic arch 19, extending toward, or partially into, ascending aorta 17. Secondary stent- graft 26 of secondary module 322 is positioned in its radially-compressed state within an outer tube of a delivery tool (either the same outer tube used to deploy the main stent-graft and/or the tertiary stent-graft, or another outer tube), typically near a leading end of the outer tube. The outer tube is advanced over the guidewire, until secondary stent-graft 26 is partially disposed in aortic arch 19, extending toward, or partially into, ascending aorta 17, and partially disposed within radially-expanded main stent-graft 324 in the upper part of the descending aorta. The guidewire is withdrawn, leaving the outer tube in place.
The secondary stent-graft is rotationally aligned such that the at least one lateral opening 174 faces left common carotid artery 18, so as to allow blood flow to the left common carotid artery (and, for applications in which the secondary stent-graft is long enough, so as to allow blood flow into brachiocephalic artery 70). The secondary stent- graft may comprise one or more radiopaque markers to facilitate such proper rotational alignment. For example, the radiopaque markers may be positioned on one or more edges of the at least one lateral opening.
The secondary stent-graft is held in place as the outer tube is withdrawn, thereby delivering the secondary stent-graft from the outer tube. Secondary stent-graft 26 typically self-expands, until it assumes its radially-expanded state, upon reaching its maximum unconstrained size, and/or being constrained from further expansion by the
wall of the blood vessels. Secondary stent-graft 26 is thus adapted for transluminal delivery in its radially-compressed state through a portion of main stent-graft 324 and first (inferior) lateral fenestration 34, while the main stent-graft is in its radially-expanded state. A distal portion of secondary stent-graft 26, including distal secondary-module end 136, is positioned within main stent-graft 324, and sealing interface 172 of secondary stent-graft 26 is sealingly coupled to first (inferior) lateral fenestration 34 of main stent- graft 324. A proximal portion of secondary stent-graft 26, including proximal end 138, is positioned in aortic arch 19. As mentioned, the at least one lateral opening 174 faces left common carotid artery 18. Secondary module 322 reduces blood turbulence in the aortic arch, and serves as a funnel that creates a gradual taper of the blood flow into first (inferior) lateral fenestration 34 of main stent-graft 324.
Alternatively, secondary module 322 is deployed before tertiary module 328 is deployed. Reference is made to Figs. 1, 3, 4, 5, 6, 7, 8, and 11. For some applications, sealing interface 172 is shaped so as to define a neck portion longitudinally flanked by proximal and distal portions. The neck portion is generally radially narrower than the proximal and distal portions. For some applications, sealing interface 172 and/or lateral fenestration 34 implement sealing techniques described in US Patent Application Publication 2012/0179236 to Benary et al. and/or PCT Publication WO 2013/005207 to Shalev, which are incorporated herein by reference. Alternatively, all of the configurations of secondary module 22 described with reference to Figs. 1, 3, 4, 5, 6, 7, 8, and 11 may implement the sealing techniques described hereinabove regarding secondary module 222 with reference to Figs. 9 and 10 (i.e., rather than defining a narrower neck portion, secondary covering element 132 of secondary stent-graft 26 may instead only partially axially cover secondary support element 130 and define sealing interface 172B).
Reference is again made to Figs. 1 and 2A-B, as well as to Figs. 14A-B, which are schematic illustrations of kinking properties of different axial portions of main stent-graft 24, in accordance with an application of the present invention. For some applications: · if distal axial portion 58 of main stent-graft 24, when the main stent-graft is in the radially-expanded state, is placed and constrained in a first curved tube 390 having a circular cross-section and an inner diameter equal to an outer
diameter of distal axial portion 58, distal axial portion 58 experiences kinking only when at least an axial portion 392 of the first curved tube has less than a first radius of curvature rl, as shown in Fig. 14A, and
• if dissection-reinforcement axial portion 48 of main stent-graft 24, when the main stent-graft is in the radially-expanded state, is placed and constrained in a second curved tube 394 having a circular cross-section and an inner diameter equal to an outer diameter of dissection-reinforcement axial portion 48, dissection-reinforcement axial portion 48 experiences kinking only when at least an axial portion 396 of the second curved tube has less than a second radius of curvature r2, which second radius of curvature is at least 30%, e.g., at least 50%, less than the first radius of curvature rl, as shown in Fig. 14B.
As used in the present application, including in the claims, "kinking," means that the graft material of main covering element 32 is pinched, or folded in a blood-flow- disturbing manner. It is noted that the outer diameters of the axial portions may vary axially therealong, in which case the inner diameters of the curved tubes would also correspondingly vary. It is also noted that the first and second curved tubes are not elements of multi-component stent-graft system 10, but are rather geometric constructs used to describe certain features of the main stent-graft.
Reference is now made to Fig. 15, which is a schematic illustration of kinking in a stent-graft 400. As described hereinabove with reference to Figs. 2A-B and 14A-B, for some applications dissection-reinforcement axial portion 48 is configured to avoid kinking. Without such configuration, for example if substantial axial spacing is provided between adjacent stent springs 402 of stent-graft 400, the stent-graft would be more prone to kinking 404, as shown in Fig. 14. Although multi-component stent-graft systems 10 and 310 are generally described herein as being used for treating Type B aortic dissection, the scope of the present invention also includes using these systems for treating other conditions, such as aortic aneurysms.
The scope of the present invention includes embodiments described in the following applications, which are assigned to the assignee of the present application and are incorporated herein by reference. In an embodiment, techniques and apparatus described in one or more of the following applications are combined with techniques and
apparatus described herein:
• US Application 12/529,936, filed September 4, 2009, which issued as US Patent 8,317,856
• US Provisional Application 60/892,885, filed March 5, 2007 · US Provisional Application 60/991 ,726, filed December 2, 2007
• US Provisional Application 61/219,758, filed June 23, 2009
• US Provisional Application 61/221,074, filed June 28, 2009
• US Application 13/380,278, filed December 22, 2011, which published as US Patent Application Publication 2012/0150274 · US Application 13/384,075, filed January 13, 2012, which published as US Patent
Application Publication 2012/0179236
• US Application 13/505,996, filed May 3, 2012, which published as US Patent Application Publication 2012/0310324
• US Application 13/512,778, filed September 24, 2012, which published as US Patent Application Publication 2013/0013050
• US Application 13/513,397, filed June 1, 2012, which published as US Patent Application Publication 2012/0330399
• US Application 13/514,240, filed June 6, 2012, which published as US Patent Application Publication 2013/0013051 · US Application 13/577,161, filed August 3, 2012, which published as US Patent
Application Publication 2013/0035751
• US Application 13/031,871, filed February 22, 2011, which published as US Patent Application Publication 2011/0208289
• US Provisional Application 61/496,613, filed June 14, 2011 · US Provisional Application 61/505,132, filed July 7, 2011
• US Provisional Application 61/529,931, filed September 1, 2011
• PCT Application PCT/IL2012/000060, filed February 2, 2012, which published as PCT Publication WO 2012/104842
PCT Application PCT/IL2012/000083, filed February 16, 2012, which published as PCT Publication WO 2012/111006
PCT Application PCT/IL2012/000095, filed March 1, 2012, which published as PCT Publication WO 2012/117395
PCT Application PCT/IL2012/000148, filed April 4, 2012, which published as PCT Publication WO 2013/030818
PCT Application PCT/IL2012/000190, filed May 15, 2012, which published as PCT Publication WO 2013/171730
US Patent Application 13/523,296, filed June 14, 2012, which published as US Patent Application Publication 2012/0323305
PCT Application PCT/IL2012/000241, filed June 19, 2012, which published as PCT Publication WO 2012/176187
PCT Application PCT/IL2012/000269, filed July 2, 2012, which published as PCT Publication WO 2013/005207
PCT Application PCT/IL2012/050424, filed October 29, 2012, which published as PCT Publication WO 2013/065040
PCT Application PCT/IL2012/050506, filed December 4, 2012, which published as PCT Publication WO 2013/084235
• US Provisional Application 61/749,965, filed January 8, 2013, entitled, "Minimization of stent-graft migration during implantation"
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
Claims
1. Apparatus comprising a generally tubular stent-graft, which has distal and proximal stent-graft ends and comprises:
a generally tubular support element, which comprises a plurality of structural stent elements; and
a covering element that is attached to and at least partially covers the support element,
wherein when the stent-graft is unconstrained in a radially-expanded state:
the covering element and the support element are shaped so as to together define a lateral fenestration having distal and proximal fenestration ends,
a first perimeter of the distal stent-graft end equals at least 200% of a second perimeter of the proximal stent-graft end, and
the stent-graft includes a dissection-reinforcement axial portion, which (a) includes a portion of the structural stent elements, (b) has (i) a distal dissection- reinforcement end and (ii) a proximal dissection-reinforcement end that is disposed along the stent-graft no more than 20 mm proximal to the proximal fenestration end, (c) extends along the stent-graft for a distance equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end, and (d) has a radial strength that is at least 10% greater than an average radial strength of the entire stent-graft.
2. The apparatus according to claim 1,
wherein the portion of the structural stent elements included by the dissection- reinforcement axial portion is a first portion of the structural stent elements, and
wherein when the stent-graft is unconstrained in the radially-expanded state:
the stent-graft includes a distal-end axial portion, which includes a second portion of the structural stent elements, and
the distal-end axial portion axially extends along the stent-graft from the distal end of stent-graft for a distance equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end, and
the distal-end axial portion has a radial strength that is at least a 10% greater than the average radial strength of the entire stent-graft.
3. The apparatus according to claim 1, wherein an axial length of the dissection-
reinforcement axial portion is between 1 and 3 cm when the stent-graft is unconstrained in the radially-expanded state.
4. The apparatus according to claim 1, wherein the proximal dissection- reinforcement end is disposed along the stent-graft no more proximal than the distal fenestration end when the stent-graft is unconstrained in the radially-expanded state.
5. The apparatus according to claim 1, wherein the proximal dissection- reinforcement end is disposed along the stent-graft between the distal fenestration end and the proximal fenestration end, inclusive, when the stent-graft is unconstrained in the radially-expanded state.
6. The apparatus according to claim 1, wherein a distance between the distal dissection-reinforcement end and the distal stent-graft end equals between 32% and 160% of a largest perimeter of the stent-graft when the stent-graft is unconstrained in the radially-expanded state.
7. The apparatus according to claim 1, wherein the dissection-reinforcement axial portion extends along the stent-graft for a distance equal to between 10% and 22% of a greatest perimeter of the stent-graft distally to the distal fenestration end when the stent- graft is unconstrained in the radially-expanded state.
8. The apparatus according to claim 1, wherein the first perimeter equals at least 250% of the second perimeter.
9. The apparatus according to any one of claims 1-8, wherein the dissection- reinforcement axial portion is configured to be generally straight when the stent-graft is unconstrained in the radially-expanded state.
10. The apparatus according to any one of claims 1-8, wherein the structural stent elements of the dissection-reinforcement axial portion are arranged as a plurality of circumferential stent springs, and wherein a height, measured axially along the stent-graft, of at least one of the stent springs varies by less than 10% around a circumference of the stent spring when the stent-graft is unconstrained in the radially-expanded state.
11. The apparatus according to any one of claims 1-8, wherein the structural stent elements of the dissection-reinforcement axial portion are arranged as a plurality of circumferential stent springs, and wherein, for each one of the stent springs, a height, measured axially along the stent-graft, of the stent spring varies by less than 10% around a
circumference of the stent spring when the stent-graft is unconstrained in the radially- expanded state.
12. The apparatus according to any one of claims 1-8, wherein the first perimeter is between 5 and 15 cm, and the second perimeter is between 2.5 and 5.7 cm.
13. The apparatus according to any one of claims 1-8, wherein the stent-graft is shaped so as to define exactly one lateral fenestration when the stent-graft is unconstrained in the radially-expanded state.
14. The apparatus according to any one of claims 1-8,
wherein the lateral fenestration is an inferior first lateral fenestration, which faces in a first radial direction, and
wherein, when the main stent-graft is unconstrained in the radially-expanded state, the main covering element and the main support element are shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction.
15. Apparatus comprising a generally tubular stent-graft, which has distal and proximal stent-graft ends and comprises:
a generally tubular support element, which comprises a plurality of structural stent elements arranged as a plurality circumferential stent springs; and
a covering element that is attached to and at least partially cover the support element,
wherein when the stent-graft is unconstrained in a radially-expanded state:
the covering element and the support element are shaped so as to together define a lateral fenestration having distal and proximal fenestration ends,
a first perimeter of the distal stent-graft end equals at least 200% of a second perimeter of the proximal stent-graft end,
the stent-graft includes a dissection-reinforcement axial portion, which (a) includes a first plurality of the stent springs, (b) has (i) a distal dissection- reinforcement end and (ii) a proximal dissection-reinforcement end that is disposed along the stent-graft no more than 20 mm proximal to the proximal fenestration end, (c) extends along the stent-graft for a distance equal to between
5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end, and (d) is configured to be generally straight,
the stent-graft includes a distal axial portion, which (a) includes a second plurality of the stent springs, (b) is disposed along the stent-graft distal and axially adjacent to the distal dissection-reinforcement end, (c) extends along the stent- graft for a distance equal to between 5% and 32% of the greatest perimeter of the stent-graft distally to the distal fenestration end,
the stent springs have respective average heights, measured axially along the stent-graft, and
an average of the average heights of the first plurality of the stent springs is less than 75% of the average height of a proximal-most one of the second plurality of the stent springs.
16. The apparatus according to claim 15, wherein each of the average heights of the first plurality of the stent springs is less than 75% of the average heights of the proximal- most one of the second plurality of stent springs when the stent-graft is unconstrained in the radially-expanded state.
17. The apparatus according to any one of claims 15 and 16, wherein the average of the average heights of the first plurality of the stent springs is less than 75% of the average height of a second one of the second plurality of stent springs, other than the proximal-most one of the second plurality of stent springs when the stent-graft is unconstrained in the radially-expanded state.
18. The apparatus according to any one of claims 15 and 16, wherein the average of the average heights of the first plurality of the stent springs is less than 75% of each of the average heights of the second plurality of stent springs when the stent-graft is unconstrained in the radially-expanded state.
19. The apparatus according to claim 15, wherein the distal axial portion is configured to be generally straight when the stent-graft is unconstrained in the radially-expanded state.
20. The apparatus according to claim 15, wherein an axial length of the dissection- reinforcement axial portion is between 1 and 3 cm when the stent-graft is unconstrained in the radially-expanded state.
21. The apparatus according to claim 15, wherein the proximal dissection- reinforcement end is disposed along the stent-graft no more proximal than the distal
fenestration end when the stent-graft is unconstrained in the radially-expanded state.
22. The apparatus according to claim 15, wherein the proximal dissection- reinforcement end is disposed along the stent-graft between the distal fenestration end and the proximal fenestration end, inclusive, when the stent-graft is unconstrained in the radially-expanded state.
23. The apparatus according to claim 15, wherein an axial spacing between two of the first plurality of the stent springs equals less than 10% of an average of the average heights of the two stent springs.
24. The apparatus according to claim 15, wherein the first perimeter equals at least 300% of the second perimeter.
25. The apparatus according to claim 15, wherein the dissection-reinforcement axial portion extends along the stent-graft for a distance equal to between 10% and 32% of the greatest perimeter of the stent-graft distally to the distal fenestration end when the stent- graft is unconstrained in the radially-expanded state.
26. The apparatus according to claim 15, wherein the distal axial portion extends to and reaches the distal stent-graft end.
27. The apparatus according to any one of claims 15-16, wherein the average height of at least one of the first plurality of stent springs varies by less than 10% around a circumference of the stent spring when the stent-graft is unconstrained in the radially- expanded state.
28. The apparatus according to any one of claims 15-26, wherein, for each one of the first plurality of stent springs, the average height thereof varies by less than 10% around a circumference of the stent spring when the stent-graft is unconstrained in the radially- expanded state.
29. The apparatus according to any one of claims 15-26,
wherein, if the distal axial portion, when the stent-graft is in the radially-expanded state, is placed and constrained in a first curved tube having a circular cross-section and an inner diameter equal to an outer diameter of the distal axial portion, the distal axial portion experiences kinking only when at least an axial portion of the first curved tube has less than a first radius of curvature, and
wherein, if the dissection-reinforcement axial portion, when the stent-graft is in
the radially-expanded state, is placed and constrained in a second curved tube having a circular cross-section and an inner diameter equal to an outer diameter of the dissection- reinforcement axial portion, the dissection-reinforcement axial portion experiences kinking only when at least an axial portion of the second curved tube has less than a second radius of curvature, which second radius of curvature is at least 30% less than the first radius of curvature.
30. The apparatus according to any one of claims 15-26,
wherein the lateral fenestration is an inferior first lateral fenestration, which faces in a first radial direction, and
wherein, when the main stent-graft is unconstrained in the radially-expanded state, the main covering element and the main support element are shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction.
31. Apparatus comprising a stent-graft system, which comprises:
a main module, which has distal and proximal main-module ends, and comprises a generally tubular main stent-graft, which comprises (a) a main generally tubular support element, which comprises main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element, wherein the main covering element and the main support element are shaped so as to together define a lateral fenestration when the main module is unconstrained in a radially-expanded state thereof; and
a secondary module, which comprises a non-bifurcated secondary stent-graft, which comprises (a) a secondary support element, which comprises secondary structural stent elements, and (b) a secondary covering element that is attached to and at least partially covers the secondary support element,
wherein when the secondary module is unconstrained in a radially-expanded state thereof:
the secondary module is shaped so as to define (a) a proximal secondary- module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) a central longitudinal axis therebetween, wherein the sealing interface is sized and configured to form a blood -impervious seal with the lateral fenestration of the main module, and
the secondary covering element is shaped so as to define at least one lateral opening that begins at and extends from the proximal secondary-module end toward the sealing interface along the central longitudinal axis for a distance equal to at least 50% of a greatest width of the secondary module, measured perpendicular to the central longitudinal axis.
32. The apparatus according to claim 31, wherein a greatest width of the at least one lateral opening, measured circumferentially around the secondary module, equals at least 90 degrees circumferentially around the proximal secondary -module end, the 90 degrees being measured at the sealing interface.
33. The apparatus according to claim 31, wherein at least one of the secondary structural stent elements traverses the at least one lateral opening when the secondary module is unconstrained in the radially-expanded state thereof.
34. The apparatus according to claim 31, wherein the at least one lateral opening extends from the proximal secondary-module end toward the sealing interface along at least 70% of a greatest width of the secondary module, measured perpendicular to the central longitudinal axis when the secondary module is unconstrained in the radially- expanded state thereof.
35. The apparatus according to claim 31, wherein the cross-sectional area of the secondary module, measured perpendicular to the central longitudinal axis, gradually tapers from the proximal secondary-module end to the sealing interface when the secondary module is unconstrained in the radially-expanded state thereof.
36. The apparatus according to any one of claims 31-35, wherein when the secondary module is unconstrained in the radially-expanded state thereof:
the at least one lateral opening includes at least first and second lateral openings, the secondary covering element is shaped so as to define the first and the second lateral openings, each of extends from the proximal secondary-module end toward the sealing interface along the central longitudinal axis for the distance equal to at least 50% of the greatest width of the secondary module,
the first and the second lateral openings face in different first and second radial directions extending from the central longitudinal axis, and
the first and the second lateral openings at least partially axially overlap along the central longitudinal axis.
37. The apparatus according to claim 36, wherein the first and the second lateral openings axially coincide along the central longitudinal axis.
38. The apparatus according to claim 36, wherein the first and the second radial directions are opposite each other.
39. The apparatus according to claim 38, wherein the secondary covering element is shaped so as to define two portions, which (a) extend to and reach the proximal secondary-module end, and (b) are shaped so as to define respective concave inner surfaces that face each other and the central longitudinal axis, and (c) are not joined to each other at the proximal secondary-module end.
40. The apparatus according to any one of claims 31-35, wherein the at least one lateral opening comprises exactly one lateral opening.
41. The apparatus according to claim 40, wherein when the secondary module is unconstrained in the radially-expanded state thereof:
the lateral opening faces in a first radial direction extending from the central longitudinal axis, and
a portion of the secondary covering element that faces in a second radial direction opposite the first radial direction extends to and reaches the proximal secondary-module end.
42. The apparatus according to any one of claims 31-41, wherein a first perimeter of the distal main-module end equals at least 200% of a second perimeter of the proximal main-module end when the main module is unconstrained in the radially-expanded state thereof.
43. The apparatus according to claim 42, wherein the first perimeter equals at least 300% of the second perimeter.
44. The apparatus according to any one of claims 31-41,
wherein the lateral fenestration is an inferior first lateral fenestration, which faces in a first radial direction,
wherein, when the main stent-graft is unconstrained in the radially-expanded state, the main covering element and the main support element are shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction,
wherein the stent-graft system further comprises a generally tubular tertiary stent- graft, and
wherein the main and the tertiary stent-grafts are configured such that the tertiary stent-graft forms a blood-impervious seal with the main stent-graft around the superior second lateral fenestration when the tertiary stent-graft is disposed therethrough, and the main stent-graft is in the radially-expanded state thereof and the tertiary stent-graft is in a radially-expanded state thereof.
45. Apparatus comprising a stent-graft system, which comprises:
a main module, which has distal and proximal main-module ends, and comprises a generally tubular main stent-graft, which comprises (a) a main generally tubular support element, which comprises main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element, wherein the main covering element and the main support element are shaped so as to together define a main-module lateral fenestration when the main module is unconstrained in a radially- expanded state thereof; and
a secondary module, which comprises a non-bifurcated secondary stent-graft, which comprises (a) a secondary support element, which comprises secondary structural stent elements, and (b) a secondary covering element that is attached to and at least partially covers the secondary support element,
wherein when the secondary module is unconstrained in a radially-expanded state thereof:
the secondary module is shaped so as to define (a) a proximal secondary- module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) a central longitudinal axis therebetween, wherein the sealing interface is sized and configured to form a blood-impervious seal with the main-module lateral fenestration of the main module,
the secondary covering element is shaped so as to define at least one secondary-module lateral fenestration disposed distal to the proximal secondary- module end and proximal to the sealing interface, and
a greatest axial length of the secondary-module lateral fenestration, measured parallel to the central longitudinal axis, equals at least 33% of a first perimeter of the distal main-module end when the main module is unconstrained in the radially-expanded state thereof.
46. The apparatus according to claim 45, wherein at least one of the secondary structural stent elements traverses the secondary-module lateral fenestration.
47. The apparatus according to claim 45, wherein the greatest axial length of the secondary-module lateral fenestration equals at least 50% of the first perimeter of the distal main-module end when the secondary module is unconstrained in the radially- expanded state thereof.
48. The apparatus according to claim 45, wherein the cross-sectional area of the secondary module gradually tapers from the proximal secondary-module end to the sealing interface when the secondary module is unconstrained in the radially-expanded state thereof.
49. The apparatus according to any one of claims 45-48, wherein the at least one secondary-module lateral fenestration comprises exactly one secondary-module lateral fenestration.
50. The apparatus according to claim 49, wherein when the secondary module is unconstrained in the radially-expanded state thereof:
the secondary-module lateral fenestration faces in a first radial direction extending from the central longitudinal axis, and
a portion of the secondary covering element that faces in a second radial direction opposite the first radial direction extends to and reaches the proximal secondary-module end.
51. The apparatus according to any one of claims 45-48, wherein the first perimeter of the distal main-module end equals at least 200% of a second perimeter of the proximal main-module end when the main module is unconstrained in the radially-expanded state thereof.
52. The apparatus according to claim 51, wherein the first perimeter equals at least 300% of the second perimeter.
53. The apparatus according to any one of claims 45-48, wherein the secondary module further comprises a flexible sheet, which (a) is blood- sealingly joined to a portion of the secondary border, which portion extends around at least 25% of a perimeter of the secondary border and includes a distal end of the secondary border when the secondary module is unconstrained in the radially-expanded state thereof, and (b) extends radially
inward from the secondary border when the secondary module is unconstrained in the radially-expanded state thereof.
54. The apparatus according to claim 53, wherein a portion of the secondary structural stent elements are attached to the flexible sheet.
55. The apparatus according to any one of claims 45-48,
wherein the main-module lateral fenestration is an inferior first lateral fenestration, which faces in a first radial direction,
wherein, when the main stent-graft is unconstrained in the radially-expanded state, the main covering element and the main support element are shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction,
wherein the stent-graft system further comprises a generally tubular tertiary stent- graft, and
wherein the main and the tertiary stent-grafts are configured such that the tertiary stent-graft forms a blood-impervious seal with the main stent-graft around the superior second lateral fenestration when the tertiary stent-graft is disposed therethrough, and the main stent-graft is in the radially-expanded state thereof and the tertiary stent-graft is in a radially-expanded state thereof.
56. Apparatus comprising a stent-graft system, which comprises:
a main module, which has distal and proximal main-module ends, and comprises a generally tubular main stent-graft, which comprises (a) a main generally tubular support element, which comprises main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element, wherein the main covering element and the main support element are shaped so as to together define a main-module lateral fenestration when the main module is unconstrained in a radially- expanded state thereof; and
a secondary module, which comprises a non-bifurcated secondary stent-graft, which comprises (a) a secondary support element, which comprises secondary structural stent elements, (b) a secondary covering element that is attached to and at least partially covers the secondary support element, and (c) a flexible sheet,
wherein when the secondary module is unconstrained in a radially-expanded state thereof:
the secondary module is shaped so as to define (a) a proximal secondary- module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) a central longitudinal axis therebetween, wherein the sealing interface is sized and configured to form a blood-impervious seal with the main-module lateral fenestration of the main module,
the secondary covering element is shaped so as to define at least one secondary-module lateral fenestration disposed distal to the proximal secondary- module end and proximal to the sealing interface, and
the flexible sheet (a) is blood-sealingly joined to a portion of a secondary border of the secondary-module lateral fenestration, which portion extends around at least 25% of a perimeter of the secondary border and includes a distal end of the secondary border when the secondary module is unconstrained in the radially- expanded state thereof, and (b) extends radially inward from the secondary border when the secondary module is unconstrained in the radially-expanded state thereof.
57. The apparatus according to claim 56, wherein a portion of the secondary structural stent elements are attached to the flexible sheet.
58. The apparatus according to claim 56,
wherein the main-module lateral fenestration is an inferior first lateral fenestration, which faces in a first radial direction,
wherein, when the main stent-graft is unconstrained in the radially-expanded state, the main covering element and the main support element are shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction,
wherein the stent-graft system further comprises a generally tubular tertiary stent- graft, and
wherein the main and the tertiary stent-grafts are configured such that the tertiary stent-graft forms a blood-impervious seal with the main stent-graft around the superior second lateral fenestration when the tertiary stent-graft is disposed therethrough, and the main stent-graft is in the radially-expanded state thereof and the tertiary stent-graft is in a radially-expanded state thereof.
59. Apparatus comprising a stent-graft system, which comprises:
a main module, which has distal and proximal main-module ends, and comprises a generally tubular main stent-graft, which comprises (a) a main generally tubular support element, which comprises main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element, wherein the main covering element and the main support element are shaped so as to together define a lateral fenestration when the main module is unconstrained in a radially-expanded state thereof; and
a secondary module, which comprises a non-bifurcated secondary stent-graft, which comprises (a) a secondary support element, which comprises secondary structural stent elements, and (b) a secondary covering element that is attached to and partially covers the secondary support element,
wherein when the secondary module is unconstrained in a radially-expanded state thereof:
the secondary module is shaped so as to define (a) a proximal secondary- module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) an anchoring axial portion therebetween having a central longitudinal axis and an anchoring-portion length, measured along the central longitudinal axis from the distal sealing interface to the proximal secondary-module end,
the sealing interface is sized and configured to form a blood-impervious seal with the lateral fenestration of the main module,
the secondary covering element at least covers the secondary support element along a covered axial portion of the anchoring axial portion, which covered axial portion extends proximally from the distal sealing interface for an axial covering distance equal to between 10% and 50% of the anchoring-portion length, the axial covering distance measured along the central longitudinal axis, wherein the secondary support element is uncovered proximally to the secondary covering element, and
the anchoring axial portion has a greatest anchoring-portion width that is (a) greater than a greatest proximal-end width at the proximal secondary-module end and (b) at least 20% greater than a greatest sealing-interface width at a narrowest portion of the distal sealing interface, the greatest anchoring-portion, sealing-interface, and proximal-end widths measured perpendicular to the central longitudinal axis.
60. The apparatus according to claim 59, wherein the anchoring axial portion has the greatest anchoring-portion width at an axial location at an axial distance from the proximal secondary-module end equal to between 33% and 60% of the anchoring-portion length, the axial distance measured along the central longitudinal axis, when the secondary module is unconstrained in the radially-expanded state thereof.
61. The apparatus according to claim 59, wherein the greatest anchoring-portion width is at least 50% greater than the greatest sealing-interface width at the narrowest portion of the distal sealing interface, when the secondary module is unconstrained in the radially- expanded state thereof.
62. The apparatus according to claim 59, wherein the axial covering distance from the distal sealing interface is equal to between 20% and 100% of an axial distance between the distal sealing interface and an axial location of the greatest anchoring-portion width, the axial distance measured along the central longitudinal axis, when the secondary module is unconstrained in the radially-expanded state thereof.
63. The apparatus according to claim 62, wherein the axial covering distance from the distal sealing interface is equal to between 30% and 60% of the axial distance between the distal sealing interface and the axial location of the greatest anchoring-portion width, when the secondary module is unconstrained in the radially-expanded state thereof.
64. The apparatus according to claim 59, wherein the axial covering distance equals between 10% and 35% of the anchoring-portion length, when the secondary module is unconstrained in the radially-expanded state thereof.
65. The apparatus according to claim 59, wherein the axial covering distance is at least 15% of the anchoring-portion length, when the secondary module is unconstrained in the radially-expanded state thereof.
66. The apparatus according to any one of claims 59-65, wherein the anchoring axial portion includes a plurality of the secondary structural stent elements, each of which has two longitudinal portions that extend toward the distal sealing interface, and an intermediary longitudinal portion that curves around the proximal secondary-module end, when the secondary module is unconstrained in the radially-expanded state thereof.
67. The apparatus according to any one of claims 59-65, wherein the anchoring axial portion includes a plurality of the secondary structural stent elements, some of which
touch one another, and none of which are fixed to one another, when the secondary module is unconstrained in the radially-expanded state thereof.
68. The apparatus according to any one of claims 59-65, wherein an uncovered axial portion of the anchoring portion extends from the proximal secondary-module end to a proximal end of the covered axial portion, for an axial uncovered distance equal to between 30 and 120 mm, when the secondary module is unconstrained in the radially- expanded state thereof.
69. The apparatus according to any one of claims 59-65, wherein the greatest proximal-end width equals zero.
70. A method for treating a patient comprising:
endovascularly introducing a generally tubular stent-graft, while in a radially- compressed state, and positioning the stent-graft such that (a) a proximal stent-graft end of the stent-graft is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery left subclavian artery, and a left common carotid artery, and (b) a distal stent-graft end of the stent-graft is positioned in a descending aorta, wherein the stent-graft includes (a) a generally tubular support element, which includes a plurality of structural stent elements, and (b) a covering element that is attached to and at least partially covers the support element; and
thereafter, transitioning the stent-graft to a radially-expanded state, in which (a) the covering element and the support element are shaped so as to together define a lateral fenestration that is disposed in the aortic arch, with the lateral fenestration facing upstream generally toward an ascending aorta, the lateral fenestration having distal and proximal fenestration ends, (b) a first perimeter of a distal stent-graft end of the stent-graft equals at least 200% of a second perimeter of the proximal stent-graft end, and (c) the stent-graft includes a dissection-reinforcement axial portion, which (i) includes a portion of the structural stent elements, (ii) has (x) a distal dissection-reinforcement end and (y) a proximal dissection-reinforcement end that is disposed along the stent-graft no more than 20 mm proximal to the proximal fenestration end, (iii) extends along the stent-graft for an axial distance equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end, and (iv) has a radial strength that is at least 10% greater than an average radial strength of the entire stent-graft.
71. The method according to claim 70,
wherein the lateral fenestration is an inferior first lateral fenestration, which faces in a first radial direction,
wherein, when the main stent-graft is in the radially-expanded state, the main covering element and the main support element are shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction, and
wherein positioning the stent-graft comprises positioning the stent-graft such that (a) the proximal stent-graft end is positioned in the left common carotid artery, (b) the inferior first lateral fenestration is disposed in the aortic arch, with the inferior first lateral fenestration facing upstream generally toward the ascending aorta, and (c) the superior second lateral fenestration is axially aligned with and faces the left subclavian artery.
72. A method for treating a patient comprising:
endovascularly introducing a generally tubular stent-graft, while in a radially- compressed state, and positioning the stent-graft such that (a) a proximal stent-graft end of the stent-graft is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery left subclavian artery, and a left common carotid artery, and (b) a distal stent-graft end of the stent-graft is positioned in a descending aorta, wherein the stent-graft includes (a) a generally tubular support element, which includes a plurality of structural stent elements arranged as a plurality circumferential stent springs, and (b) a covering element that is attached to and at least partially covers the support element; and
thereafter, transitioning the stent-graft to a radially-expanded state, in which (a) the covering element and the support element are shaped so as to together define a lateral fenestration that is disposed in the aortic arch, with the lateral fenestration facing upstream generally toward an ascending aorta, the lateral fenestration having distal and proximal fenestration ends, (b) a first perimeter of a distal stent-graft end of the stent-graft equals at least 200% of a second perimeter of the proximal stent-graft end, (c) the stent- graft includes a dissection-reinforcement axial portion, which (i) includes a first plurality of the stent springs, (ii) has (x) a distal dissection-reinforcement end and (y) a proximal dissection-reinforcement end that is disposed along the stent-graft no more than 20 mm proximal to the proximal fenestration end, (iii) extends along the stent-graft for a distance equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end, and (iv) is configured to be generally straight when the stent-graft
is unconstrained in the radially-constrained state, (d) the stent-graft includes a distal axial portion, which (i) includes a second plurality of the stent springs, (ii) is disposed along the stent-graft distal and axially adjacent to the distal dissection-reinforcement end, (iii) extends along the stent-graft for a distance equal to between 5% and 32% of the greatest perimeter of the stent-graft distally to the distal fenestration end, (e) the stent springs have respective average heights, measured axially along the stent-graft, and (f) an average of the average heights of the first plurality of the stent springs is less than 75% of the average height of a proximal-most one of the second plurality of the stent springs.
73. The method according to claim 72,
wherein the lateral fenestration is an inferior first lateral fenestration, which faces in a first radial direction,
wherein, when the main stent-graft is in the radially-expanded state, the main covering element and the main support element are shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction, and
wherein positioning the stent-graft comprises positioning the stent-graft such that (a) the proximal stent-graft end is positioned in the left common carotid artery, (b) the inferior first lateral fenestration is disposed in the aortic arch, with the inferior first lateral fenestration facing upstream generally toward the ascending aorta, and (c) the superior second lateral fenestration is axially aligned with and faces the left subclavian artery.
74. A method for treating a patient comprising:
endovascularly introducing a main module, while in a radially-compressed state thereof, and positioning the main module such that (a) a proximal main-module end of the main module is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery left subclavian artery, and a left common carotid artery, and (b) a distal main-module end of the main module is positioned in a descending aorta, wherein the main module includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element;
thereafter, transitioning the main stent-graft to a radially-expanded state thereof, in which the main covering element and the main support element are shaped so as to
together define a lateral fenestration that is disposed in the aortic arch, with the lateral fenestration facing upstream generally toward an ascending aorta;
endovascularly introducing and passing a secondary module, while in a radially- compressed state thereof, through a distal portion of the main stent-graft such that the secondary module is disposed through the lateral fenestration and is disposed partially in the aortic arch, wherein the secondary module includes a non-bifurcated secondary stent- graft, which includes (a) a secondary support element, which includes secondary structural stent elements, and (b) a secondary covering element that is attached to and at least partially covers the secondary support element; and
thereafter, transitioning the secondary module to a radially-expanded state thereof, in which the secondary module is shaped so as to define (a) a proximal secondary-module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) a central longitudinal axis therebetween, such that the sealing interface forms a blood-impervious seal with the lateral fenestration of the main module, and the secondary covering element is shaped so as to define at least one lateral opening that begins at and extends from the proximal secondary-module end toward the sealing interface along the central longitudinal axis for a distance equal to at least 50% of a greatest width of the secondary module, measured perpendicular to the central longitudinal axis.
75. The method according to claim 74,
wherein the lateral fenestration is an inferior first lateral fenestration, which faces in a first radial direction,
wherein, when the main stent-graft is in the radially-expanded state, the main covering element and the main support element are shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction, and
wherein positioning the stent-graft comprises positioning the stent-graft such that (a) the proximal stent-graft end is positioned in the left common carotid artery, (b) the inferior first lateral fenestration is disposed in the aortic arch, with the inferior first lateral fenestration facing upstream generally toward the ascending aorta, and (c) the superior second lateral fenestration is axially aligned with and faces the left subclavian artery.
76. A method for treating a patient comprising:
endovascularly introducing a main module, while in a radially-compressed state
thereof, and positioning the main module such that (a) a proximal main-module end of the main module is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery left subclavian artery, and a left common carotid artery, and (b) a distal main-module end of the main module is positioned in a descending aorta, wherein the main module includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element;
thereafter, transitioning the main stent-graft to a radially-expanded state thereof, in which the main covering element and the main support element are shaped so as to together define a main-module lateral fenestration that is disposed in the aortic arch, with the main-module lateral fenestration facing upstream generally toward an ascending aorta; endovascularly introducing and passing a secondary module, while in a radially- compressed state thereof, through a distal portion of the main stent-graft such that the secondary module is disposed through the main-module lateral fenestration and is disposed partially in the aortic arch, wherein the secondary module includes a non- bifurcated secondary stent-graft, which includes (a) a secondary support element, which includes secondary structural stent elements, and (b) a secondary covering element that is attached to and at least partially covers the secondary support element; and
thereafter, transitioning the secondary module to a radially-expanded state thereof, in which the secondary module is shaped so as to define (a) a proximal secondary-module end, (b) a sealing interface distal to the proximal secondary -module end, and (c) a central longitudinal axis therebetween, such that the sealing interface forms a blood -impervious seal with the main-module lateral fenestration of the main module, and the secondary covering element is shaped so as to define at least one secondary-module lateral fenestration disposed distal to the proximal secondary-module end and proximal to the sealing interface, wherein a greatest axial length of the secondary-module lateral fenestration, measured parallel to the central longitudinal axis, equals at least 33% of a first perimeter of the distal main-module end.
77. A method for treating a patient comprising:
endovascularly introducing a main module, while in a radially-compressed state thereof, and positioning the main module such that (a) a proximal main-module end of the main module is positioned in a branch of an aortic arch selected from the group consisting
of: a left subclavian artery left subclavian artery, and a left common carotid artery, and (b) a distal main-module end of the main module is positioned in a descending aorta, wherein the main module includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element;
thereafter, transitioning the main stent-graft to a radially-expanded state thereof, in which the main covering element and the main support element are shaped so as to together define a main-module lateral fenestration that is disposed in the aortic arch, with the main-module lateral fenestration facing upstream generally toward an ascending aorta; endovascularly introducing and passing a secondary module, while in a radially- compressed state thereof, through a distal portion of the main stent-graft such that the secondary module is disposed through the main-module lateral fenestration and is disposed partially in the aortic arch, wherein the secondary module includes a non- bifurcated secondary stent-graft, which includes (a) a secondary support element, which includes secondary structural stent elements, (b) a secondary covering element that is attached to and at least partially covers the secondary support element, and (c) a flexible sheet; and
thereafter, transitioning the secondary module to a radially-expanded state thereof, in which (a) the secondary module is shaped so as to define (a) a proximal secondary- module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) a central longitudinal axis therebetween, such that the sealing interface forms a blood- impervious seal with the main-module lateral fenestration of the main module, (b) the secondary covering element is shaped so as to define at least one secondary -module lateral fenestration disposed distal to the proximal secondary-module end and proximal to the sealing interface, and (c) the flexible sheet (i) is blood- sealingly joined to a portion of a secondary border of the secondary-module lateral fenestration, which portion extends around at least 25% of a perimeter of the secondary border and includes a distal end of the secondary border, and (ii) extends radially inward from the secondary border when the secondary module is unconstrained in the radially-expanded state thereof.
78. A method for treating a patient comprising:
endovascularly introducing a main module, while in a radially-compressed state thereof, and positioning the main module such that (a) a proximal main-module end of the
main module is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery left subclavian artery, and a left common carotid artery, and (b) a distal main-module end of the main module is positioned in a descending aorta, wherein the main module includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element;
thereafter, transitioning the main stent-graft to a radially-expanded state thereof, in which the main covering element and the main support element are shaped so as to together define a lateral fenestration that is disposed in the aortic arch, with the lateral fenestration facing upstream generally toward an ascending aorta;
endovascularly introducing and passing a secondary module, while in a radially- compressed state thereof, through a distal portion of the main stent-graft such that the secondary module is disposed through the lateral fenestration and is disposed partially in the aortic arch, wherein the secondary module includes a non-bifurcated secondary stent- graft, which includes (a) a secondary support element, which includes secondary structural stent elements, and (b) a secondary covering element that is attached to and partially covers the secondary support element; and
thereafter, transitioning the secondary module to a radially-expanded state thereof, in which the secondary module is shaped so as to define (a) a proximal secondary-module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) an anchoring axial portion therebetween having a central longitudinal axis and an anchoring- portion length, measured along the central longitudinal axis from the distal sealing interface to the proximal secondary-module end, such that the sealing interface forms a blood-impervious seal with the lateral fenestration of the main module, the secondary covering element at least covers the secondary support element along a covered axial portion of the anchoring axial portion, which covered axial portion extends proximally from the distal sealing interface for an axial covering distance equal to between 10% and 50% of the anchoring-portion length, the axial covering distance measured along the central longitudinal axis, wherein the secondary support element is uncovered proximally to the secondary covering element, and the anchoring axial portion has a greatest anchoring-portion width that is (a) greater than a greatest proximal-end width at the proximal secondary-module end and (b) at least 20% greater than a greatest sealing-
interface width at a narrowest portion of the distal sealing interface, the greatest anchoring-portion, sealing-interface, and proximal-end widths measured perpendicular to the central longitudinal axis.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/772,016 US9668892B2 (en) | 2013-03-11 | 2014-02-18 | Multi-component stent-graft system for aortic dissections |
CN201480026943.XA CN105208969B (en) | 2013-03-11 | 2014-02-18 | Multicompartment stent graft system for dissection of aorta |
EP14762507.3A EP2967830B1 (en) | 2013-03-11 | 2014-02-18 | Multi-component stent-graft system for aortic dissections |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361775964P | 2013-03-11 | 2013-03-11 | |
US61/775,964 | 2013-03-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014141232A1 true WO2014141232A1 (en) | 2014-09-18 |
Family
ID=51535992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2014/050174 WO2014141232A1 (en) | 2013-03-11 | 2014-02-18 | Multi-component stent-graft system for aortic dissections |
Country Status (4)
Country | Link |
---|---|
US (1) | US9668892B2 (en) |
EP (1) | EP2967830B1 (en) |
CN (1) | CN105208969B (en) |
WO (1) | WO2014141232A1 (en) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016098113A1 (en) | 2014-12-18 | 2016-06-23 | Endospan Ltd. | Endovascular stent-graft with fatigue-resistant lateral tube |
WO2016113731A1 (en) | 2015-01-12 | 2016-07-21 | Endospan Ltd. | Self-curving stent-graft |
WO2016122862A1 (en) * | 2015-01-28 | 2016-08-04 | Aortic Innovations, Llc | Modular endo-aortic device and method of using the same |
WO2016125137A1 (en) | 2015-02-02 | 2016-08-11 | Endospan Ltd. | Self-orienting endovascular delivery system |
US9427339B2 (en) | 2011-10-30 | 2016-08-30 | Endospan Ltd. | Triple-collar stent-graft |
US9597204B2 (en) | 2011-12-04 | 2017-03-21 | Endospan Ltd. | Branched stent-graft system |
WO2017081679A1 (en) | 2015-11-12 | 2017-05-18 | Endospan Ltd. | Stent-grafts systems with skirt |
US9668892B2 (en) | 2013-03-11 | 2017-06-06 | Endospan Ltd. | Multi-component stent-graft system for aortic dissections |
US9770350B2 (en) | 2012-05-15 | 2017-09-26 | Endospan Ltd. | Stent-graft with fixation elements that are radially confined for delivery |
US9839510B2 (en) | 2011-08-28 | 2017-12-12 | Endospan Ltd. | Stent-grafts with post-deployment variable radial displacement |
US9918825B2 (en) | 2009-06-23 | 2018-03-20 | Endospan Ltd. | Vascular prosthesis for treating aneurysms |
US9993360B2 (en) | 2013-01-08 | 2018-06-12 | Endospan Ltd. | Minimization of stent-graft migration during implantation |
WO2018173056A1 (en) | 2017-03-21 | 2018-09-27 | Endospan Ltd. | Stent-grafts for sealing around external disturbances |
EP3310305A4 (en) * | 2015-06-18 | 2019-02-20 | Ascyrus Medical, LLC | Branched aortic graft and method of using the same |
US10603197B2 (en) | 2013-11-19 | 2020-03-31 | Endospan Ltd. | Stent system with radial-expansion locking |
WO2020074598A1 (en) * | 2018-10-12 | 2020-04-16 | Canaud Ludovic | Stent-type aortic implant and assembly formed by two such implants |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8128677B2 (en) | 2007-12-12 | 2012-03-06 | Intact Vascular LLC | Device and method for tacking plaque to a blood vessel wall |
JP6129867B2 (en) | 2011-12-06 | 2017-05-17 | エイオールティック イノベーションズ エルエルシーAortic Innovations Llc | Intravascular aortic repair device and method of use thereof |
US9861474B2 (en) | 2013-07-18 | 2018-01-09 | The Trustees Of The University Of Pennsylvania | Cardiac repair prosthesis sets and methods |
US9808363B2 (en) * | 2014-09-10 | 2017-11-07 | The Cleveland Clinic Foundation | Frame structures, stent grafts incorporating the same, and methods for extended aortic repair |
US9375336B1 (en) | 2015-01-29 | 2016-06-28 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9433520B2 (en) | 2015-01-29 | 2016-09-06 | Intact Vascular, Inc. | Delivery device and method of delivery |
US10993824B2 (en) | 2016-01-01 | 2021-05-04 | Intact Vascular, Inc. | Delivery device and method of delivery |
US10881497B2 (en) * | 2017-01-26 | 2021-01-05 | DePuy Synthes Products, Inc. | Composite vascular flow diverter |
JP7299838B2 (en) * | 2017-02-01 | 2023-06-28 | エンドーロジックス リミテッド ライアビリティ カンパニー | LONGITUDINALLY EXPANDABLE STENT GRAFT SYSTEM AND METHOD |
US10772719B2 (en) * | 2017-02-14 | 2020-09-15 | Cook Medical Technologies Llc | Method of making a contoured internal limb for a prosthesis and prosthesis with a contoured internal limb |
EP3648705A4 (en) | 2017-07-07 | 2021-03-24 | Endologix LLC | Endovascular graft systems and methods for deployment in main and branch arteries |
US11660218B2 (en) | 2017-07-26 | 2023-05-30 | Intact Vascular, Inc. | Delivery device and method of delivery |
WO2019071268A1 (en) | 2017-10-07 | 2019-04-11 | The Cleveland Clinic Foundation | Endovascular grafts and methods for extended aortic repair |
CA3133857A1 (en) | 2019-03-20 | 2020-09-24 | inQB8 Medical Technologies, LLC | Aortic dissection implant |
WO2021092453A1 (en) * | 2019-11-07 | 2021-05-14 | Jeko Metodiev Madjarov | Endograft with bristles |
WO2024057320A1 (en) | 2022-09-15 | 2024-03-21 | Endospan Ltd. | Double-branching ascending aortic stent-graft systems |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070067014A1 (en) * | 2005-09-22 | 2007-03-22 | Microport Medical Co., Ltd. | Method for aortic graft installation |
US20070168018A1 (en) * | 2006-01-13 | 2007-07-19 | Aga Medical Corporation | Intravascular deliverable stent for reinforcement of abdominal aortic aneurysm |
US20080114446A1 (en) * | 2006-11-07 | 2008-05-15 | Wiiliam A. Cook Australia Pty Ltd. | Fenestration for stent graft arrangements and stent graft including the same |
US20090157014A1 (en) * | 2007-12-17 | 2009-06-18 | William Cook Europe Aps | Device for enabling repeated access to a vessel |
US20090319022A1 (en) * | 2006-08-18 | 2009-12-24 | William Cook Australia Pty. Ltd. | Stent graft |
US20100161025A1 (en) * | 2008-08-29 | 2010-06-24 | Cook, Incorporated | Variable weave graft with metal strand reinforcement for in situ fenestration |
US20100249899A1 (en) * | 2009-03-26 | 2010-09-30 | Cook Incorporated | Pararenal stent graft |
US20110319983A1 (en) * | 2009-03-18 | 2011-12-29 | Microport Medical (Shanghai) Co., Ltd. | Branched stent graft |
Family Cites Families (472)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4281669A (en) | 1975-05-09 | 1981-08-04 | Macgregor David C | Pacemaker electrode with porous system |
US4180613A (en) | 1977-09-01 | 1979-12-25 | E. I. Du Pont De Nemours And Company | Craze-resistant polysiloxane resin coatings and coating compositions containing a discontinuous phase |
US4665906A (en) | 1983-10-14 | 1987-05-19 | Raychem Corporation | Medical devices incorporating sim alloy elements |
US4505767A (en) | 1983-10-14 | 1985-03-19 | Raychem Corporation | Nickel/titanium/vanadium shape memory alloy |
US4787899A (en) | 1983-12-09 | 1988-11-29 | Lazarus Harrison M | Intraluminal graft device, system and method |
US4562596A (en) | 1984-04-25 | 1986-01-07 | Elliot Kornberg | Aortic graft, device and method for performing an intraluminal abdominal aortic aneurysm repair |
US4617932A (en) | 1984-04-25 | 1986-10-21 | Elliot Kornberg | Device and method for performing an intraluminal abdominal aortic aneurysm repair |
US4577631A (en) | 1984-11-16 | 1986-03-25 | Kreamer Jeffry W | Aneurysm repair apparatus and method |
US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4878906A (en) | 1986-03-25 | 1989-11-07 | Servetus Partnership | Endoprosthesis for repairing a damaged vessel |
US4816339A (en) | 1987-04-28 | 1989-03-28 | Baxter International Inc. | Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation |
US4969458A (en) | 1987-07-06 | 1990-11-13 | Medtronic, Inc. | Intracoronary stent and method of simultaneous angioplasty and stent implant |
US5133732A (en) | 1987-10-19 | 1992-07-28 | Medtronic, Inc. | Intravascular stent |
US5782903A (en) | 1987-10-19 | 1998-07-21 | Medtronic, Inc. | Intravascular stent and method |
US4886062A (en) | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
US4938740A (en) | 1988-05-25 | 1990-07-03 | Trustees Of The University Of Pennsylvania | Reducing stress at vascular graft anastomoses |
US5425739A (en) | 1989-03-09 | 1995-06-20 | Avatar Design And Development, Inc. | Anastomosis stent and stent selection system |
US6004330A (en) | 1989-08-16 | 1999-12-21 | Medtronic, Inc. | Device or apparatus for manipulating matter |
US5509923A (en) | 1989-08-16 | 1996-04-23 | Raychem Corporation | Device for dissecting, grasping, or cutting an object |
US5749879A (en) | 1989-08-16 | 1998-05-12 | Medtronic, Inc. | Device or apparatus for manipulating matter |
US5632746A (en) | 1989-08-16 | 1997-05-27 | Medtronic, Inc. | Device or apparatus for manipulating matter |
CA2026604A1 (en) | 1989-10-02 | 1991-04-03 | Rodney G. Wolff | Articulated stent |
US5439446A (en) | 1994-06-30 | 1995-08-08 | Boston Scientific Corporation | Stent and therapeutic delivery system |
US5122136A (en) | 1990-03-13 | 1992-06-16 | The Regents Of The University Of California | Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US5360443A (en) | 1990-06-11 | 1994-11-01 | Barone Hector D | Aortic graft for repairing an abdominal aortic aneurysm |
US5064435A (en) | 1990-06-28 | 1991-11-12 | Schneider (Usa) Inc. | Self-expanding prosthesis having stable axial length |
ES2241527T3 (en) | 1990-10-09 | 2005-11-01 | Medtronic, Inc. | MATERIAL HANDLING DEVICE. |
US5042707A (en) | 1990-10-16 | 1991-08-27 | Taheri Syde A | Intravascular stapler, and method of operating same |
US5192286A (en) | 1991-07-26 | 1993-03-09 | Regents Of The University Of California | Method and device for retrieving materials from body lumens |
AU669338B2 (en) | 1991-10-25 | 1996-06-06 | Cook Incorporated | Expandable transluminal graft prosthesis for repair of aneurysm and method for implanting |
US5234448A (en) | 1992-02-28 | 1993-08-10 | Shadyside Hospital | Method and apparatus for connecting and closing severed blood vessels |
US5342387A (en) | 1992-06-18 | 1994-08-30 | American Biomed, Inc. | Artificial support for a blood vessel |
US5417699A (en) | 1992-12-10 | 1995-05-23 | Perclose Incorporated | Device and method for the percutaneous suturing of a vascular puncture site |
US5425765A (en) | 1993-06-25 | 1995-06-20 | Tiefenbrun; Jonathan | Surgical bypass method |
US5632772A (en) | 1993-10-21 | 1997-05-27 | Corvita Corporation | Expandable supportive branched endoluminal grafts |
US5639278A (en) | 1993-10-21 | 1997-06-17 | Corvita Corporation | Expandable supportive bifurcated endoluminal grafts |
US5527322A (en) | 1993-11-08 | 1996-06-18 | Perclose, Inc. | Device and method for suturing of internal puncture sites |
DE9319267U1 (en) | 1993-12-15 | 1994-02-24 | Vorwerk Dierk Dr | Aortic endoprosthesis |
US5507769A (en) | 1994-10-18 | 1996-04-16 | Stentco, Inc. | Method and apparatus for forming an endoluminal bifurcated graft |
US5556413A (en) | 1994-03-11 | 1996-09-17 | Advanced Cardiovascular Systems, Inc. | Coiled stent with locking ends |
US5843120A (en) | 1994-03-17 | 1998-12-01 | Medinol Ltd. | Flexible-expandable stent |
US5449373A (en) | 1994-03-17 | 1995-09-12 | Medinol Ltd. | Articulated stent |
US6165210A (en) | 1994-04-01 | 2000-12-26 | Gore Enterprise Holdings, Inc. | Self-expandable helical intravascular stent and stent-graft |
EP0754017B1 (en) | 1994-04-29 | 2002-06-19 | SciMed Life Systems, Inc. | Stent with collagen |
US5554181A (en) | 1994-05-04 | 1996-09-10 | Regents Of The University Of Minnesota | Stent |
WO1995032671A1 (en) | 1994-06-01 | 1995-12-07 | Perclose, Inc. | Method and device for providing vascular hemostasis |
EP0689805B1 (en) | 1994-06-27 | 2003-05-28 | Corvita Corporation | Bistable luminal graft endoprostheses |
US5609605A (en) | 1994-08-25 | 1997-03-11 | Ethicon, Inc. | Combination arterial stent |
US5843170A (en) | 1994-09-02 | 1998-12-01 | Ahn; Sam Seunghae | Apparatus and method for performing aneurysm repair |
US6015429A (en) | 1994-09-08 | 2000-01-18 | Gore Enterprise Holdings, Inc. | Procedures for introducing stents and stent-grafts |
US5653743A (en) | 1994-09-09 | 1997-08-05 | Martin; Eric C. | Hypogastric artery bifurcation graft and method of implantation |
JP2911763B2 (en) | 1994-10-27 | 1999-06-23 | 三桜子 布川 | Artificial blood vessel |
CA2134997C (en) | 1994-11-03 | 2009-06-02 | Ian M. Penn | Stent |
US5549662A (en) | 1994-11-07 | 1996-08-27 | Scimed Life Systems, Inc. | Expandable stent using sliding members |
NL9500094A (en) | 1995-01-19 | 1996-09-02 | Industrial Res Bv | Y-shaped stent and method of deployment. |
US5755770A (en) | 1995-01-31 | 1998-05-26 | Boston Scientific Corporatiion | Endovascular aortic graft |
US5575818A (en) | 1995-02-14 | 1996-11-19 | Corvita Corporation | Endovascular stent with locking ring |
US5683449A (en) | 1995-02-24 | 1997-11-04 | Marcade; Jean Paul | Modular bifurcated intraluminal grafts and methods for delivering and assembling same |
WO1996039104A1 (en) | 1995-06-06 | 1996-12-12 | Endotex Interventional Systems, Inc. | Prosthetic graft and method for aneurysm repair |
US5902311A (en) | 1995-06-15 | 1999-05-11 | Perclose, Inc. | Low profile intraluminal suturing device and method |
US5769882A (en) | 1995-09-08 | 1998-06-23 | Medtronic, Inc. | Methods and apparatus for conformably sealing prostheses within body lumens |
US6071300A (en) | 1995-09-15 | 2000-06-06 | Sub-Q Inc. | Apparatus and method for percutaneous sealing of blood vessel punctures |
US6348066B1 (en) | 1995-11-07 | 2002-02-19 | Corvita Corporation | Modular endoluminal stent-grafts and methods for their use |
US5824040A (en) | 1995-12-01 | 1998-10-20 | Medtronic, Inc. | Endoluminal prostheses and therapies for highly variable body lumens |
US6042605A (en) | 1995-12-14 | 2000-03-28 | Gore Enterprose Holdings, Inc. | Kink resistant stent-graft |
DE69732794T2 (en) | 1996-01-05 | 2006-04-06 | Medtronic, Inc., Minneapolis | EXPANDABLE ENDOLUMINARY PROSTHESIS |
CN1194577A (en) | 1996-05-31 | 1998-09-30 | 巴德·戈尔韦有限公司 | Bifurcated endovascular stents and method and apparatus for their placement |
US5769884A (en) | 1996-06-27 | 1998-06-23 | Cordis Corporation | Controlled porosity endovascular implant |
US5676697A (en) | 1996-07-29 | 1997-10-14 | Cardiovascular Dynamics, Inc. | Two-piece, bifurcated intraluminal graft for repair of aneurysm |
US5755781A (en) | 1996-08-06 | 1998-05-26 | Iowa-India Investments Company Limited | Embodiments of multiple interconnected stents |
WO1998006355A1 (en) | 1996-08-09 | 1998-02-19 | Edoga John K | Endoluminal graft replacement of abdominal aortic aneurysms |
US5728134A (en) | 1996-09-17 | 1998-03-17 | Barak; Shlomo | Method and apparatus for hemostasis |
US5749825A (en) | 1996-09-18 | 1998-05-12 | Isostent, Inc. | Means method for treatment of stenosed arterial bifurcations |
US6432127B1 (en) | 1996-10-11 | 2002-08-13 | Transvascular, Inc. | Devices for forming and/or maintaining connections between adjacent anatomical conduits |
US6599316B2 (en) | 1996-11-04 | 2003-07-29 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US7341598B2 (en) | 1999-01-13 | 2008-03-11 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US6325826B1 (en) | 1998-01-14 | 2001-12-04 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US6692483B2 (en) | 1996-11-04 | 2004-02-17 | Advanced Stent Technologies, Inc. | Catheter with attached flexible side sheath |
US6036702A (en) | 1997-04-23 | 2000-03-14 | Vascular Science Inc. | Medical grafting connectors and fasteners |
US5976178A (en) | 1996-11-07 | 1999-11-02 | Vascular Science Inc. | Medical grafting methods |
WO1998020810A1 (en) | 1996-11-12 | 1998-05-22 | Medtronic, Inc. | Flexible, radially expansible luminal prostheses |
US6015431A (en) | 1996-12-23 | 2000-01-18 | Prograft Medical, Inc. | Endolumenal stent-graft with leak-resistant seal |
US6406420B1 (en) | 1997-01-02 | 2002-06-18 | Myocor, Inc. | Methods and devices for improving cardiac function in hearts |
US6152956A (en) | 1997-01-28 | 2000-11-28 | Pierce; George E. | Prosthesis for endovascular repair of abdominal aortic aneurysms |
US5827321A (en) | 1997-02-07 | 1998-10-27 | Cornerstone Devices, Inc. | Non-Foreshortening intraluminal prosthesis |
US5911732A (en) | 1997-03-10 | 1999-06-15 | Johnson & Johnson Interventional Systems, Co. | Articulated expandable intraluminal stent |
CA2424551A1 (en) | 1997-05-27 | 1998-11-27 | Schneider (Usa) Inc. | Stent and stent-graft for treating branched vessels |
US5906641A (en) | 1997-05-27 | 1999-05-25 | Schneider (Usa) Inc | Bifurcated stent graft |
US5944750A (en) | 1997-06-30 | 1999-08-31 | Eva Corporation | Method and apparatus for the surgical repair of aneurysms |
US5855600A (en) | 1997-08-01 | 1999-01-05 | Inflow Dynamics Inc. | Flexible implantable stent with composite design |
US5984955A (en) | 1997-09-11 | 1999-11-16 | Wisselink; Willem | System and method for endoluminal grafting of bifurcated or branched vessels |
US6074416A (en) | 1997-10-09 | 2000-06-13 | St. Jude Medical Cardiovascular Group, Inc. | Wire connector structures for tubular grafts |
US6231516B1 (en) | 1997-10-14 | 2001-05-15 | Vacusense, Inc. | Endoluminal implant with therapeutic and diagnostic capability |
US6033435A (en) | 1997-11-03 | 2000-03-07 | Divysio Solutions Ulc | Bifurcated stent and method for the manufacture and delivery of same |
US6030414A (en) | 1997-11-13 | 2000-02-29 | Taheri; Syde A. | Variable stent and method for treatment of arterial disease |
WO1999034748A1 (en) | 1998-01-07 | 1999-07-15 | Boston Scientific, Limited | Implantable band and stent graft for treating a vessel aneurysm |
US6533807B2 (en) | 1998-02-05 | 2003-03-18 | Medtronic, Inc. | Radially-expandable stent and delivery system |
US6395018B1 (en) | 1998-02-09 | 2002-05-28 | Wilfrido R. Castaneda | Endovascular graft and process for bridging a defect in a main vessel near one of more branch vessels |
US6623521B2 (en) | 1998-02-17 | 2003-09-23 | Md3, Inc. | Expandable stent with sliding and locking radial elements |
US5938697A (en) | 1998-03-04 | 1999-08-17 | Scimed Life Systems, Inc. | Stent having variable properties |
US6099497A (en) | 1998-03-05 | 2000-08-08 | Scimed Life Systems, Inc. | Dilatation and stent delivery system for bifurcation lesions |
EP1065993B1 (en) | 1998-03-05 | 2010-08-11 | Boston Scientific Limited | Intraluminal stent |
US6129756A (en) | 1998-03-16 | 2000-10-10 | Teramed, Inc. | Biluminal endovascular graft system |
US6224609B1 (en) | 1998-03-16 | 2001-05-01 | Teramed Inc. | Bifurcated prosthetic graft |
AU3342499A (en) | 1998-04-02 | 1999-10-25 | Salviac Limited | An implant comprising a support structure and a transition material made of porous plastics material |
US6206914B1 (en) | 1998-04-30 | 2001-03-27 | Medtronic, Inc. | Implantable system with drug-eluting cells for on-demand local drug delivery |
US6168615B1 (en) | 1998-05-04 | 2001-01-02 | Micrus Corporation | Method and apparatus for occlusion and reinforcement of aneurysms |
JP2002516696A (en) | 1998-05-29 | 2002-06-11 | バイ−パス・インク. | Methods and devices for vascular surgery |
AU761192B2 (en) | 1998-06-10 | 2003-05-29 | Converge Medical, Inc. | Sutureless anastomosis systems |
US6036725A (en) | 1998-06-10 | 2000-03-14 | General Science And Technology | Expandable endovascular support device |
US6156064A (en) | 1998-08-14 | 2000-12-05 | Schneider (Usa) Inc | Stent-graft-membrane and method of making the same |
US6368345B1 (en) | 1998-09-30 | 2002-04-09 | Edwards Lifesciences Corporation | Methods and apparatus for intraluminal placement of a bifurcated intraluminal garafat |
US6325820B1 (en) | 1998-11-16 | 2001-12-04 | Endotex Interventional Systems, Inc. | Coiled-sheet stent-graft with exo-skeleton |
US20010049554A1 (en) | 1998-11-18 | 2001-12-06 | Carlos E. Ruiz | Endovascular prosthesis and method of making |
US6733523B2 (en) | 1998-12-11 | 2004-05-11 | Endologix, Inc. | Implantable vascular graft |
US6692520B1 (en) | 1998-12-15 | 2004-02-17 | C. R. Bard, Inc. | Systems and methods for imbedded intramuscular implants |
US6059824A (en) | 1998-12-23 | 2000-05-09 | Taheri; Syde A. | Mated main and collateral stent and method for treatment of arterial disease |
EP1073385A2 (en) | 1999-01-22 | 2001-02-07 | Gore Enterprise Holdings, Inc. | A biliary stent-graft |
US7914564B2 (en) | 1999-02-09 | 2011-03-29 | Innercool Therapies, Inc. | System and method for patient temperature control employing temperature projection algorithm |
US6077298A (en) | 1999-02-20 | 2000-06-20 | Tu; Lily Chen | Expandable/retractable stent and methods thereof |
US6200339B1 (en) | 1999-02-23 | 2001-03-13 | Datascope Investment Corp. | Endovascular split-tube bifurcated graft prosthesis and an implantation method for such a prosthesis |
JP4067225B2 (en) | 1999-03-31 | 2008-03-26 | テルモ株式会社 | Angioplasty vessel stent |
DE19916060A1 (en) | 1999-04-09 | 2000-10-19 | Braun Melsungen Ag | Stent device |
US6273911B1 (en) | 1999-04-22 | 2001-08-14 | Advanced Cardiovascular Systems, Inc. | Variable strength stent |
US6287335B1 (en) | 1999-04-26 | 2001-09-11 | William J. Drasler | Intravascular folded tubular endoprosthesis |
WO2001006952A1 (en) | 1999-07-16 | 2001-02-01 | Med Institute, Inc. | Stent adapted for tangle-free deployment |
US7662161B2 (en) | 1999-09-13 | 2010-02-16 | Rex Medical, L.P | Vascular hole closure device |
CA2381818C (en) | 1999-09-13 | 2009-08-04 | Rex Medical, L.P. | Vascular closure |
US6344056B1 (en) | 1999-12-29 | 2002-02-05 | Edwards Lifesciences Corp. | Vascular grafts for bridging a vessel side branch |
WO2001026584A1 (en) | 1999-10-14 | 2001-04-19 | United Stenting, Inc. | Stents with multilayered struts |
US6613075B1 (en) | 1999-10-27 | 2003-09-02 | Cordis Corporation | Rapid exchange self-expanding stent delivery catheter system |
US6325823B1 (en) | 1999-10-29 | 2001-12-04 | Revasc Corporation | Endovascular prosthesis accommodating torsional and longitudinal displacements and methods of use |
US6652567B1 (en) | 1999-11-18 | 2003-11-25 | David H. Deaton | Fenestrated endovascular graft |
US6280466B1 (en) | 1999-12-03 | 2001-08-28 | Teramed Inc. | Endovascular graft system |
US6663667B2 (en) | 1999-12-29 | 2003-12-16 | Edwards Lifesciences Corporation | Towel graft means for enhancing tissue ingrowth in vascular grafts |
US6537311B1 (en) | 1999-12-30 | 2003-03-25 | Advanced Cardiovascular Systems, Inc. | Stent designs for use in peripheral vessels |
US6544285B1 (en) | 2000-01-17 | 2003-04-08 | Heinemen Medical Research, Inc. | Aortic root prosthesis with compliant sinuses |
US6312458B1 (en) | 2000-01-19 | 2001-11-06 | Scimed Life Systems, Inc. | Tubular structure/stent/stent securement member |
US6814752B1 (en) | 2000-03-03 | 2004-11-09 | Endovascular Technologies, Inc. | Modular grafting system and method |
US6942691B1 (en) | 2000-04-27 | 2005-09-13 | Timothy A. M. Chuter | Modular bifurcated graft for endovascular aneurysm repair |
US7632303B1 (en) | 2000-06-07 | 2009-12-15 | Advanced Cardiovascular Systems, Inc. | Variable stiffness medical devices |
US6846321B2 (en) | 2000-06-21 | 2005-01-25 | Cardiodex, Ltd. | Mechanical method and apparatus for enhancing hemostatis following arterial catheterization |
JP2002035135A (en) | 2000-07-31 | 2002-02-05 | Manii Kk | Stent and method for manufacturing stent |
US6613078B1 (en) | 2000-08-02 | 2003-09-02 | Hector Daniel Barone | Multi-component endoluminal graft assembly, use thereof and method of implanting |
US6695833B1 (en) | 2000-09-27 | 2004-02-24 | Nellix, Inc. | Vascular stent-graft apparatus and forming method |
US7616997B2 (en) | 2000-09-27 | 2009-11-10 | Kieval Robert S | Devices and methods for cardiovascular reflex control via coupled electrodes |
US6890349B2 (en) | 2000-10-13 | 2005-05-10 | Rex Medical, L.P. | Covered stent with side branch |
US7029481B1 (en) | 2000-11-06 | 2006-04-18 | Abbott Laboratories | Systems, devices and methods for suturing patient tissue |
US6506211B1 (en) | 2000-11-13 | 2003-01-14 | Scimed Life Systems, Inc. | Stent designs |
US7229472B2 (en) | 2000-11-16 | 2007-06-12 | Cordis Corporation | Thoracic aneurysm repair prosthesis and system |
JP4532070B2 (en) | 2000-11-17 | 2010-08-25 | エビーシオ・メディカル・デバイセズ・ユーエルシー | Endovascular prosthesis |
US6648911B1 (en) | 2000-11-20 | 2003-11-18 | Avantec Vascular Corporation | Method and device for the treatment of vulnerable tissue site |
US20040106972A1 (en) | 2000-11-20 | 2004-06-03 | Deaton David H. | Fenestrated endovascular graft |
US7306598B2 (en) | 2000-11-24 | 2007-12-11 | Dfine, Inc. | Polymer matrix devices for treatment of vascular malformations |
US8870946B1 (en) | 2000-12-11 | 2014-10-28 | W.L. Gore & Associates, Inc. | Method of deploying a bifurcated side-access intravascular stent graft |
US6645242B1 (en) | 2000-12-11 | 2003-11-11 | Stephen F. Quinn | Bifurcated side-access intravascular stent graft |
US6929660B1 (en) | 2000-12-22 | 2005-08-16 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US20020123791A1 (en) | 2000-12-28 | 2002-09-05 | Harrison William J. | Stent design with increased vessel coverage |
DE60207799T2 (en) | 2001-01-08 | 2006-08-31 | Boston Scientific Ltd., St. Michael | FENCING BASKET WITH SOLVABLE END PIECE |
US6445953B1 (en) | 2001-01-16 | 2002-09-03 | Kenergy, Inc. | Wireless cardiac pacing system with vascular electrode-stents |
CA2438005A1 (en) | 2001-02-07 | 2002-08-15 | Synthes (U.S.A.) | Device and method for intraoperative navigation |
JP4673987B2 (en) | 2001-02-27 | 2011-04-20 | 株式会社トップ | Stent and stent member |
CA2441119A1 (en) | 2001-03-08 | 2002-09-19 | Atritech, Inc. | Atrial filter implants |
US6743195B2 (en) | 2001-03-14 | 2004-06-01 | Cardiodex | Balloon method and apparatus for vascular closure following arterial catheterization |
FR2822370B1 (en) | 2001-03-23 | 2004-03-05 | Perouse Lab | TUBULAR ENDOPROSTHESIS COMPRISING A DEFORMABLE RING AND REQUIRED OF INTERVENTION FOR ITS IMPLANTATION |
US7175651B2 (en) | 2001-07-06 | 2007-02-13 | Andrew Kerr | Stent/graft assembly |
US6761733B2 (en) | 2001-04-11 | 2004-07-13 | Trivascular, Inc. | Delivery system and method for bifurcated endovascular graft |
US6824560B2 (en) | 2001-06-13 | 2004-11-30 | Advanced Cardiovascular Systems, Inc. | Double-butted superelastic nitinol tubing |
US6635083B1 (en) | 2001-06-25 | 2003-10-21 | Advanced Cardiovascular Systems, Inc. | Stent with non-linear links and method of use |
US6554855B1 (en) | 2001-07-03 | 2003-04-29 | Scimed Life Systems, Inc. | Low profile, high stretch, low dilation knit prosthetic device |
EP1427469A4 (en) | 2001-08-22 | 2007-03-28 | Hasan Semih Oktay | Flexible mems actuated controlled expansion stent |
US6675809B2 (en) | 2001-08-27 | 2004-01-13 | Richard S. Stack | Satiation devices and methods |
US6953469B2 (en) | 2001-08-30 | 2005-10-11 | Ethicon, Inc, | Device and method for treating intraluminal tissue |
AUPR748801A0 (en) | 2001-09-04 | 2001-09-27 | Stentco Llc | A stent |
US7912554B2 (en) | 2001-09-26 | 2011-03-22 | Medtronic Cryocath Lp | Method for treatment of aneurysms |
US20030065345A1 (en) | 2001-09-28 | 2003-04-03 | Kevin Weadock | Anastomosis devices and methods for treating anastomotic sites |
US20030074055A1 (en) | 2001-10-17 | 2003-04-17 | Haverkost Patrick A. | Method and system for fixation of endoluminal devices |
US7749243B2 (en) | 2001-10-19 | 2010-07-06 | Boston Scientific Scimed, Inc. | Embolus extractor |
AUPR847201A0 (en) | 2001-10-26 | 2001-11-15 | Cook Incorporated | Endoluminal graft |
AUPR847301A0 (en) | 2001-10-26 | 2001-11-15 | Cook Incorporated | Endoluminal prostheses for curved lumens |
US8740973B2 (en) | 2001-10-26 | 2014-06-03 | Icon Medical Corp. | Polymer biodegradable medical device |
US20090112302A1 (en) | 2001-11-28 | 2009-04-30 | Josh Stafford | Devices, systems, and methods for endovascular staple and/or prosthesis delivery and implantation |
US6776794B1 (en) | 2001-11-28 | 2004-08-17 | Advanced Cardiovascular Systems, Inc. | Stent pattern with mirror image |
US20030176914A1 (en) | 2003-01-21 | 2003-09-18 | Rabkin Dmitry J. | Multi-segment modular stent and methods for manufacturing stents |
AU2002351311A1 (en) | 2001-12-06 | 2003-06-23 | Thomas J. Clement | Medical device |
US20030114061A1 (en) | 2001-12-13 | 2003-06-19 | Kazuhisa Matsuda | Adhesion preventive membrane, method of producing a collagen single strand, collagen nonwoven fabric and method and apparatus for producing the same |
US6752826B2 (en) | 2001-12-14 | 2004-06-22 | Thoratec Corporation | Layered stent-graft and methods of making the same |
CA2470824A1 (en) | 2001-12-21 | 2003-08-28 | Cardiovasc, Inc. | Composite stent with polymeric covering and bioactive coating |
US20030212449A1 (en) | 2001-12-28 | 2003-11-13 | Cox Daniel L. | Hybrid stent |
US20030130720A1 (en) | 2002-01-08 | 2003-07-10 | Depalma Donald F. | Modular aneurysm repair system |
US7018404B2 (en) | 2002-01-24 | 2006-03-28 | St. Jude Medical, Inc. | Conduit for aorta or pulmonary artery replacement |
EP1336392A1 (en) | 2002-02-14 | 2003-08-20 | John S. Geis | Body vessel support and catheter system |
US7918883B2 (en) | 2002-02-25 | 2011-04-05 | Boston Scientific Scimed, Inc. | Non-invasive heating of implanted vascular treatment device |
US7708771B2 (en) | 2002-02-26 | 2010-05-04 | Endovascular Technologies, Inc. | Endovascular graft device and methods for attaching components thereof |
JP4208075B2 (en) | 2002-03-25 | 2009-01-14 | クック インコーポレイティド | Bifurcated / branched vascular prosthesis |
US7131991B2 (en) | 2002-04-24 | 2006-11-07 | Medtronic Vascular, Inc. | Endoluminal prosthetic assembly and extension method |
US7083822B2 (en) | 2002-04-26 | 2006-08-01 | Medtronic Vascular, Inc. | Overlapping coated stents |
US7105031B2 (en) | 2002-04-26 | 2006-09-12 | Medtronic Vascular, Inc. | Balloon-tipped, multi-lumen catheter for endoluminal repair of endoluminal leaks in aortic or aorto-iliac endoluminal grafts |
US7887575B2 (en) | 2002-05-22 | 2011-02-15 | Boston Scientific Scimed, Inc. | Stent with segmented graft |
EP1513470A2 (en) | 2002-05-28 | 2005-03-16 | The Cleveland Clinic Foundation | Minimally invasive treatment system for aortic aneurysms |
EP1509271B1 (en) | 2002-05-29 | 2005-11-23 | William A. Cook Australia Pty. Ltd. | Trigger wire system for a prosthesis deployment device |
US7399313B2 (en) | 2002-06-07 | 2008-07-15 | Brown Peter S | Endovascular graft with separable sensors |
US7261733B1 (en) | 2002-06-07 | 2007-08-28 | Endovascular Technologies, Inc. | Endovascular graft with sensors design and attachment methods |
US6748953B2 (en) | 2002-06-11 | 2004-06-15 | Scimed Life Systems, Inc. | Method for thermal treatment of type II endoleaks in arterial aneurysms |
US7044962B2 (en) | 2002-06-25 | 2006-05-16 | Scimed Life Systems, Inc. | Implantable prosthesis with displaceable skirt |
US20040002752A1 (en) | 2002-06-26 | 2004-01-01 | Scimed Life Systems, Inc. | Sacrificial anode stent system |
JP5108997B2 (en) | 2002-06-28 | 2012-12-26 | クック メディカル テクノロジーズ エルエルシー | Thoracic aortic aneurysm stent graft |
US20040015229A1 (en) | 2002-07-22 | 2004-01-22 | Syntheon, Llc | Vascular stent with radiopaque markers |
US20040034407A1 (en) | 2002-08-16 | 2004-02-19 | John Sherry | Covered stents with degradable barbs |
US8043365B2 (en) | 2002-08-19 | 2011-10-25 | Jeffery Thramann | Methods for placement of vascular stent grafts and vascular stents |
AU2003258337A1 (en) | 2002-08-23 | 2004-03-11 | Cook Incorporated | Asymmetric stent graft attachment |
US8518096B2 (en) | 2002-09-03 | 2013-08-27 | Lifeshield Sciences Llc | Elephant trunk thoracic endograft and delivery system |
US7485143B2 (en) | 2002-11-15 | 2009-02-03 | Abbott Cardiovascular Systems Inc. | Apparatuses and methods for heart valve repair |
CA2506423C (en) | 2002-12-04 | 2011-04-19 | Cook Incorporated | Method and device for treating aortic dissection |
US7371256B2 (en) | 2002-12-16 | 2008-05-13 | Poly-Med, Inc | Composite vascular constructs with selectively controlled properties |
EP1583487B1 (en) | 2003-01-14 | 2016-11-02 | The Cleveland Clinic Foundation | Branched vessel endoluminal device |
US8080026B2 (en) | 2003-01-21 | 2011-12-20 | Angioscore, Inc. | Apparatus and methods for treating hardened vascular lesions |
US7223266B2 (en) | 2003-02-04 | 2007-05-29 | Cardiodex Ltd. | Methods and apparatus for hemostasis following arterial catheterization |
US7115127B2 (en) | 2003-02-04 | 2006-10-03 | Cardiodex, Ltd. | Methods and apparatus for hemostasis following arterial catheterization |
US7025779B2 (en) | 2003-02-26 | 2006-04-11 | Scimed Life Systems, Inc. | Endoluminal device having enhanced affixation characteristics |
WO2004075789A2 (en) | 2003-02-26 | 2004-09-10 | Cook Incorporated | PROTHESIS ADAPTED FOR PLACEDd UNDER EXTERNAL IMAGING |
US7537606B2 (en) | 2003-04-03 | 2009-05-26 | Cook Incorporated | Branch stent graft deployment and method |
US7279003B2 (en) | 2003-04-24 | 2007-10-09 | Medtronic Vascular, Inc. | Stent graft tapered spring |
US7438721B2 (en) | 2003-04-25 | 2008-10-21 | Medtronic Vascular, Inc. | Universal modular stent graft assembly to accommodate flow to collateral branches |
US20040215320A1 (en) | 2003-04-25 | 2004-10-28 | James Machek | Integral stent graft |
ES2375566T3 (en) | 2003-04-28 | 2012-03-02 | Kips Bay Medical, Inc. | DISTENSIBLE VENOUS GRAFT. |
WO2004100836A1 (en) | 2003-05-12 | 2004-11-25 | Cook Incorporated | Stent graft |
CN1849102B (en) | 2003-07-08 | 2011-01-19 | 文托技术有限公司 | Implantable prosthetic devices particularly for transarterial delivery in the treatment of aortic stenosis, and methods of implanting such devices |
US7201772B2 (en) | 2003-07-08 | 2007-04-10 | Ventor Technologies, Ltd. | Fluid flow prosthetic device |
US20050033406A1 (en) | 2003-07-15 | 2005-02-10 | Barnhart William H. | Branch vessel stent and graft |
WO2005011535A2 (en) | 2003-07-31 | 2005-02-10 | Cook Incorporated | Prosthetic valve for implantation in a body vessel |
US8500792B2 (en) | 2003-09-03 | 2013-08-06 | Bolton Medical, Inc. | Dual capture device for stent graft delivery system and method for capturing a stent graft |
US7763063B2 (en) | 2003-09-03 | 2010-07-27 | Bolton Medical, Inc. | Self-aligning stent graft delivery system, kit, and method |
US7789891B2 (en) | 2003-09-23 | 2010-09-07 | Boston Scientific Scimed, Inc. | External activation of vaso-occlusive implants |
US7122052B2 (en) | 2003-09-29 | 2006-10-17 | Stout Medical Group Lp | Integral support stent graft assembly |
CA2540830C (en) | 2003-10-10 | 2012-08-14 | William A. Cook Australia Pty. Ltd. | Fenestrated stent grafts |
EP1673040B1 (en) | 2003-10-10 | 2008-07-30 | Cook Incorporated | Stretchable prosthesis fenestration |
WO2005034809A1 (en) | 2003-10-10 | 2005-04-21 | William A. Cook Australia Pty. Ltd. | Stent graft fenestration |
AU2004281704B2 (en) | 2003-10-10 | 2008-11-13 | Cardiaq Valve Technologies, Inc. | System and method for endoluminal grafting of bifurcated and branched vessels |
WO2005037138A2 (en) | 2003-10-14 | 2005-04-28 | Peacock James C Iii | Aneurysm treatment system and method |
US7998186B2 (en) | 2003-10-14 | 2011-08-16 | William A. Cook Australia Pty. Ltd. | Introducer for a side branch device |
US20070167898A1 (en) | 2003-10-30 | 2007-07-19 | Sunshine Heart Company Pty Ltd. | Methods and devices for tensioning a wrap around a blood vessel |
US7862499B2 (en) | 2003-10-30 | 2011-01-04 | Sunshine Heart Company Pty Ltd | Blood vessel wrap |
US7144421B2 (en) | 2003-11-06 | 2006-12-05 | Carpenter Judith T | Endovascular prosthesis, system and method |
US20050149166A1 (en) | 2003-11-08 | 2005-07-07 | Schaeffer Darin G. | Branch vessel prosthesis with anchoring device and method |
US20050131512A1 (en) | 2003-12-12 | 2005-06-16 | Design & Performance-Cyprus Ltd | Stent delivery catheter |
US20050177228A1 (en) | 2003-12-16 | 2005-08-11 | Solem Jan O. | Device for changing the shape of the mitral annulus |
WO2005058202A1 (en) | 2003-12-17 | 2005-06-30 | Cook Incorporated | Interconnected leg extensions for an endoluminal prostehsis |
US7803178B2 (en) | 2004-01-30 | 2010-09-28 | Trivascular, Inc. | Inflatable porous implants and methods for drug delivery |
US7637903B2 (en) | 2004-02-09 | 2009-12-29 | Cryocor, Inc. | Catheter articulation segment with alternating cuts |
US7294145B2 (en) | 2004-02-26 | 2007-11-13 | Boston Scientific Scimed, Inc. | Stent with differently coated inside and outside surfaces |
US20050203606A1 (en) | 2004-03-09 | 2005-09-15 | Vancamp Daniel H. | Stent system for preventing restenosis |
US7959634B2 (en) | 2004-03-29 | 2011-06-14 | Soteira Inc. | Orthopedic surgery access devices |
US7674284B2 (en) | 2004-03-31 | 2010-03-09 | Cook Incorporated | Endoluminal graft |
US8048140B2 (en) | 2004-03-31 | 2011-11-01 | Cook Medical Technologies Llc | Fenestrated intraluminal stent system |
US8034096B2 (en) | 2004-03-31 | 2011-10-11 | Cook Medical Technologies Llc | Stent-graft with graft to graft attachment |
US8715340B2 (en) | 2004-03-31 | 2014-05-06 | Merlin Md Pte Ltd. | Endovascular device with membrane |
US8623067B2 (en) | 2004-05-25 | 2014-01-07 | Covidien Lp | Methods and apparatus for luminal stenting |
US20050266042A1 (en) | 2004-05-27 | 2005-12-01 | Medtronic Vascular, Inc. | Methods and apparatus for treatment of aneurysmal tissue |
CA2573922C (en) | 2004-06-15 | 2012-12-11 | Cook Incorporated | Stent graft with internal tube |
CA2573889C (en) | 2004-06-16 | 2014-02-04 | Cook Incorporated | Thoracic deployment device and stent graft |
US20060015170A1 (en) | 2004-07-16 | 2006-01-19 | Jones Ryan A | Contrast coated stent and method of fabrication |
US20060030911A1 (en) | 2004-08-03 | 2006-02-09 | Medtronic Vascular, Inc. | Stabilization of aortic iliac neck diameter by use of radio frequency |
CA2577061C (en) | 2004-08-23 | 2014-02-18 | Eli Lilly And Company | Histamine h3 receptor agents, preparation and therapeutic uses |
AU2005282782B2 (en) | 2004-09-02 | 2010-07-29 | Cook Medical Technologies Llc | Modular prosthesis and method for branch vessels |
US7998187B2 (en) | 2004-09-21 | 2011-08-16 | William A. Cook Australia Pty. Ltd. | Stent graft connection arrangement |
US8226706B2 (en) | 2004-09-22 | 2012-07-24 | Cook Medical Technologies Llc | Stent graft with integral side arm |
US20060106406A1 (en) | 2004-09-27 | 2006-05-18 | Judah Weinberger | Methods and devices for extravascular intervention |
US20060069426A1 (en) | 2004-09-27 | 2006-03-30 | Weinberger Judah Z | Methods and devices for extravascular intervention |
US20060155366A1 (en) | 2005-01-10 | 2006-07-13 | Laduca Robert | Apparatus and method for deploying an implantable device within the body |
US20070150051A1 (en) | 2005-01-10 | 2007-06-28 | Duke Fiduciary, Llc | Vascular implants and methods of fabricating the same |
US8287583B2 (en) | 2005-01-10 | 2012-10-16 | Taheri Laduca Llc | Apparatus and method for deploying an implantable device within the body |
US7306623B2 (en) | 2005-01-13 | 2007-12-11 | Medtronic Vascular, Inc. | Branch vessel graft design and deployment method |
US7708773B2 (en) | 2005-01-21 | 2010-05-04 | Gen4 Llc | Modular stent graft employing bifurcated graft and leg locking stent elements |
US20060173530A1 (en) | 2005-01-28 | 2006-08-03 | Das Gladwin S | Flexible cells for interconnecting stent components |
US20060190072A1 (en) | 2005-01-28 | 2006-08-24 | Das Gladwin S | Flexible cells for axially interconnecting stent components |
US7544160B2 (en) | 2005-02-10 | 2009-06-09 | Yossi Gross | Extracardiac blood flow amplification device |
US7828837B2 (en) | 2005-02-17 | 2010-11-09 | Khoury Medical Devices, LLC. | Vascular endograft |
US20060190070A1 (en) | 2005-02-23 | 2006-08-24 | Dieck Martin S | Rail stent and methods of use |
US20060229709A1 (en) | 2005-03-30 | 2006-10-12 | Morris Liam G | Vascular graft |
WO2006113501A1 (en) | 2005-04-13 | 2006-10-26 | The Cleveland Clinic Foundation | Endoluminal prosthesis |
CN2817768Y (en) | 2005-05-24 | 2006-09-20 | 微创医疗器械(上海)有限公司 | Tectorium stand and host cage section thereof |
US20080109058A1 (en) | 2005-06-01 | 2008-05-08 | Cook Incorporated | Intraoperative Anastomosis Method |
US7846194B2 (en) | 2005-06-01 | 2010-12-07 | William A. Cook Australia Pty. Ltd. | Iliac artery stent graft |
US7637939B2 (en) | 2005-06-30 | 2009-12-29 | Boston Scientific Scimed, Inc. | Hybrid stent |
WO2007014088A2 (en) | 2005-07-25 | 2007-02-01 | Cook Incorporated | Intraluminal prosthesis and stent |
CA2615535C (en) | 2005-07-27 | 2013-12-24 | Cook Critical Care Incorporated | Stent/graft device and method for open surgical placement |
US7473272B2 (en) | 2005-08-17 | 2009-01-06 | Medtronic Vascular, Inc. | Recapturable stent with minimum crossing profile |
US8172895B2 (en) | 2005-08-18 | 2012-05-08 | Cook Medical Technologies Llc | Design and assembly of fenestrated stent grafts |
EP1933777B1 (en) | 2005-08-22 | 2017-06-14 | Incept, LLC | Flared stents and apparatus for using them |
CN100408003C (en) | 2005-08-24 | 2008-08-06 | 褚建国 | Pre-stressed rack of intrahepatic portacaval shunt |
US20070050011A1 (en) | 2005-08-26 | 2007-03-01 | Medlogics Device Corporation | Lumen-supporting stents and methods for creating lumen-supporting stents with various open/closed designs |
US20070061002A1 (en) | 2005-09-01 | 2007-03-15 | Cook Incorporated | Attachment of material to an implantable frame by cross-linking |
DE602006019753D1 (en) | 2005-09-01 | 2011-03-03 | Medtronic Vascular Inc | METHOD AND APPARATUS FOR THE TREATMENT OF ANEURYSMS OF A. THORACICA |
US7955374B2 (en) | 2005-09-02 | 2011-06-07 | Medtronic Vascular, Inc. | Modular branch vessel stent-graft assembly |
EP1933764A2 (en) | 2005-09-02 | 2008-06-25 | Medtronic Vascular, Inc. | Methods and apparatus for treatment of aneurysms adjacent to branch arteries |
WO2007030415A2 (en) | 2005-09-07 | 2007-03-15 | The Foundry, Inc. | Apparatus and method for disrupting subcutaneous structures |
EP1940316B1 (en) | 2005-09-26 | 2015-10-21 | AttenueX Technologies, Inc. | Pressure attenuation device |
US8562666B2 (en) | 2005-09-28 | 2013-10-22 | Nitinol Development Corporation | Intraluminal medical device with nested interlocking segments |
US7670369B2 (en) | 2005-10-13 | 2010-03-02 | Cook Incorporated | Endoluminal prosthesis |
US8343204B2 (en) | 2005-10-31 | 2013-01-01 | Cook Medical Technologies Llc | Composite stent graft |
US20070106368A1 (en) | 2005-11-07 | 2007-05-10 | Carlos Vonderwalde | Graft-stent assembly |
US20080275540A1 (en) | 2005-11-09 | 2008-11-06 | Ning Wen | Artificial Heart Valve Stent and Weaving Method Thereof |
US8251963B2 (en) | 2005-12-08 | 2012-08-28 | Boston Scientific Scimed, Inc. | Flexible needle |
US7540881B2 (en) | 2005-12-22 | 2009-06-02 | Boston Scientific Scimed, Inc. | Bifurcation stent pattern |
CA2636794C (en) | 2006-01-18 | 2014-08-12 | William A. Cook Australia Pty. Ltd. | Endoluminal delivery device |
WO2007084981A2 (en) | 2006-01-19 | 2007-07-26 | The Regents Of The University Of Michigan | System and method for photoacoustic imaging and monitoring of laser therapy |
US20070179598A1 (en) | 2006-02-01 | 2007-08-02 | Duerig Thomas W | Method and system of attaching vessels to grafts |
US7914572B2 (en) | 2006-02-13 | 2011-03-29 | William A. Cook Australia Pty. Ltd. | Side branch stent graft construction |
CA2634604C (en) | 2006-02-17 | 2013-09-10 | Invatec S.R.L. | Endoluminal prosthesis |
WO2007098234A2 (en) | 2006-02-21 | 2007-08-30 | Med Institute, Inc. | Graft material for prostheses |
US8801777B2 (en) | 2007-04-18 | 2014-08-12 | David Elmaleh | Intravascular device with netting system |
US9155641B2 (en) | 2006-03-09 | 2015-10-13 | Cook Medical Technologies Llc | Expandable stent grafts |
US7955380B2 (en) | 2006-03-17 | 2011-06-07 | Medtronic Vascular, Inc. | Prosthesis fixation apparatus and methods |
US20070219610A1 (en) | 2006-03-20 | 2007-09-20 | Israel Henry M | Stent with flap |
US20070239256A1 (en) | 2006-03-22 | 2007-10-11 | Jan Weber | Medical devices having electrical circuits with multilayer regions |
CN101045022B (en) | 2006-03-30 | 2010-08-25 | 温宁 | Self-expanding stent axial wire-drawing tensioning mechanism |
US9757260B2 (en) | 2006-03-30 | 2017-09-12 | Medtronic Vascular, Inc. | Prosthesis with guide lumen |
US8066760B2 (en) | 2006-04-18 | 2011-11-29 | Medtronic Vascular, Inc. | Stent with movable crown |
US20070244547A1 (en) | 2006-04-18 | 2007-10-18 | Medtronic Vascular, Inc., A Delaware Corporation | Device and Method for Controlling the Positioning of a Stent Graft Fenestration |
US7678141B2 (en) | 2006-04-18 | 2010-03-16 | Medtronic Vascular, Inc. | Stent graft having a flexible, articulable, and axially compressible branch graft |
US9707113B2 (en) | 2006-04-19 | 2017-07-18 | Cook Medical Technologies Llc | Twin bifurcated stent graft |
EP1849440A1 (en) | 2006-04-28 | 2007-10-31 | Younes Boudjemline | Vascular stents with varying diameter |
DE102006024242A1 (en) | 2006-05-23 | 2007-11-29 | Siemens Ag | X-ray system`s deviation detecting method for e.g. medical examination device, involves recording current image of actual position of measuring object by x-ray system, and comparing current image with provided reference image of object |
JP2009542421A (en) | 2006-07-07 | 2009-12-03 | アンソニー・ヌネズ | Method and system for monitoring an endoprosthesis implant |
US8632581B2 (en) | 2006-07-10 | 2014-01-21 | Cook Medical Technologies Llc | Conformable end sealing stent |
WO2008008291A2 (en) | 2006-07-13 | 2008-01-17 | Icon Medical Corp. | Stent |
US8202310B2 (en) | 2006-07-14 | 2012-06-19 | Cordis Corporation | AAA repair device with aneurysm sac access port |
US7708704B2 (en) | 2006-07-31 | 2010-05-04 | Codman & Shurtleff, Pc | Interventional medical device component having an interrupted spiral section and method of making the same |
US8080053B2 (en) | 2006-08-01 | 2011-12-20 | Merit Medical Systems, Inc. | Stent, stent removal and repositioning device, and associated methods |
WO2008031033A2 (en) | 2006-09-07 | 2008-03-13 | Spence Paul A | Ultrasonic implant, systems and methods related to diverting material in blood flow away from the head |
US8348995B2 (en) | 2006-09-19 | 2013-01-08 | Medtronic Ventor Technologies, Ltd. | Axial-force fixation member for valve |
US20080082159A1 (en) | 2006-09-28 | 2008-04-03 | Cook Incorporated | Stent for Endovascular Procedures |
GB0620495D0 (en) | 2006-10-16 | 2006-11-22 | Anson Medical Ltd | Apparatus and method for positioning a stent graft |
EP2083901B1 (en) | 2006-10-16 | 2017-12-27 | Medtronic Ventor Technologies Ltd. | Transapical delivery system with ventriculo-arterial overflow bypass |
US20080097578A1 (en) | 2006-10-20 | 2008-04-24 | Medtronic Vascular, Inc. | Extender Cuff for Branch Vessel |
EP2079397B1 (en) | 2006-10-24 | 2010-03-24 | Cook Incorporated | Stent member |
WO2008053469A2 (en) | 2006-10-29 | 2008-05-08 | Alon Shalev | An extra-vascular wrapping for treating aneurysmatic aorta and methods thereof |
US20080114444A1 (en) | 2006-11-09 | 2008-05-15 | Chun Ho Yu | Modular stent graft and delivery system |
US20090099648A1 (en) | 2006-11-09 | 2009-04-16 | Chun Ho Yu | Modular stent graft and delivery system |
JP2010510021A (en) | 2006-11-21 | 2010-04-02 | ザ メディカル リサーチ, インフラストラクチャー, アンド ヘルス サーヴィシーズ ファンド オブ ザ テル アヴィヴ メディカル センター | Bifurcated stent graft for aortic aneurysm repair |
AU2007325652B2 (en) | 2006-11-30 | 2012-07-12 | Cook Medical Technologies Llc | Implant release mechanism |
US20080147173A1 (en) | 2006-12-18 | 2008-06-19 | Medtronic Vascular, Inc. | Prosthesis Deployment Apparatus and Methods |
US8216298B2 (en) | 2007-01-05 | 2012-07-10 | Medtronic Vascular, Inc. | Branch vessel graft method and delivery system |
WO2008089282A2 (en) | 2007-01-16 | 2008-07-24 | Silver James H | Sensors for detecting subtances indicative of stroke, ischemia, infection or inflammation |
US7704275B2 (en) | 2007-01-26 | 2010-04-27 | Reva Medical, Inc. | Circumferentially nested expandable device |
EP2142142B1 (en) | 2007-03-05 | 2017-02-08 | Endospan Ltd | Multi-component expandable supportive bifurcated endoluminal grafts and methods for using same |
US20080228256A1 (en) | 2007-03-13 | 2008-09-18 | Medtronic Vascular, Inc. | Braided Flange Branch Graft for Branch Vessel |
US8715336B2 (en) | 2007-04-19 | 2014-05-06 | Medtronic Vascular, Inc. | Methods and apparatus for treatment of aneurysms adjacent to branch arteries |
US8273115B2 (en) | 2007-04-24 | 2012-09-25 | W. L. Gore & Associates, Inc. | Side branched endoluminal prostheses and methods of delivery thereof |
US20080269789A1 (en) | 2007-04-27 | 2008-10-30 | Uri Eli | Implantable device with miniature rotating portion for the treatment of atherosclerosis, especially vulnerable plaques |
WO2008140796A1 (en) | 2007-05-11 | 2008-11-20 | William A. Cook Australia Pty. Ltd. | Stent grafts for the thoracic aorta |
DE102007025921A1 (en) | 2007-06-02 | 2008-12-04 | Biotronik Vi Patent Ag | Medical implant, in particular stent |
US20110022149A1 (en) | 2007-06-04 | 2011-01-27 | Cox Brian J | Methods and devices for treatment of vascular defects |
CN201058061Y (en) | 2007-06-12 | 2008-05-14 | 中国人民解放军第二军医大学 | Implant in vascellum cavity of aortic arch with branch |
US20080319528A1 (en) | 2007-06-25 | 2008-12-25 | Abbott Laboratories | Modular endoprosthesis with flexible interconnectors between modules |
US8092510B2 (en) | 2007-07-25 | 2012-01-10 | Cook Medical Technologies Llc | Retention wire for self-expanding stent |
US20090030502A1 (en) | 2007-07-26 | 2009-01-29 | Jichao Sun | Socket For Fenestrated Tubular Prosthesis |
AU2008284279B2 (en) | 2007-08-08 | 2014-03-20 | Cleveland Clinic Foundation | Branched stent graft system |
US20090062846A1 (en) | 2007-08-31 | 2009-03-05 | Ken Christopher G M | Closure medical device |
US7959669B2 (en) | 2007-09-12 | 2011-06-14 | Boston Scientific Scimed, Inc. | Bifurcated stent with open ended side branch support |
US8066755B2 (en) | 2007-09-26 | 2011-11-29 | Trivascular, Inc. | System and method of pivoted stent deployment |
US20090082841A1 (en) | 2007-09-26 | 2009-03-26 | Boston Scientific Corporation | Apparatus for securing stent barbs |
US10159557B2 (en) | 2007-10-04 | 2018-12-25 | Trivascular, Inc. | Modular vascular graft for low profile percutaneous delivery |
US9414842B2 (en) | 2007-10-12 | 2016-08-16 | St. Jude Medical, Cardiology Division, Inc. | Multi-component vascular device |
EP3025685B1 (en) | 2007-10-19 | 2019-07-17 | CeloNova Biosciences, Inc. | Implantable and lumen-supporting stents |
US20090112233A1 (en) | 2007-10-30 | 2009-04-30 | Medtronic Vascular, Inc. | Prosthesis Fixation Apparatus and Methods |
US20090125096A1 (en) | 2007-11-12 | 2009-05-14 | Medtronic Vascular, Inc. | Stent Graft With Pins |
US8540758B2 (en) | 2007-11-27 | 2013-09-24 | Vimal I. Nanavati | Bifurcation stent and delivery system |
US8551128B2 (en) | 2007-12-06 | 2013-10-08 | Cardiovascular Systems, Inc. | Rotational atherectomy device with pre-curved drive shaft |
EP2231066B1 (en) | 2007-12-15 | 2017-04-26 | Endospan Ltd. | Extra-vascular wrapping for treating aneurysmatic aorta in conjunction with endovascular stent-graft |
US20090164001A1 (en) | 2007-12-21 | 2009-06-25 | Biggs David P | Socket For Fenestrated Tubular Prosthesis |
US9180030B2 (en) | 2007-12-26 | 2015-11-10 | Cook Medical Technologies Llc | Low profile non-symmetrical stent |
US8574284B2 (en) | 2007-12-26 | 2013-11-05 | Cook Medical Technologies Llc | Low profile non-symmetrical bare alignment stents with graft |
JP2011507657A (en) | 2007-12-26 | 2011-03-10 | メッド・インスティテュート・インコーポレイテッド | Stent and method for making a stent |
US8992593B2 (en) | 2007-12-26 | 2015-03-31 | Cook Medical Technologies Llc | Apparatus and methods for deployment of a modular stent-graft system |
US8157852B2 (en) | 2008-01-24 | 2012-04-17 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
EP2242454A1 (en) | 2008-02-13 | 2010-10-27 | Nellix, Inc. | Graft endoframe having axially variable characteristics |
WO2009105699A1 (en) | 2008-02-22 | 2009-08-27 | Endologix, Inc. | Design and method of placement of a graft or graft system |
GB0803302D0 (en) | 2008-02-22 | 2008-04-02 | Barts & London Nhs Trust | Blood vessel prosthesis and delivery apparatus |
DE102008012113A1 (en) | 2008-03-02 | 2009-09-03 | Transcatheter Technologies Gmbh | Implant e.g. heart-valve-carrying stent, for e.g. arresting blood vessel, has fiber by which section of implant is reducible according to increasing of implant at extended diameter by unfolding or expansion of diameter with expansion unit |
US8197475B2 (en) | 2008-03-17 | 2012-06-12 | Medtronic Vascular, Inc. | Method and structure for ameliorating side-effects of performing in situ fenestration using a plasma RF catheter |
US8313525B2 (en) | 2008-03-18 | 2012-11-20 | Medtronic Ventor Technologies, Ltd. | Valve suturing and implantation procedures |
US8696689B2 (en) | 2008-03-18 | 2014-04-15 | Medtronic Ventor Technologies Ltd. | Medical suturing device and method for use thereof |
US8100960B2 (en) | 2008-03-20 | 2012-01-24 | Medtronic Vascular, Inc. | Bloused stent-graft and fenestration method |
IL190438A0 (en) | 2008-03-25 | 2008-12-29 | K M B Y Ltd | A method of setting a drill for drilling a hole in a bone coaxial to the hole in the nail and aiming device for realizing this method |
US7815673B2 (en) | 2008-04-01 | 2010-10-19 | Medtronic Vascular, Inc. | Double-walled stent system |
US7806923B2 (en) | 2008-04-11 | 2010-10-05 | Medtronic Vascular, Inc. | Side branch stent having a proximal split ring |
US20090259290A1 (en) | 2008-04-14 | 2009-10-15 | Medtronic Vascular, Inc. | Fenestration Segment Stent-Graft and Fenestration Method |
US7655037B2 (en) | 2008-04-17 | 2010-02-02 | Cordis Corporation | Combination barb restraint and stent attachment deployment mechanism |
US20090287145A1 (en) | 2008-05-15 | 2009-11-19 | Altura Interventional, Inc. | Devices and methods for treatment of abdominal aortic aneurysms |
CN101283937B (en) | 2008-05-21 | 2010-08-18 | 微创医疗器械(上海)有限公司 | Overlay film frame with an opening and bonding method of the overlay film frame |
US9101456B2 (en) | 2008-08-26 | 2015-08-11 | Cook Medical Technologies Llc | Thoracic aorta stent graft with access region |
US8911488B2 (en) | 2008-08-26 | 2014-12-16 | The Cleveland Clinic Foundation | Thoracic introducer |
AU2009286139B2 (en) | 2008-08-27 | 2013-04-04 | Cleveland Clinic Foundation | Stent graft fixation coupling |
EP4018967A1 (en) | 2008-09-15 | 2022-06-29 | Medtronic Ventor Technologies Ltd | Prosthetic heart valve having identifiers for aiding in radiographic positioning |
US9237960B2 (en) | 2008-10-10 | 2016-01-19 | Cook Medical Technologies Llc | Apparatus for curving an implantable medical device in a lumen |
US8137398B2 (en) | 2008-10-13 | 2012-03-20 | Medtronic Ventor Technologies Ltd | Prosthetic valve having tapered tip when compressed for delivery |
GB2464977B (en) | 2008-10-31 | 2010-11-03 | William Cook Europe As | Introducer for deploying a stent graft in a curved lumen and stent graft therefor |
CA2750228C (en) | 2009-02-09 | 2016-06-21 | Evysio Medical Devices Ulc | Stent |
US8052741B2 (en) | 2009-03-23 | 2011-11-08 | Medtronic Vascular, Inc. | Branch vessel prosthesis with a roll-up sealing assembly |
GB2469297B (en) | 2009-04-07 | 2011-05-25 | Cook Inc | Introducer assembly and implantable medical device |
US8506622B2 (en) | 2009-04-17 | 2013-08-13 | Medtronic Vascular, Inc. | Mobile external coupling for branch vessel connection |
US8540764B2 (en) | 2009-04-17 | 2013-09-24 | Medtronic Vascular, Inc. | Mobile external coupling for branch vessel connection |
US8876877B2 (en) | 2009-04-23 | 2014-11-04 | Medtronic Vascular, Inc. | Centering for a TAA |
US8876883B2 (en) | 2009-04-24 | 2014-11-04 | Medtronic Vascular, Inc. | Self-flaring active fixation element for a stent graft |
GB2470083A (en) | 2009-05-08 | 2010-11-10 | Nat Univ Ireland | Closed loop stent |
EP2429453B1 (en) | 2009-05-14 | 2021-01-27 | Orbusneich Medical Pte. Ltd | Self-expanding stent with polygon transition zone |
DE102009042150A1 (en) | 2009-05-29 | 2010-12-02 | Aesculap Ag | Surgical instrument to be used in combination with a trocar or something similar has proximal and distal ends as well as an end section with an articulated zone |
US20100318171A1 (en) | 2009-06-15 | 2010-12-16 | Boston Scientific Scimed, Inc. | Multiple Stent Delivery System |
CA2766347C (en) | 2009-06-23 | 2017-04-25 | Endospan Ltd. | Vascular prostheses for treating aneurysms |
US8409269B2 (en) | 2009-12-21 | 2013-04-02 | Covidien Lp | Procedures for vascular occlusion |
CA2767596C (en) | 2009-07-09 | 2015-11-24 | Endospan Ltd. | Apparatus for closure of a lumen and methods of using the same |
CN102470031B (en) | 2009-07-14 | 2015-11-25 | 恩多斯潘有限公司 | For the Ce Kou engaged and sealing mechanism of pipe Endovascular stent-graft |
US8118856B2 (en) | 2009-07-27 | 2012-02-21 | Endologix, Inc. | Stent graft |
US20110093002A1 (en) | 2009-10-20 | 2011-04-21 | Wilson-Cook Medical Inc. | Stent-within-stent arrangements |
CA2780048A1 (en) | 2009-11-04 | 2011-05-12 | Endospan Ltd. | Treatment of a main body lumen in the vicinity of a branching body lumen |
WO2011064782A2 (en) | 2009-11-30 | 2011-06-03 | Endospan Ltd. | Multi-component stent-graft system for implantation in a blood vessel with multiple branches |
US20120330399A1 (en) | 2009-12-02 | 2012-12-27 | Endospan Ltd. | Endovascular fenestrated stent-grafting |
WO2011070576A1 (en) | 2009-12-08 | 2011-06-16 | Endospan Ltd. | Endovascular stent-graft system with fenestrated and crossing stent-grafts |
US8956397B2 (en) | 2009-12-31 | 2015-02-17 | Endospan Ltd. | Endovascular flow direction indicator |
US9468517B2 (en) | 2010-02-08 | 2016-10-18 | Endospan Ltd. | Thermal energy application for prevention and management of endoleaks in stent-grafts |
EP2533721B1 (en) | 2010-02-09 | 2016-03-30 | Cook Medical Technologies LLC | Thoracic aorta stent graft |
US20110218609A1 (en) | 2010-02-10 | 2011-09-08 | Trivascular, Inc. | Fill tube manifold and delivery methods for endovascular graft |
US10433956B2 (en) | 2010-02-24 | 2019-10-08 | Medtronic Ventor Technologies Ltd. | Mitral prosthesis and methods for implantation |
US9414914B2 (en) | 2010-02-24 | 2016-08-16 | Medtronic Ventor Technologies Ltd. | Catheter assembly with valve crimping accessories |
US20110208289A1 (en) | 2010-02-25 | 2011-08-25 | Endospan Ltd. | Flexible Stent-Grafts |
US20110218617A1 (en) | 2010-03-02 | 2011-09-08 | Endologix, Inc. | Endoluminal vascular prosthesis |
AU2010201067B1 (en) * | 2010-03-19 | 2011-06-09 | Cook Incorporated | Thoracic stent graft |
US8764811B2 (en) | 2010-04-20 | 2014-07-01 | Medtronic Vascular, Inc. | Controlled tip release stent graft delivery system and method |
US20110257725A1 (en) | 2010-04-20 | 2011-10-20 | Medtronic Vascular, Inc. | Blood Inflating Prosthesis |
EP3461459B1 (en) | 2010-04-23 | 2022-08-17 | Biotronik Ag | Implant and method for manufacturing the same |
AU2010201676B1 (en) | 2010-04-23 | 2010-07-22 | Cook Medical Technologies Llc | Curve forming stent graft |
WO2011139521A2 (en) | 2010-04-26 | 2011-11-10 | Paul Andre Heltai | Sleeve and tubing device for restricting and constricting aneurysms and a system and method for using such a device |
US8333800B2 (en) | 2010-04-29 | 2012-12-18 | Medtronic Vascular, Inc. | Mobile external coupling with internal sealing cuff for branch vessel connection |
US8337546B2 (en) | 2010-04-29 | 2012-12-25 | Medtronic Vascular, Inc. | Mobile external coupling for branch vessel connection |
US8292951B2 (en) | 2010-04-29 | 2012-10-23 | Medtronic Vascular, Inc. | Tethered pop up branch structure stent graft and method |
US20130204311A1 (en) | 2010-05-12 | 2013-08-08 | Helical Solutions, Inc. | Implants and methods for treating cardiac arrhythmias |
US9561102B2 (en) | 2010-06-02 | 2017-02-07 | Medtronic, Inc. | Transcatheter delivery system and method with controlled expansion and contraction of prosthetic heart valve |
US8870939B2 (en) | 2010-08-21 | 2014-10-28 | Cook Medical Technologies Llc | Prosthesis having pivoting fenestration |
WO2012039748A2 (en) | 2010-09-20 | 2012-03-29 | St. Jude Medical, Cardiology Division, Inc. | Delivery device having a curved shaft and a straightening member for transcatheter aortic valve implantation |
WO2012078678A1 (en) | 2010-12-06 | 2012-06-14 | Tyco Healthcare Group Lp | Vascular remodeling device |
US9717420B2 (en) | 2010-12-20 | 2017-08-01 | Empire Technology Development Llc | Implantable apparatus for facilitating imaging-based diagnoses |
US9198787B2 (en) | 2010-12-31 | 2015-12-01 | Cook Medical Technologies Llc | Conformable prosthesis delivery system and method for deployment thereof |
WO2012099731A1 (en) | 2011-01-19 | 2012-07-26 | Cook Medical Technologies Llc | Rotary and linear handle mechanism for constrained stent delivery system |
CA2826022A1 (en) | 2011-02-03 | 2012-08-09 | Endospan Ltd. | Implantable medical devices constructed of shape memory material |
US9839542B2 (en) | 2011-04-19 | 2017-12-12 | Medtronic Ardian Luxembourg S.A.R.L. | Mobile external coupling for branch vessel connection |
EP2579811B1 (en) | 2011-06-21 | 2016-03-16 | Endospan Ltd | Endovascular system with circumferentially-overlapping stent-grafts |
US9254209B2 (en) | 2011-07-07 | 2016-02-09 | Endospan Ltd. | Stent fixation with reduced plastic deformation |
US9839510B2 (en) | 2011-08-28 | 2017-12-12 | Endospan Ltd. | Stent-grafts with post-deployment variable radial displacement |
EP2750635A4 (en) | 2011-09-01 | 2015-05-20 | Endospan Ltd | Cross-reference to related applications |
WO2013065040A1 (en) | 2011-10-30 | 2013-05-10 | Endospan Ltd. | Triple-collar stent-graft |
US8771341B2 (en) | 2011-11-04 | 2014-07-08 | Reverse Medical Corporation | Protuberant aneurysm bridging device and method of use |
US8728148B2 (en) | 2011-11-09 | 2014-05-20 | Cook Medical Technologies Llc | Diameter reducing tie arrangement for endoluminal prosthesis |
WO2013084235A2 (en) | 2011-12-04 | 2013-06-13 | Endospan Ltd. | Branched stent-graft system |
US9278018B2 (en) | 2011-12-14 | 2016-03-08 | Cook Medical Technologies Llc | Circumferential trigger wire for deploying an endoluminal prosthesis |
US9555217B2 (en) | 2012-01-31 | 2017-01-31 | Terumo Kabushiki Kaisha | Catheter |
US8968384B2 (en) | 2012-04-27 | 2015-03-03 | Medtronic Vascular, Inc. | Circumferentially constraining sutures for a stent-graft |
US9770350B2 (en) | 2012-05-15 | 2017-09-26 | Endospan Ltd. | Stent-graft with fixation elements that are radially confined for delivery |
US9066828B2 (en) | 2012-06-15 | 2015-06-30 | Trivascular, Inc. | Endovascular delivery system with flexible and torqueable hypotube |
WO2014020609A1 (en) | 2012-08-01 | 2014-02-06 | Endospan Ltd. | Stent-grafts configured for post-implantation expansion |
JP6399558B2 (en) | 2012-10-29 | 2018-10-03 | スクリップス ヘルス | Method for producing pluripotent stem cells from chondrocytes |
AU2012258394B1 (en) | 2012-11-27 | 2013-03-07 | Cook Medical Technologies Llc | Stent graft having a closeable fenestration |
US10350096B2 (en) | 2012-12-26 | 2019-07-16 | Cook Medical Technologies Llc | Expandable stent-graft system having diameter reducing connectors |
CN105007860B (en) | 2013-01-08 | 2017-05-10 | 恩多斯潘有限公司 | Minimization of stent-graft migration during implantation |
CN105208969B (en) | 2013-03-11 | 2017-10-20 | 恩多斯潘有限公司 | Multicompartment stent graft system for dissection of aorta |
CN105407836B (en) | 2013-05-23 | 2018-10-02 | 恩都思潘有限公司 | Aorta ascendens holder implanting body system |
AU2013206712B1 (en) | 2013-07-03 | 2013-11-28 | Cook Medical Technologies Llc | Endovascular graft having a cannulation pocket |
WO2015075708A1 (en) | 2013-11-19 | 2015-05-28 | Endospan Ltd. | Stent system with radial-expansion locking |
GB2522034B (en) | 2014-01-10 | 2015-12-02 | Cook Medical Technologies Llc | Implantable medical device with flexible connection |
GB2527550B (en) | 2014-06-25 | 2016-09-21 | Cook Medical Technologies Llc | Implantable medical device with lumen constriction |
US10314699B2 (en) | 2015-03-13 | 2019-06-11 | St. Jude Medical, Cardiology Division, Inc. | Recapturable valve-graft combination and related methods |
-
2014
- 2014-02-18 CN CN201480026943.XA patent/CN105208969B/en active Active
- 2014-02-18 US US14/772,016 patent/US9668892B2/en active Active
- 2014-02-18 WO PCT/IL2014/050174 patent/WO2014141232A1/en active Application Filing
- 2014-02-18 EP EP14762507.3A patent/EP2967830B1/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070067014A1 (en) * | 2005-09-22 | 2007-03-22 | Microport Medical Co., Ltd. | Method for aortic graft installation |
US20070168018A1 (en) * | 2006-01-13 | 2007-07-19 | Aga Medical Corporation | Intravascular deliverable stent for reinforcement of abdominal aortic aneurysm |
US20090319022A1 (en) * | 2006-08-18 | 2009-12-24 | William Cook Australia Pty. Ltd. | Stent graft |
US20080114446A1 (en) * | 2006-11-07 | 2008-05-15 | Wiiliam A. Cook Australia Pty Ltd. | Fenestration for stent graft arrangements and stent graft including the same |
US20090157014A1 (en) * | 2007-12-17 | 2009-06-18 | William Cook Europe Aps | Device for enabling repeated access to a vessel |
US20100161025A1 (en) * | 2008-08-29 | 2010-06-24 | Cook, Incorporated | Variable weave graft with metal strand reinforcement for in situ fenestration |
US20110319983A1 (en) * | 2009-03-18 | 2011-12-29 | Microport Medical (Shanghai) Co., Ltd. | Branched stent graft |
US20100249899A1 (en) * | 2009-03-26 | 2010-09-30 | Cook Incorporated | Pararenal stent graft |
Non-Patent Citations (1)
Title |
---|
See also references of EP2967830A4 * |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11090148B2 (en) | 2009-06-23 | 2021-08-17 | Endospan Ltd. | Vascular prosthesis for treating aneurysms |
US9918825B2 (en) | 2009-06-23 | 2018-03-20 | Endospan Ltd. | Vascular prosthesis for treating aneurysms |
US9839510B2 (en) | 2011-08-28 | 2017-12-12 | Endospan Ltd. | Stent-grafts with post-deployment variable radial displacement |
US9427339B2 (en) | 2011-10-30 | 2016-08-30 | Endospan Ltd. | Triple-collar stent-graft |
US9597204B2 (en) | 2011-12-04 | 2017-03-21 | Endospan Ltd. | Branched stent-graft system |
US9770350B2 (en) | 2012-05-15 | 2017-09-26 | Endospan Ltd. | Stent-graft with fixation elements that are radially confined for delivery |
US9993360B2 (en) | 2013-01-08 | 2018-06-12 | Endospan Ltd. | Minimization of stent-graft migration during implantation |
US9668892B2 (en) | 2013-03-11 | 2017-06-06 | Endospan Ltd. | Multi-component stent-graft system for aortic dissections |
US10603197B2 (en) | 2013-11-19 | 2020-03-31 | Endospan Ltd. | Stent system with radial-expansion locking |
US11419742B2 (en) | 2014-12-18 | 2022-08-23 | Endospan Ltd. | Endovascular stent-graft with fatigue-resistant lateral tube |
WO2016098113A1 (en) | 2014-12-18 | 2016-06-23 | Endospan Ltd. | Endovascular stent-graft with fatigue-resistant lateral tube |
US10485684B2 (en) | 2014-12-18 | 2019-11-26 | Endospan Ltd. | Endovascular stent-graft with fatigue-resistant lateral tube |
EP3632376A1 (en) | 2015-01-12 | 2020-04-08 | Endospan Ltd. | Self-curving stent graft |
WO2016113731A1 (en) | 2015-01-12 | 2016-07-21 | Endospan Ltd. | Self-curving stent-graft |
WO2016122862A1 (en) * | 2015-01-28 | 2016-08-04 | Aortic Innovations, Llc | Modular endo-aortic device and method of using the same |
US10478320B2 (en) | 2015-01-28 | 2019-11-19 | Aortic Innovations, Llc | Modular endo-aortic device for endovascular aortic repair of dissections and being configured for adaptability of organs of various anatomical characteristics and method of using the same |
CN107427376A (en) * | 2015-01-28 | 2017-12-01 | 俄奥梯科创新有限公司 | Sustainer device and its application method in modularization |
CN107427376B (en) * | 2015-01-28 | 2020-09-01 | 俄奥梯科创新有限公司 | Modular internal aortic device and method of use |
WO2016125137A1 (en) | 2015-02-02 | 2016-08-11 | Endospan Ltd. | Self-orienting endovascular delivery system |
US11389313B2 (en) | 2015-02-02 | 2022-07-19 | Endospan Ltd. | Self-orienting endovascular delivery system |
US11813185B2 (en) | 2015-02-02 | 2023-11-14 | Endospan Ltd. | Self-orienting endovascular delivery system |
US11259911B2 (en) | 2015-06-18 | 2022-03-01 | Ascyrus Medical, Llc | Branched aortic graft and method of using the same |
EP3310305A4 (en) * | 2015-06-18 | 2019-02-20 | Ascyrus Medical, LLC | Branched aortic graft and method of using the same |
WO2017081679A1 (en) | 2015-11-12 | 2017-05-18 | Endospan Ltd. | Stent-grafts systems with skirt |
WO2018173056A1 (en) | 2017-03-21 | 2018-09-27 | Endospan Ltd. | Stent-grafts for sealing around external disturbances |
WO2020074598A1 (en) * | 2018-10-12 | 2020-04-16 | Canaud Ludovic | Stent-type aortic implant and assembly formed by two such implants |
CN112804964A (en) * | 2018-10-12 | 2021-05-14 | 吕多维克·卡诺 | Aortic implant of the stent type and assembly formed by two such implants |
Also Published As
Publication number | Publication date |
---|---|
EP2967830B1 (en) | 2017-11-01 |
US20160030209A1 (en) | 2016-02-04 |
CN105208969B (en) | 2017-10-20 |
US9668892B2 (en) | 2017-06-06 |
EP2967830A4 (en) | 2016-09-28 |
EP2967830A1 (en) | 2016-01-20 |
CN105208969A (en) | 2015-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2967830B1 (en) | Multi-component stent-graft system for aortic dissections | |
US20220346987A1 (en) | Endovascular stent-graft with fatigue-resistant lateral tube | |
EP2999429B1 (en) | Ascending aorta stent-graft system | |
EP1507490B1 (en) | Stent with segmented graft | |
EP2579811B1 (en) | Endovascular system with circumferentially-overlapping stent-grafts | |
US9597204B2 (en) | Branched stent-graft system | |
CA2783554C (en) | Endovascular stent-graft system with fenestrated and crossing stent-grafts | |
US6102940A (en) | Device forming an endoluminal intracorporeal endoprosthesis, in particular for the abdominal aorta | |
US8945203B2 (en) | Multi-component stent-graft system for implantation in a blood vessel with multiple branches | |
EP1441782B1 (en) | Interlocking endoluminal stent-graft | |
WO2017081679A1 (en) | Stent-grafts systems with skirt | |
GB2517689A (en) | Stent-Graft | |
WO2024057320A1 (en) | Double-branching ascending aortic stent-graft systems |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14762507 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14772016 Country of ref document: US |
|
REEP | Request for entry into the european phase |
Ref document number: 2014762507 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2014762507 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |